Document:

License Agreement

 Exhibit 10.28 
 LICENSE AGREEMENT 
 Between 

Oragenics Inc 
 and 
 The Texas A& M University System 

This agreement (“Agreement”) is made between Oragenics, Inc., a corporation with principal offices in Tampa, Florida,
(“ORAGENICS”) and The Texas A&M University System, an agency of the State of Texas, with principal offices in College Station, Texas, (“SYSTEM”), collectively referred to as “Parties” and individually as
“Party.” 
 W I T N E S S E T H : 

WHEREAS, SYSTEM and ORAGENICS are the joint owners of a certain intellectual property related to “new antibiotic variants of mutacin
1140”, and 
 WHEREAS, SYSTEM desires that such intellectual property be commercialized for the public benefit and welfare;
and 
 WHEREAS, ORAGENICS has represented that it has certain marketing, technical and financial capabilities, and that it will
undertake a thorough and diligent program of development and commercialization of SYSTEM’s intellectual property for public benefit; and 
 WHEREAS, SYSTEM is willing to grant to ORAGENICS, and ORAGENICS is willing to accept, a license to use SYSTEM’s intellectual property, upon the terms and conditions below. 

NOW THEREFORE, in consideration of the mutual covenants and premises contained in this Agreement, the receipt and sufficiency of which is
acknowledged, the Parties agree as follows: 
 ARTICLE I — DEFINITIONS 

 

	1.01	“LICENSED TECHNOLOGY” means the Parties’ rights in their jointly owned proprietary technology relating to SYSTEM Disclosure of Invention Number TAMUS
3447 entitled “Site Directed Mutagenesis of Mutacin 1140 and Its Effect on Bactericidal Activity,” and for the purposes of this Agreement, MATERIALS. 

 

	1.02	“PATENT RIGHTS” means the Parties’ rights in each: 

  

	 	(a)	United States patent application filed for protection of LICENSED TECHNOLOGY; 

 

	 	(b)	Each divisional, continuation, or continuation-in-part application of the patent applications described in (a) above to the extent the claims are directed to
subject matter specifically described in such patent applications; 

  

	 	(c)	Equivalent patent application in each country other than the United States which claims priority under the applications described in (a) or (b) above; and

  

	 	(d)	Patent issuing from the applications described above and each extension or reissue of such patents. 

	1.03	“LICENSED PRODUCT’ or “LICENSED PRODUCTS” means any product, process, or composition of matter that is within the scope of any Valid Claim of PATENT
RIGHTS. Valid Claim means and includes a claim of a patent application or an unexpired patent or a patent whose expiration date has been extended by law, so long as the claim has not been held invalid and/or unenforceable in an unappealable decision
of a court or other authority of competent jurisdiction. 

  

	1.04	“MATERIAL” or “MATERIALS” means the Streptococcus mutans JH1140 mutant strains listed in Exhibit A. For the purposes of this Agreement,
MATERIALS shall also include any progeny, unmodified derivatives and modifications therefrom, specifically modifications substantially based on, or incorporating a substantial element of, the MATERIALS, or any modifications which are not new or not
obviously distinct from the MATERIALS. 

  

	1.05	“EFFECTIVE DATE’ means the date this Agreement has been executed by the last Party. 

 

	1.06	“NET SALES’ means ORAGENICS’ and its sublicensees’ receipts for sales of LICENSED PRODUCTS or for services requiring the use of LICENSED PRODUCTS
less the sum of the following: 

  

	 	(a)	sales taxes, tariffs, duties and/or use taxes directly imposed with reference to particular sales; 

 

	 	(b)	outbound transportation prepaid or allowed; and 

  

	 	(c)	amounts allowed or credited on returns. 

 Commissions paid to individuals, whether independent sales agents or regularly employed by ORAGENICS, and the cost of collections may not be deducted from NET SALES. 

 

	1.07	“TERRITORY” means worldwide. 

 ARTICLE II — LICENSE GRANT 
  

	2.01	Grant. SYSTEM grants ORAGENICS an exclusive license and right under SYSTEM’s rights in PATENT RIGHTS and LICENSED TECHNOLOGY to make, have made, import, export,
use, and sell the LICENSED PRODUCTS in the TERRITORY, and to grant sublicenses of the same scope, to the end of the term of this Agreement as prescribed in Article VIII. 

 

	2.02	Reservation. SYSTEM reserves an irrevocable, nonexclusive, royalty-free right to practice the grant made in paragraph 2.01 for research and educational purposes only,
and not for commercial purposes. 

 ARTICLE III — CONSIDERATION 

 

	3.01	License Fec. hi consideration for the license granted in this Agreement, ORAGENICS must make an initial payment in the amount of five thousand dollars ($5,000). This
payment is due no later than thirty (30) days after the EFFECTIVE DATE. Failure to make this payment within the specified period will cause this Agreement to immediately terminate. 

3.02 Royalty Rate. As additional consideration for the license granted in this Agreement, ORAGENICS must remit to SYSTEM a royalty of five percent
(5%) of NET SALES. ORAGENICS may not accept anything of value in lieu of money payment without the express written permission of SYSTEM. 

  
 Page 2 of 12

	3.03	Royalty Stacking. In the event that LICENSED PRODUCT contains technology subject to royalties payable to third parties, the royalty due in accordance with paragraph
3.02 shall be reduced by one half of the royalty due to third parties, but in no event shall royalties due to SYSTEM under this Agreement be less than two percent (2%) of NET SALES. LICENSEE shall provide evidence to SYSTEM of its royalties due
to third parties in association with a LICENSED PRODUCT. 

  

	3.04	Minimum Annual Consideration. In order to maintain this exclusive license to PATENT RIGHTS and LICENSED TECHNOLOGY, ORAGENICS must pay SYSTEM minimum annual
consideration according to the following schedule: 

  

					
	 (a)    Calendar Year 2014 and each year thereafter prior to the Calendar Year of the first sale of a LICENSED
PRODUCT
	  	$	15,000	  
		
	 (b)    Calendar Year of the first sale of a LICENSED PRODUCT and every year thereafter through the expiration
of this Agreement
	  	$	100,000	  

 In the event that ORAGENICS’ payment of royalties for the Calendar Year due under paragraph 3.02 do
not meet or exceed the required minimum annual consideration, ORAGENICS’ royalty payment for the last quarter of the Calendar Year must include payment of the balance needed to achieve the required minimum. If this Agreement expires or is
terminated before the end of a Calendar Year, the corresponding minimum annual consideration will be prorated for that year. 
  

	3.05	Patent Expense Responsibility. As additional consideration for the license granted in this Agreement, ORAGENICS will be responsible for all expenses incurred in the
filing, prosecution and maintenance of PATENT RIGHTS, as further described in Article VI. 

 ARTICLE IV —
SUBLICENSES 
  

	4.01	Sublicenses. ORAGENICS may grant sublicenses to persons, firms or corporations under such conditions as it may arrange, as consistent with this Agreement, as long as
each such sublicense comports with all applicable law, rules and regulations and provided that ORAGENICS includes the following in any of its sublicenses and any other provisions that logically would flow-down to any sublicensees:

  

	 	1.	Indemnification. [INSERT NAME OF SUBLICENSEE] MUST AT ALL TIMES DURING AND AFTER THE TERM OF THIS AGREEMENT INDEMNIFY, DEFEND, AND HOLD HARMLESS THE TEXAS A&M
UNIVERSITY SYSTEM (“SYSTEM”), ITS REGENTS, OFFICERS, AND EMPLOYEES AGAINST ANY CLAIM, PROCEEDING, DEMAND, LIABILITY OR EXPENSE (INCLUDING LEGAL EXPENSE AND REASONABLE ATTORNEYS’ FEES) WHICH RELATES TO INJURY TO PERSONS OR PROPERTY,
ANY ACTION BROUGHT BY A THIRD PARTY ALLEGING INFRINGEMENT OF INTELLECTUAL PROPERTY RIGHTS OR AGAINST ANY OTHER CLAIM, PROCEEDING, DEMAND, EXPENSE, OR LIABILITY OF ANY KIND RESULTING FROM THE PRODUCTION, MANUFACTURE, SALE, COMMERCIAL USE, LEASE,
CONSUMPTION, OR ADVERTISEMENT OF LICENSED PRODUCTS OR ARISING FROM ANY OBLIGATION OF [INSERT NAME OF SUBLICENSEE] UNDER THIS AGREEMENT. 

  
 Page 3 of 12

	 	2.	Compliance with Law. [insert sublicensee name] ,must comply with all applicable federal, state and local laws and regulations in its exercise of all rights granted
under this Agreement. 

  

	4.02	Sublicensee Consideration. Sales of LICENSED PRODUCTS by each sublicensee will be subject to the unit royalty due to SYSTEM prescribed in paragraph 3.02. Further, for
any sublicense executed within two years of the EFFECTIVE DATE of this Agreement, ORAGENICS must pay SYSTEM forty percent (40%) of other considerations not in the form of royalty received by ORAGENICS from each sublicensee for a grant of rights
in PATENT RIGHTS or LICENSED TECHNOLOGY. For any sublicense executed after two years of the EFFECTIVE DATE of this Agreement, ORAGENICS must pay SYSTEM twenty percent (20%) of any such other considerations from each sublicensee. Notwithstanding
the above, ORAGENICS may not be required to remit to SYSTEM any portion of funds it receives from any sublicensee(s) when the funds are documented in writing as payments for the following purposes: (i) research, development, or testing of
LICENSED PRODUCTS, or (ii) patent expenses for protection of PATENT RIGHTS to which the sublicensee is contributing. 

  

	4.03	Reporting. ORAGENICS must notify SYSTEM of the grant of sublicense to a third party and must provide SYSTEM with copies of each sublicense and of each
sublicensee’s report as is pertinent to calculation of amounts due SYSTEM under this Agreement. 

  

	4.04	Non-Cash Transactions. ORAGENICS may not accept anything of value in lieu of money payment under a sublicense without the express written permission of SYSTEM, which
shall not be unreasonably withheld or delayed, 

 ARTICLE V — ORAGENICS RESPONSIBILITIES 

 

	5.01	Commercial Development Milestones. In accomplishing the development and commercialization under this Agreement, ORAGENICS shall use commercially reasonable efforts to
achieve the following milestones to the satisfaction of SYSTEM: 

  

									
	 Milestone
	  	Due Date for
First 
Occurrence	 	  	Milestone
Achievement
Payment	 
	 Enrollment of the first patient in a Phase I clinical trial of a Product
	  	 	June 1, 2015	  	  	$	50,000	  
	 Successful completion of a Phase II clinical trial of a Product, where “successful completion” means enrollment of the
first patient in a Phase III clinical trial of a Product
	  	 	June 1, 2019	  	  	$	100,000	  
	 Successful completion of a Phase III clinical trial of a Product, where “successful completion” means receipt of an
approved New Drug Application (NDA) from the FDA or foreign equivalent for a Product
	  	 	June 1, 2022	  	  	$	150,000	  
	 First sale of a Product
	  	 	June 1, 2025	  	  	$	400,000	  

  
 Page 4 of 12

 For the purposes of this Section 5.01, a “Product” means a therapeutic
composition within the LICENSED PRODUCTS that is selected for entry into clinical trials for a specified indication. Milestone Achievement Payments, according to the above schedule, shall be payable to SYSTEM upon the attainment of the milestone
with respect to each Product. LICENSEE shall provide written notification to SYSTEM within thirty (30) days of achieving each milestone. 
  

	5.02	Failure to Accomplish Milestones. Should ORAGENICS fail to achieve any milestone specified in paragraph 5.01, or should ORAGENICS fail to record NET SALES for two
(2) consecutive Calendar Years once sales begin, SYSTEM, at its sole option, may waive the requirement to achieve the milestone, renegotiate the missed milestone, or terminate this Agreement under paragraph 8.03. 

 

	5.03	Legal Compliance. ORAGENICS must comply with all applicable federal, state and local laws and regulations in its exercise of all rights granted by SYSTEM under this
Agreement. 

  

	5.04	No Royalties for Sales to U.S. Government. Under 35 USC Section 200-212, ORAGENICS has no duty to pay SYSTEM royalties under this Agreement on NET SALES made to
the United States Government, including any United States Government agency. ORAGENICS must reduce the amount charged for a LICENSED PRODUCT sold to the United States Government by an amount equal to the royalty otherwise due SYSTEM.

  

	5.05	U.S. Manufacture. Under 35 USC Section 200-212, LICENSED PRODUCTS must be manufactured substantially in the United States of America. 

ARTICLE VI — PROTECTION OF INTELLECTUAL PROPERTY 

 

	6.01	Authorization. As to prosecution, registration, and/or protection of PATENT RIGHTS, SYSTEM hereby authorizes ORAGENICS to: 1) direct the preparation and filing of
patent applications, 2) direct the prosecution of broad patent claims for the mutual benefit of ORAGENICS and SYSTEM, 3) maintain U.S. and non-U.S. issued and granted patents, and 4) be invoiced directly by ORAGENICS’ outside patent counsel (as
approved by SYSTEM under paragraph 6.02 herein) and/or annuity service providers for patent prosecution and associated maintenance fees and costs. 

  

	6.02	Selection of Counsel. ORAGENICS may select an outside patent counsel (Counsel) law firm staffed by experienced, reputable, and licensed intellectual property attorneys
for the prosecution, registration, protection, and maintenance of PATENT RIGHTS. ORAGENICS will notify SYSTEM of its selection of Counsel. 

  

	6.03	Contract with Counsel. ORAGENICS shall execute a written agreement with Counsel establishing that: 1) the attorney/client relationship relative to the prosecution,
registration, or protection of PATENT RIGHTS will be with SYSTEM and ORAGENICS jointly; 2) Counsel will not take any actions adverse to the interests of SYSTEM in relation to PATENT RIGHTS including, for example and without limitation, any future
invalidity or adverse litigation actions; 3) costs for prosecution, registration, or protection of PATENT RIGHTS will be invoiced directly to ORAGENICS with a courtesy copy of the. invoice to SYSTEM; and 4) SYSTEM will not be responsible for payment
of invoices relating to prosecution, registration, or protection of PATENT RIGHTS conducted under this Agreement, including, without limitation, attorneys’ fees, costs, official filing fees, and foreign associates’ fees and costs.
ORAGENICS shall provide a copy of such written agreement to SYSTEM. Additionally, ORAGENICS shall ensure that Counsel promptly signs the standard Outside Counsel Agreement, which Counsel can obtain from SYSTEM’s Office of General Counsel.

  
 Page 5 of 12

	6.04	Approvals. ORAGENICS shall notify SYSTEM before any substantive actions are taken in prosecuting, continuing, or abandoning any patents or patent applications or
otherwise affecting PATENT RIGHTS. and ORAGENICS will instruct Counsel to so notify SYSTEM. In addition to other substantive actions, ORAGENICS and SYSTEM must jointly approve the filing of any action or application that seeks to, or effects,
changes in inventorship related to PATENT RIGHTS, and will so instruct Counsel. ORAGENICS and SYSTEM must jointly approve how to proceed with any substantive actions relating to and/or affecting PATENT RIGHTS. 

 

	6.05	Patent Maintenance. During the term of this Agreement, ORAGENICS shall be directly responsible for annual or periodic annuity payments to maintain the pendency of
non-U.S. patent applications in countries that require such annual or periodic annuities. Furthermore, during the term of this Agreement, ORAGENICS agrees to continue any required annual and periodic payments for maintenance of U.S. and non-U.S.
issued and granted patents that ORAGENICS and SYSTEM jointly agree to procure. 

  

	6.06	Patent Maintenance Contract. ORAGENICS shall engage Counsel or a reputable annuity service to be responsible for docketing and payment of annual or periodic annuities
and maintenance fees for both U.S. and non-U.S. pending applications and U.S. and non-U.S. issued and granted patents during the term of this Agreement. 

  

	6.07	Confidential Communications. SYSTEM and ORAGENICS have a community of interest with regard to work conducted in relation to PATENT RIGHTS due to their common interest
in the generation of enforceable intellectual property rights relating to LICENSED PRODUCTS. Any communications between ORAGENICS and Counsel shall not be confidential vis-à-vis SYSTEM, but shall be otherwise confidential and protected by
attorney client privilege. 

  

	6.08	 Correspondence. ORAGENICS shall contemporaneously copy SYSTEM on all correspondence to and from any patent office, U.S. or non-U.S., including all
periodic annuities and maintenance fees correspondence, and ORAGENICS agrees to so instruct Counsel to provide copies of such correspondence to SYSTEM. ORAGENICS further agrees that ORAGENICS- failure to timely provide such correspondence will be considered a breach of this Agreement in accordance midi
Paragraph 8.03 below. 

  

	6.09	Information. To aid ORAGENICS in the prosecution, registration, protection, and maintenance of PATENT RIGHTS, SYSTEM at its expense will provide information, execute
and deliver documents, and perform other acts as ORAGENICS reasonably requests from time to time. 

  

	6.10	Abandonment. Should ORAGENICS decide to abandon withdraw, or otherwise cease prosecution or maintenance of any U.S. or non-U.S. patent application or issued or granted
patent for any reason (including but not limited to declining to make an annuity or maintenance payment), ORAGENICS shall so notify SYSTEM in writing at least sixty (60) days prior to taking (or not taking) any action which would result in
abandonment, withdrawal, or lapse of such patent or application. SYSTEM shall then have the right to continue patent prosecution or maintenance of each such patent or application at its own expense and any such patent application and granted or
issued patent there from will be excluded from LICENSED PATENT RIGHTS in this License Agreement. 

  
 Page 6 of 12

	6.11	 Assignee. All patent applications and patents related to this Agreement shall have “The Texas A&M University System” and -Oragenics, Inc.” named as an assignee.

  

	6.12	Previous Obligations. All previously approved. authorized, and accrued obligations and instructions under this Agreement, including ORAGENICS’ reimbursement of
patent expenses to SYSTEM, shall remain enforceable. All other matters survive per Paragraph 8.04 below. 

  

	6.13	Obligation to File or Maintain. Should ORAGENICS decide not to file or maintain patent protection, SYSTEM may, at its own expense, without reimbursement from ORAGENICS,
file, prosecute, or maintain the patent protection and ORAGENICS hereby agrees that any such patent will be excluded from the rights granted herein. 

 ARTICLE VII — PAYMENTS AND REPORTS 
  

	7.01	When Payments are Due. Unless otherwise specified, ORAGENICS must make payments to The Texas A&M University System, in College Station. Texas, not later than sixty
(60) days after the last day of the calendar quarter in which they accrue. 

  

	7.02	Royalty Reports. ORAGENICS must provide a sales report to SYSTEM each quarter, providing information sufficient to allow SYSTEM to calculate amounts due SYSTEM for the
reporting period. No quarterly reports are due until sales of LICENSED PRODUCTS begin. After product sales begin, quarterly reports shall be provided even if no royalties accrued during the quarter. 

 

	7.03	Currency. Payment due to SYSTEM must be paid in U.S. dollars. Royalty payments requiring conversion must use the exchange rate as reported in The Wall Street
Journal on the last business day of the royalty reporting period. 

  

	7.04	Inspection of Books and Records. At its own expense, SYSTEM may no more than once annually inspect ORAGENICS’ books and records as needed to determine royalties
payable. ORAGENICS must maintain those books and records for at least three (3) years following the dates of the underlying transactions. Any inspections will be in confidence and conducted during ordinary business hours, and SYSTEM will
provide ORAGENICS advance notice no less than two (2) weeks before making an inspection. SYSTEM may employ a Certified Public Accountant for this purpose. If SYSTEM’s audit identifies a shortage of five percent (5%) or more of amounts
due to SYSTEM, then ORAGENICS must pay the costs of SYSTEM’s audit. ORAGENICS must pay all amounts due as a consequence of an audit to SYSTEM promptly, with interest. 

 

	7.05	Interest Charges. SYSTEM may, in its sole discretion, charge daily interest on overdue payments commencing on the 31st day after the payment is due, compounded monthly,
at the lower of either 1.5% per month or the highest legal interest rate. The payment of interest will not foreclose SYSTEM from exercising any other rights it may have due to the lateness of any payment. 

 

	7.06	Commercialization Report. Within sixty (60) days following the close of each Calendar Year, ORAGENICS shall deliver to SYSTEM a written report as to
ORAGENICS’ efforts and accomplishments during the preceding year in commercializing LICENSED PRODUCTS, as well as its commercialization plans for the coming year. 

  
 Page 7 of 12

 ARTICLE VIII — TERM AND TERMINATION 

 

	8.01	Expiration. This Agreement, unless sooner terminated as provided below, will remain in effect until (a) failure to obtain at least one issued patent for protection
of LICENSED TECHNOLOGY, (b) expiration of the last to expire patent under PATENT RIGHTS, or (c) final and unappealable determination by a court of competent jurisdiction that PATENT RIGHTS are invalid. 

 

	8.02	Termination by ORAGENICS. ORAGENICS may terminate this Agreement by providing written notice to SYSTEM at least ninety (90) days before the termination is to take
effect. 

  

	8.03	Termination by System. If ORAGENICS materially breaches this Agreement, SYSTEM may give ORAGENICS written notice of the breach. ORAGENICS will have a period of sixty
(60) days from receipt of the notice to cure the breach. If ORAGENICS does not cure the breach within this period, SYSTEM may terminate this Agreement without further notice. 

 

	8.04	Matters Surviving Termination. All accrued obligations and claims, including payment of patent expenses, license fee obligations, royalty obligations, minimum annual
consideration obligations, interest charge obligations, and all other financial obligations, and claims or causes of action for breach of this Agreement, will survive termination of this Agreement. Obligations of confidentiality will survive
termination of this Agreement. This section controls in the case of a conflict with any other section of this Agreement. 

 ARTICLE IX — INDEMNIFICATION AND REPRESENTATION 
  

	9.01	Indemnification. ORAGENICS MUST AT ALL TIMES DURING AND AFTER THE TERM OF THIS AGREEMENT INDEMNIFY, DEFEND, AND HOLD HARM LESS SYSTEM, ITS REGENTS, OFFICERS AND
EMPLOYEES AGAINST ANY CLAIM, PROCEEDING, DEMAND, LIABILITY OR EXPENSE (INCLUDING LEGAL EXPENSE AND REASONABLE ATTORNEYS’ FEES) WHICH RELATES TO INJURY TO PERSONS OR PROPERTY, ANY ACTION BROUGHT BY A THIRD PARTY ALLEGING INFRINGEMENT OF
INTELLECTUAL PROPERTY RIGHTS OR AGAINST ANY OTHER CLAIM, PROCEEDING, DEMAND, EXPENSE, OR LIABILITY OF ANY KIND RESULTING FROM THE PRODUCTION, MANUFACTURE, SALE, COMMERCIAL USE, LEASE, CONSUMPTION, OR ADVERTISEMENT OF LICENSED PRODUCTS OR ARISING
FROM ANY OBLIGATION OF ORAGENICS OR SUBLICENSEE(S) UNDER THIS AGREEMENT. 

  

	9.02	Representation. SYSTEM represents that it jointly owns with ORAGENICS PATENT RIGHTS and LICENSED TECHNOLOGY and has the full right and power to grant the license in
paragraph 2.01, and that there are no outstanding agreements, assignments, or encumbrances inconsistent with the provisions of this Agreement. SYSTEM MAKES NO OTHER REPRESENTATIONS AND EXTENDS NO OTHER WARRANTIES OF ANY KIND, EITHER
EXPRESS OR IMPLIED, INCLUDING BUT NOT LI M I TED TO WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, NOR DOES SYSTEM ASSUME ANY OBLIGATIONS REGARDING INFRINGEMENT OF PATENT RIGHTS OR OTHER RIGHTS OF THIRD PARTIES DUE TO
ORAGENICS’ ACTIVITIES UNDER THIS AGREEMENT. 

  
 Page 8 of 12

 ARTICLE X — NOTICES 

 

	10.01	Notices. Payments, notices, or other communications required by this Agreement will be sufficiently made or given if mailed by certified First Class United States mail,
postage pre-paid, or by commercial carrier (e.g., FedEx, UPS, etc.) when the carrier maintains receipt or record of delivery, addressed to the address stated below, or to the last address specified in writing by the intended recipient.

 If to SYSTEM: 
 Associate Vice Chancellor 
 Office of Technology Commercialization 

3369 TAMU 

College Station, Texas, USA 77843-3369 
 Phone: 979-847-8682 
 FAX: 979-845-1402 

If to ORAGENICS: 
 CEO, Oragenics, 
 3000 Bayport Dr. Suite 685 

Tampa, FL 33607 

Phone: 813-286-7900 
 FAX: 813-286-7904 
 ARTICLE XI — MISCELLANEOUS PROVISIONS 

 

	11.01	Notice of Infringement. Each Party must promptly notify the other in writing of any alleged infringement of PATENT RIGHTS. Within thirty (30) days after receipt of
such notice, SYSTEM and ORAGENICS will formulate a strategy for resolving the alleged infringement. SYSTEM’s involvement, participation, and representation in any enforcement litigation is contingent upon SYSTEM receiving the consent of the
Attorney General of the State of Texas, and ORAGENICS’ obligation to enforce PATENT RIGHTS is contingent upon SYSTEM being a party to any suit to the extent required by law. 

 

	11.02	Export Controls. SYSTEM is subject to United States laws and regulations controlling the export of technical data, computer software, laboratory prototypes and other
commodities, and its obligations under this Agreement are contingent on compliance with applicable laws and regulations. The transfer of certain technical data and commodities may require a license from the cognizant agency of the United States
Government or written assurances by ORAGENICS that ORAGENICS will not export data or commodities to certain countries without advance approval of such agency. SYSTEM neither represents that a license will not be required nor that, if required, it
will be issued. 

  

	11.03	Confidential Information. Sales reports submitted by ORAGENICS under ARTICLE VII will be considered Confidential Information under this Agreement and not be disclosed
by SYSTEM to any third party except as may be required by law, including but not limited to a valid court order or the Texas Public Information Act (Tex. Gov’t Code Ch. 552). If the Parties contemplate exchanging other information of a
confidential nature, they should enter into a separate confidentiality agreement. 

  
 Page 9 of 12

	11.04	Non-Use of Names. ORAGENICS may not use the names or any adaptation of the names of The Texas A&M University System, nor of any of its employees or members, in any
advertising, promotional, or sales literature without the advance written consent of SYSTEM in each case, except that ORAGENICS may state that it is licensed by SYSTEM under PATENT RIGHTS. 

 

	11.05	Trademarks. ORAGENICS may select, own and use its own trademark on LICENSED PRODUCTS. However, SYSTEM does not grant ORAGENICS any license or other right under any
trade name, trademark, or service mark owned or licensed by SYSTEM, Conversely, SYSTEM has no rights to trade names, trademarks, or service marks owned by ORAGENICS. 

 

	11.06	Assignment of this Agreement. This Agreement, with the rights and privileges it creates, is assignable only with the written consent of both Parties, which shall not be
unreasonably withheld or, delayed. 

  

	11.07	Force Majeure. Other than an obligation for the payment of money, SYSTEM, upon receipt of documentation from ORAGENICS which it deems appropriate, must excuse any
breach of this Agreement which is proximately caused by war, strike, act of God, or other similar circumstance normally deemed outside the control of well-managed businesses. 

 

	11.08	Entire Agreement. This Agreement contains the entire understanding of the Parties regarding PATENT RIGHTS and LICENSED TECHNOLOGY, and supersedes all other written and
oral agreements between the Parties regarding PATENT RIGHTS and LICENSED TECHNOLOGY. It may be modified only by a written amendment signed by the Parties. 

  

	11.09	Governing Law. The substantive laws of the State of Texas (and not its conflict of law principles), USA, govern all matters arising out of or relating to this Agreement
and all of the transactions it contemplates. Venue for any suit brought against SYSTEM in Texas state court must be in Brazos County, Texas under Tex. Educ. Code § 85.18, and venue for any suit brought against SYSTEM in federal court must be in
the Houston Division of the Southern District of Texas. Venue for any suit brought against ORAGENICS must be in Hillsborough County, Florida, and venue for any suit brought against ORAGENICS in federal court must be in the Tampa Division of the
Middle District of Florida. 

  

	11.10	Headings. Headings are solely for convenience of reference and are not part of, and may not be used to construe, this Agreement. 

 

	11.11	No Waiver; Severability. If any provision of this Agreement is invalid, illegal, or unenforceable, the validity, legality and enforceability of the remaining provisions
will not in any way be affected or impaired. A waiver of any breach of this Agreement does not waive any other breach of the same or other provision of this Agreement. A waiver is not effective unless made in writing. 

 

	11.12	Privileges and Immunities. SYSTEM is an agency of the State of Texas and nothing in this Agreement waives or relinquishes the right of SYSTEM to claim any exemptions,
privileges, or immunities as may be provided by law. 

  

	11.13	Counterparts. This agreement may be executed in any number of counterparts, including facsimile or scanned PDF documents. Each such counterpart, facsimile, or scanned
PDF document shall be deemed an original instrument, and all of which, together, shall constitute one and the same executed Agreement. 

  
 Page 10 of 12

 The Parties have caused this Agreement to become effective as of the date last executed
below. 
  

					
	ORAGENICS,	 		 	THE TEXAS A&M UNIVERSITY SYSTEM
			
	 /s/ John Bonfiglio
	 		 	 /s/ Brett Cornwell

	  
 CEO, Oragenics, Inc.

Date: December 6, 2011
	 		 	 Brett Cornwell
 Associate Vice
Chancellor for Commercialization
 Date: December 20, 2011

  
 Page 11 of 12

 Exhibit A 
 MATERIALS 
  

	1.	Streptococcus mutans JH1140 lanA Trp4Ala 

	2.	Streptococcus mutans JH1140 lanA DhaSAla 

	3.	Streptococcus mutans JH1140 lanA Argl 3Asp 

	4.	Streptococcus mutans JH1140 lanA Trp4insAla 

	5.	Streptococcus mutans JH1140 lanA A Trp4 

	6.	 Streptococcus mutans JH1140 lanA Alas7insAla 

  
 Page 12 of 12Indenture

 Exhibit 4.1 
 DFC GLOBAL CORP. 
 3.25% Senior Convertible Notes Due 2017 

 
  
 INDENTURE 
 Dated as of April 16, 2012 

 
  
 U.S. BANK NATIONAL ASSOCIATION 
 TRUSTEE 

 
  

 Cross-Reference Table
1 

 

							
	Trust Indenture Act Section	  	Indenture Section
				
	 310
	  	(a)(1)	  		  	Section 7.10
		  	(a)(2)	  		  	Section 7.10
		  	(a)(3)	  		  	N.A.
		  	(a)(4)	  		  	N.A.
		  	(a)(5)	  		  	N.A.
		  	(b)	  		  	Section 7.08
		  		  		  	Section 7.10
		  	(c)	  		  	N.A.
	 311
	  	(a)	  		  	Section 7.11
		  	(b)	  		  	Section 7.11
		  	(c)	  		  	N.A.
	 312
	  	(a)	  		  	Section 2.05
		  	(b)	  		  	Section 12.03
		  	(c)	  		  	Section 12.03
	 313
	  	(a)	  		  	Section 7.06
		  	(b)(1)	  		  	Section 7.06
		  	(b)(2)	  		  	Section 7.06
		  	(c)	  		  	Section 7.06
		  		  		  	Section 12.02
		  	(d)	  		  	Section 7.06
	 314
	  	(a)	  		  	Section 4.02
		  	(b)	  		  	N.A.
		  	(c)(1)	  		  	Section 12.04
		  	(c)(2)	  		  	Section 12.04
		  	(c)(3)	  		  	N.A.
		  	(d)	  		  	N.A.
		  	(e)	  		  	Section 12.05
		  	(f)	  		  	Section 4.04
	 315
	  	(a)	  		  	Section 7.01(b)
		  	(b)	  		  	Section 7.05
		  	(c)	  		  	Section 7.01(b)
		  	(d)	  		  	Section 7.01(c)
		  	(e)	  		  	Section 6.11
	 316
	  	(a)(1)(A)	  		  	N.A.
		  	(a)(1)(B)	  		  	Section 6.04
		  	(a)(2)	  		  	N.A.
		  	(b)	  		  	N.A.
		  	(c)	  		  	N.A.
	 317
	  	(a)(1)	  		  	Section 6.08
		  	(a)(2)	  		  	Section 6.09
		  	(b)	  		  	Section 2.04
	 318
	  	(a)	  		  	Section 12.01

  
 N.A.
means not applicable. 
  

	1 	 This Cross-Reference Table is not part of the Indenture. 

 TABLE OF CONTENTS 

 

							
	 	  	 	  	Page	 
	
	 ARTICLE 1
 DEFINITIONS AND INCORPORATION BY REFERENCE
	   

  

			
	 Section 1.01.
	  	Definitions.	  	 	1	  
	 Section 1.02.
	  	Other Definitions.	  	 	8	  
	 Section 1.03.
	  	Incorporation by Reference of Trust Indenture Act	  	 	9	  
	 Section 1.04.
	  	Rules of Construction	  	 	9	  
	 Section 1.05.
	  	Acts of Holders	  	 	10	  
	
	ARTICLE 2	  
	THE SECURITIES	  
			
	 Section 2.01.
	  	Form and Dating	  	 	11	  
	 Section 2.02.
	  	Execution and Authentication	  	 	12	  
	 Section 2.03.
	  	Registrar, Paying Agent, Bid Solicitation Agent and Conversion Agent	  	 	12	  
	 Section 2.04.
	  	Paying Agent to Hold Money and Securities in Trust	  	 	13	  
	 Section 2.05.
	  	Securityholder Lists	  	 	13	  
	 Section 2.06.
	  	Transfer and Exchange	  	 	13	  
	 Section 2.07.
	  	Replacement Securities	  	 	15	  
	 Section 2.08.
	  	Outstanding Securities; Determinations of Holders’ Action	  	 	15	  
	 Section 2.09.
	  	Temporary Securities	  	 	16	  
	 Section 2.10.
	  	Cancellation	  	 	16	  
	 Section 2.11.
	  	Persons Deemed Owners	  	 	17	  
	 Section 2.12.
	  	Global Securities	  	 	17	  
	 Section 2.13.
	  	CUSIP Numbers	  	 	22	  
	 Section 2.14.
	  	Payment	  	 	23	  
	
	ARTICLE 3	  
	REPURCHASES	  
			
	 Section 3.01.
	  	[Reserved]	  	 	23	  
	 Section 3.02.
	  	Repurchase of Securities at Option of the Holder Upon a Fundamental Change	  	 	23	  
	 Section 3.03.
	  	Effect of Fundamental Change Repurchase Notice	  	 	25	  
	 Section 3.04.
	  	Deposit of Fundamental Change Repurchase Price	  	 	26	  
	 Section 3.05.
	  	Securities Purchased in Part	  	 	26	  
	 Section 3.06.
	  	Covenant to Comply with Securities Laws Upon Purchase of Securities	  	 	27	  
	 Section 3.07.
	  	Repayment to the Company	  	 	27	  
	
	ARTICLE 4	  
	COVENANTS	  
			
	 Section 4.01.
	  	Payment of Securities	  	 	27	  

  
 i 

							
	 Section 4.02.
	  	SEC and Other Reports	  	 	27	  
	 Section 4.03.
	  	Compliance Certificate	  	 	28	  
	 Section 4.04.
	  	Further Instruments and Acts	  	 	28	  
	 Section 4.05.
	  	Maintenance of Office or Agency	  	 	28	  
	 Section 4.06.
	  	Delivery of Certain Information	  	 	28	  
	 Section 4.07.
	  	Additional Amounts Notice	  	 	29	  
	 Section 4.08.
	  	Resale of the Securities	  	 	29	  
	 Section 4.09.
	  	No Registration Rights; Additional Interest.	  	 	29	  
	
	ARTICLE 5	  
	SUCCESSOR COMPANY	  
			
	 Section 5.01.
	  	When Company May Merge or Transfer Assets	  	 	30	  
	
	ARTICLE 6	  
	DEFAULTS AND REMEDIES	  
			
	 Section 6.01.
	  	Events of Default	  	 	31	  
	 Section 6.02.
	  	Acceleration	  	 	33	  
	 Section 6.03.
	  	Other Remedies	  	 	34	  
	 Section 6.04.
	  	Waiver of Past Defaults	  	 	34	  
	 Section 6.05.
	  	Control by Majority	  	 	34	  
	 Section 6.06.
	  	Limitation on Suits	  	 	35	  
	 Section 6.07.
	  	Rights of Holders to Receive Payment	  	 	35	  
	 Section 6.08.
	  	Collection Suit by Trustee	  	 	35	  
	 Section 6.09.
	  	Trustee May File Proofs of Claim	  	 	35	  
	 Section 6.10.
	  	Priorities	  	 	36	  
	 Section 6.11.
	  	Undertaking for Costs	  	 	36	  
	 Section 6.12.
	  	Waiver of Stay, Extension or Usury Laws	  	 	37	  
	
	ARTICLE 7	  
	TRUSTEE	  
			
	 Section 7.01.
	  	Duties of Trustee	  	 	37	  
	 Section 7.02.
	  	Rights of Trustee	  	 	38	  
	 Section 7.03.
	  	Individual Rights of Trustee	  	 	40	  
	 Section 7.04.
	  	Trustee’s Disclaimer	  	 	40	  
	 Section 7.05.
	  	Notice of Defaults	  	 	40	  
	 Section 7.06.
	  	Reports by Trustee to Holders	  	 	40	  
	 Section 7.07.
	  	Compensation and Indemnity	  	 	41	  
	 Section 7.08.
	  	Replacement of Trustee	  	 	42	  
	 Section 7.09.
	  	Successor Trustee by Merger	  	 	43	  
	 Section 7.10.
	  	Eligibility; Disqualification	  	 	43	  
	 Section 7.11.
	  	Preferential Collection of Claims Against Company	  	 	43	  

  
 ii 

							
	ARTICLE 8	  
	DISCHARGE OF INDENTURE	  
			
	 Section 8.01.
	  	Discharge of Liability on Securities	  	 	43	  
	 Section 8.02.
	  	Repayment to the Company	  	 	43	  
	 Section 8.03.
	  	Application of Trust Money	  	 	43	  
	
	ARTICLE 9	  
	AMENDMENTS	  
			
	 Section 9.01.
	  	Without Consent of Holders	  	 	44	  
	 Section 9.02.
	  	With Consent of Holders	  	 	44	  
	 Section 9.03.
	  	Compliance with Trust Indenture Act	  	 	46	  
	 Section 9.04.
	  	Revocation and Effect of Consents, Waivers and Actions	  	 	46	  
	 Section 9.05.
	  	Notice of Amendments, Notation on or Exchange of Securities	  	 	46	  
	 Section 9.06.
	  	Trustee to Sign Supplemental Indentures	  	 	46	  
	 Section 9.07.
	  	Effect of Supplemental Indentures	  	 	46	  
	
	ARTICLE 10	  
	CONVERSIONS	  
			
	 Section 10.01.
	  	Conversion Privilege	  	 	46	  
	 Section 10.02.
	  	Conversion Procedure; Applicable Conversion Rate; Fractional Shares	  	 	49	  
	 Section 10.03.
	  	Payment Upon Conversion	  	 	51	  
	 Section 10.04.
	  	Adjustment of Applicable Conversion Rate	  	 	52	  
	 Section 10.05.
	  	Conditions to Voluntary Conversion Rate Adjustments	  	 	60	  
	 Section 10.06.
	  	Effect of Reclassification, Consolidation, Merger or Sale	  	 	61	  
	 Section 10.07.
	  	Taxes on Shares Issued	  	 	63	  
	 Section 10.08.
	  	Reservation of Shares, Shares to Be Fully Paid; Compliance with Governmental Requirements	  	 	63	  
	 Section 10.09.
	  	Adjustments of Prices	  	 	63	  
	 Section 10.10.
	  	Responsibility of Trustee	  	 	63	  
	
	ARTICLE 11	  
	REDEMPTION	  
			
	 Section 11.01.
	  	Redemption	  	 	64	  
	
	ARTICLE 12	  
	MISCELLANEOUS	  
			
	 Section 12.01.
	  	Trust Indenture Act Controls	  	 	64	  
	 Section 12.02.
	  	Notices	  	 	64	  
	 Section 12.03.
	  	Communication by Holders with Other Holders	  	 	65	  
	 Section 12.04.
	  	Certificate and Opinion as to Conditions Precedent	  	 	66	  
	 Section 12.05.
	  	Statements Required in Certificate or Opinion	  	 	66	  
	 Section 12.06.
	  	Separability Clause	  	 	66	  
	 Section 12.07.
	  	Rules by Trustee, Paying Agent, Conversion Agent and Registrar	  	 	66	  

  
 iii

							
	 Section 12.08.
	  	Legal Holidays	  	 	66	  
	 Section 12.09.
	  	Governing Law	  	 	66	  
	 Section 12.10.
	  	No Recourse Against Others	  	 	67	  
	 Section 12.11.
	  	Successors	  	 	67	  
	 Section 12.12.
	  	Multiple Originals	  	 	67	  

 EXHIBIT A Form of Global Security 
 EXHIBIT B Form of Certificated Security 
 EXHIBIT C Transfer Certificate 

EXHIBIT D Notice of Occurrence of Fundamental Change 
 SCHEDULE I Amount of Make Whole Premium 

  
 iv 

			
		 	 INDENTURE dated as of April 16, 2012 between DFC GLOBAL CORP., a Delaware corporation (“Company”), and U.S.
BANK NATIONAL ASSOCIATION, a national banking association (“Trustee”).

 Each party agrees as follows for the benefit of the other party and for the equal and ratable benefit of
the Holders of the Company’s 3.25% Senior Convertible Notes Due 2017: 
 ARTICLE 1 

DEFINITIONS AND INCORPORATION BY REFERENCE 
 Section 1.01. Definitions. 
 “144A Global Security”
means a permanent Global Security in the form of the Security attached hereto as Exhibit A, and that is deposited with and registered in the name of the Depositary, representing Securities sold in reliance on Rule 144A under the Securities Act.

 “Additional Amounts” means any additional interest that is payable by the Company pursuant to
Section 4.09 or Section 6.01(k). 
 “Affiliate” of any specified person means any other person
directly or indirectly controlling or controlled by or under direct or indirect common control with such specified person. For the purposes of this definition, “control”, when used with respect to any specified person, means the power to
direct or cause the direction of the management and policies of such person, directly or indirectly, whether through the ownership of voting securities, by contract or otherwise; and the terms “controlling” and “controlled” have
meanings correlative to the foregoing. 
 “Applicable Conversion Period” means the 40 consecutive Trading Day
period (1) with respect to conversion notices received during the period beginning on, and including, the 45th Scheduled Trading Day immediately preceding the Stated Maturity and ending on, and including, the second Scheduled Trading Day
immediately preceding the Stated Maturity, beginning on, and including, the 42nd Scheduled Trading Day immediately preceding the Stated Maturity; and (2) in all other cases, beginning on, and including, the third Trading Day following the
Conversion Date. 
 “Applicable Conversion Price” means, at any given time, $1,000 divided by the Applicable
Conversion Rate at such time. 
 “Applicable Procedures” means, with respect to any transfer or transaction
involving a Global Security or beneficial interest therein, the rules and procedures of the Depositary for such Security, in each case to the extent applicable to such transaction and as in effect from time to time. 

“Board of Directors” means either the board of directors of the Company or any duly authorized committee of such board.

  
 1 

 “Board Resolution” means a resolution of the Board of Directors.

 “Business Day” means, with respect to any Security, any day, other than a Saturday, a Sunday or a day on
which the Federal Reserve Bank of New York is authorized or required by law or executive order to close or be closed. 

“Capital Stock” for any corporation means any and all shares, interests, rights to purchase, warrants, options,
participations or other equivalents of or interests in (however designated) stock issued by that corporation. 

“cash” means U.S. legal tender. 
 “Certificated Securities” means Securities that are in the form of the Securities attached hereto as Exhibit B. 
 “close of business” means 5:00 p.m. (New York City time). 

“Closing Sale Price” of a share of Common Stock or any other security on any Trading Day means the closing sale price of
such security (or if no closing sale price is reported, the average of the closing bid and closing ask prices or, if more than one in either case, the average of the average closing bid and the average closing ask prices) on such date as reported in
composite transactions for the principal U.S. securities exchange on which the Common Stock or such other security is traded or, if the Common Stock or such other security is not listed on a U.S. national or regional securities exchange, as reported
by OTC Markets Group Inc. If the Common Stock or such other security is not so quoted, the Closing Sale Price will be the average of the midpoint of the last bid and asked prices for the Common Stock or such other security on the relevant date from
each of at least three independent nationally recognized investment banking firms selected by the Company for this purpose. The Closing Sale Price will be determined without reference to extended or after hours trading. 

“Code” means the United States Internal Revenue Code of 1986, as amended from time to time. 

“Common Stock” means shares of the common stock, par value $0.001 per share, of the Company existing on the date of this
Indenture or any other shares of Capital Stock of the Company into which such Common Stock shall be reclassified or changed, including, subject to Section 10.06, in the event of a merger, consolidation or other similar transaction involving the
Company that is otherwise permitted hereunder in which the Company is not the surviving person, shares of the common stock of such surviving corporation. 
 “Company” means the party named as the “Company” in the preamble of this Indenture until a successor replaces it pursuant to the applicable provisions of this Indenture and,
thereafter, shall mean such successor. The foregoing sentence shall likewise apply to any subsequent such successor or successors. 
 “Company Notice” means a notice to Holders delivered pursuant to Section 3.02. 

  
 2 

 “Company Request” or “Company Order” means a written
request or order signed in the name of the Company by any Officer. 
 “Continuing Director” means a director
who either was a member of the Board of Directors on the date of original issuance of the Securities or who becomes a member of the Board of Directors subsequent to that date and whose appointment, election or nomination for election by the
Company’s shareholders is duly approved by a majority of the Continuing Directors on the Board of Directors at the time of such approval, either by specific vote or by approval of the proxy statement issued by the Company on behalf of the Board
of Directors in which such individual is named as nominee for director. 
 “Conversion Settlement Date” means
the third Scheduled Trading Day immediately following the final Trading Day of the Applicable Conversion Period. 
 “Corporate Trust Office” means the designated office of the Trustee at which at any time its corporate trust business shall be principally administered, which office at the date hereof is
located at 225 Asylum Street, 23rd Floor, Hartford, CT
06103, or such other address as the Trustee may designate from time to time by notice to the Holders and the Company, or the principal corporate trust office of any successor Trustee (or such other address as a successor Trustee may designate from
time to time by notice to the Holders and the Company). 
 “Daily Conversion Value” means, for any Trading Day
in the Applicable Conversion Period, one-fortieth (1/40) of the product of (1) the Applicable Conversion Rate in effect on that Trading Day and (2) the VWAP of the Common Stock on that Trading Day. 

“Default” means any event that is or, after notice or passage of time would be, an Event of Default. 

“DTC” means The Depository Trust Company. 
 “Ex-Dividend Date” means the first date on which the shares of the Common Stock trade on the applicable exchange or in the applicable market, regular way, without the right to receive the
issuance, dividend or distribution in question from the Company or, if applicable, from the seller of the Common Stock on such exchange or market (in the form of due bills or otherwise) as determined by such exchange or market. 

“Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations of the SEC
promulgated thereunder. 
 “Fair Market Value” or “fair market value” means the amount which a
willing buyer would pay a willing seller in an arm’s-length transaction. 
 “Fundamental Change” means the
occurrence at such time after the original issuance of the Securities when any of the following has occurred: 

(1) a “person” or “group” within the meaning of Section l3(d)(3) of the Exchange Act files a Schedule
TO or any schedule, form or report under the Exchange Act disclosing that such person or group has become the direct or indirect “beneficial owner”, as defined in Rule 13d-3 under the Exchange Act, of shares of Common Stock representing
more than 50% of the voting power of the Company’s Voting Stock; or 

  
 3 

 (2) the first day on which a majority of the members of the Board of
Directors does not consist of Continuing Directors; or 
 (3) a consolidation, merger or binding share exchange,
or any conveyance, transfer, sale, lease or other disposition of all or substantially all of the Company’s properties and assets to another person, other than: 

(a) any transaction (i) that does not result in any reclassification, conversion, exchange or cancellation of
outstanding shares of the Company’s Capital Stock or (ii) pursuant to which holders of the Company’s Capital Stock immediately prior to such transaction have the entitlement to exercise, directly or indirectly, 50% or more of the
total voting power of the Voting Stock of the continuing or surviving or successor person immediately after giving effect to such issuance; or 
 (b) any merger, share exchange, transfer of assets or similar transaction solely for the purpose of changing the Company’s jurisdiction of incorporation and resulting in a reclassification,
conversion or exchange of outstanding shares of Common Stock, if at all, solely into shares of common stock, ordinary shares or American Depositary Shares of the surviving entity or a direct or indirect parent of the surviving entity; or 

(c) any consolidation or merger with or into any Subsidiary, so long as such merger or consolidation is not part of a plan
or a series of transactions designed to merge or consolidate with, or having the effect of merging or consolidating with, any other person; or 
 (d) a Termination of Trading; or 
 (e) the approval by the holders
of Common Stock of any plan or proposal for the Company’s liquidation. 
 The term “person” as used in this definition includes
any syndicate or group that would be deemed to be a “person” under Section 13(d)(3) of the Exchange Act. 
 Notwithstanding
the foregoing, any transaction or event described in clause (1) or (3) above will not constitute a Fundamental Change if, in connection with such transaction or event, or as a result therefrom, at least 90% of the consideration paid for
the Common Stock (excluding cash payments for fractional shares, cash payments made pursuant to dissenters’ appraisal rights and cash dividends) consists of shares of common stock traded on any of the New York Stock Exchange, The NASDAQ Global
Market or NASDAQ (or any of their respective successors) (or will be so traded or quoted immediately following the completion of the relevant transaction) and, as a result of such transaction, the Securities become convertible into a combination of
cash (in respect of the principal portion of such Securities) and Reference Property pursuant to Section 10.06(a). 

  
 4 

 “Global Securities” means Securities that are in the form of the Securities
attached hereto as Exhibit A, and that are registered in the register of Securities in the name of a Depositary or a nominee thereof, and to the extent that such Securities are required to bear the Legend required by Section 2.06(g), such
Securities shall be in the form of a 144A Global Security. 
 “Holder” or “Securityholder”
means a person in whose name a Security is registered on the Registrar’s books. 
 “Indenture” means this
Indenture, as amended or supplemented from time to time in accordance with the terms hereof, including the provisions of the TIA that are deemed to be a part hereof. 
 “Interest” means interest payable on each Security pursuant to Section 1 of the Securities. 
 “Interest Payment Date” means April 15 and October 15 of each year, commencing October 15, 2012. 
 “Interest Record Date” means April 1 and October 1 of each year. 
 “Issue Date” of any Security means the date on which the Security was originally issued or deemed issued as set forth on the face of the Security. 

“Market Disruption Event” means (i) a failure by the principal U.S. national or regional securities exchange or
market on which the Common Stock is listed or admitted for trading to open for trading during its regular trading session or (ii) the occurrence or existence prior to 1:00 p.m., New York City time, on any Scheduled Trading Day for the Common
Stock for more than one half-hour period in the aggregate during regular trading hours of any suspension or limitation imposed on trading (by reason of movements in price exceeding limits permitted by the relevant stock exchange or otherwise) in the
Common Stock or in any options, contracts or futures contracts relating to the Common Stock. 
 “NASDAQ” means
The NASDAQ Global Select Market. 
 “Offering Memorandum” means the offering memorandum of the Company dated
April 11, 2012 relating to the offering of the Securities. 
 “Officer” means the Chairman of the Board,
the President, any Senior Vice President, Executive Vice President or Vice President, the Chief Financial Officer, the Treasurer or the Secretary of the Company. 
 “Officer’s Certificate” means a written certificate containing the information specified in Sections 12.04 and 12.05, signed in the name of the Company by any Officer (solely in
his or her capacity as such), and delivered to the Trustee. An Officer’s Certificate given pursuant to Section 4.03 shall be signed by the principal executive officer, principal financial officer or principal accounting officer of the
Company but need not contain the information specified in Sections 12.04 and 12.05. 

  
 5 

 “opening of business” means 9:00 a.m. (New York City time). 

“Opinion of Counsel” means a written opinion from legal counsel containing the information specified in
Sections 12.04 and 12.05. The counsel may be an employee of, or counsel to, the Company who is reasonably acceptable to the Trustee. 
 “Purchase Agreement” means the Purchase Agreement dated April 10, 2012 among the Company, on the one hand, and Barclays Capital Inc., as representative of the several initial
purchasers, on the other hand, relating to the Securities. 
 “Record Date” shall mean, with respect to any
dividend, distribution or other transaction or event in which the holders of Common Stock have the right to receive any cash, securities or other property, or in which the Common Stock (or other applicable security) is exchanged for or converted
into any combination of cash, securities or other property, the date fixed for determination of stockholders entitled to receive such cash, securities or other property (whether such date is fixed by the Board of Directors or by statute, contract or
otherwise). 
 “Responsible Officer” means, when used with respect to the Trustee, any officer of the Trustee
within the Corporate Trust Office of the Trustee who has direct responsibility for the administration of this Indenture and, for the purposes of Sections 7.01(c)(ii) and 7.05, shall also mean any other officer of the Trustee to whom any
corporate trust matter is referred because of such person’s knowledge of and familiarity with the particular subject matter. 
 “Restricted Security” means a Security required to bear the Legend. 
 “Rule 144A” means Rule 144A under the Securities Act (or any successor provision), as it may be amended from time to time. 

“Scheduled Trading Day” means (i) a day that is scheduled to be a Trading Day on the principal U.S. national or
regional securities exchange or market on which the Common Stock is listed for trading or, (ii) if the Common Stock is not so listed or admitted for trading, a Business Day. 

“SEC” means the Securities and Exchange Commission. 

“Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations of the SEC promulgated
thereunder. 
 “Security” means any of the Company’s 3.25% Senior Convertible Notes Due 2017, as amended
or supplemented from time to time, issued under this Indenture. 
 “Securityholder” or
“Holder” means a person in whose name a Security is registered on the Registrar’s books. 

“Significant Subsidiary” means any subsidiary of the Company that is a significant subsidiary at any determination date
pursuant to Regulation S-X, Rule 1-02(w)(1) or (2). 
 “Stated Maturity”, when used with respect
to any Security, means Apri1 15, 2017. 

  
 6 

 “Stock Price” means the price per share of Common Stock paid in connection
with a Fundamental Change transaction, which shall be equal to (i) if Holders of Common Stock receive only cash in such Fundamental Change transaction, the cash amount paid per share of Common Stock and (ii) in all other cases, the average
of the Closing Sale Prices of the Common Stock on the five Trading Days immediately before, but not including, the effective date of such Fundamental Change transaction. 
 “Subsidiary” means any person of which at least a majority of the outstanding Voting Stock shall at the time be directly or indirectly owned or controlled by the Company or by one or more
Subsidiaries, or by the Company and one or more Subsidiaries. 
 “Termination of Trading” means the occurrence,
at any time, of the Common Stock of the Company (or other common stock into which the Securities are then convertible) not being listed or admitted for trading on a U.S. national or regional securities exchange. 

“TIA” means the Trust Indenture Act of 1939 as in effect on the date of this Indenture; provided, however,
that in the event the TIA is amended after such date, TIA means, to the extent required by any such amendment, the TIA as so amended. 
 “Trading Day” means a day on which (i) trading in the Common Stock (or other security for which a Closing Sale Price must be determined) generally occurs on NASDAQ or, if the Common
Stock (or such other security) is not then listed on NASDAQ, on the principal other U.S. national or regional securities exchange on which the Common Stock (or such other security) is then listed or, if the Common Stock (or such other security) is
not then listed on a U.S. national or regional securities exchange, on the principal other market on which the Common Stock (or such other security) is then traded, and (ii) a Closing Sale Price for the Common Stock (or Closing Sale Price for
such other security) is available on such securities exchange or market; provided that for the purposes of determining the Conversion Settlement Amount upon conversion of Securities only, “Trading Day” means a day on which
(a) there is no Market Disruption Event and (b) trading in the Common Stock generally occurs on NASDAQ or, if the Common Stock is not then listed on NASDAQ, on the principal other U.S. national or regional securities exchange on which the
Common Stock is then listed or, if the Common Stock is not then listed on a U.S. national or regional securities exchange, on the principal other market on which the Common Stock is then traded. If the Common Stock (or such other security) is not so
listed or traded, “Trading Day” means a Business Day. 
 “Trading Price” of the Securities on any
date of determination means the average of the secondary market bid quotations per $1,000 principal amount of the Securities obtained by the Trustee for $2,000,000 principal amount of the Securities at approximately 3:30 p.m., New York City
time, on such determination date from three independent nationally recognized securities dealers the Company selects; provided that if at least three such bids cannot reasonably be obtained by the Trustee, but two such bids are obtained, then
the average of the two bids shall be used, and if only one such bid can reasonably be obtained by the Trustee, then one bid shall be used; provided further that if no such bids can reasonably be obtained, or in the Company’s
reasonable judgment the bid quotations are not indicative of the secondary market value of the Securities then for purposes of determining whether the condition to conversion of the Securities set forth in Section 10.01(a)(ii) has been
satisfied, the Trading Price per $1,000 principal amount of the Securities will be deemed to be less than 98% of the product of the Closing Sale Price of the Common Stock and the Applicable Conversion Rate on such date. 

  
 7 

 “Trustee” means the party named as the “Trustee” in the preamble
of this Indenture, unless and until a successor replaces it pursuant to the applicable provisions of this Indenture and, thereafter, shall mean such successor. The foregoing sentence shall likewise apply to any subsequent such successor or
successors. 
 “Voting Stock” of a person means Capital Stock of such person of the class or classes pursuant
to which the holders thereof have the general voting power under ordinary circumstances to elect at least a majority of the board of directors, managers or trustees of such person (irrespective of whether or not at the time Capital Stock of any
other class or classes shall have or might have voting power by reason of the happening of any contingency). 

“VWAP” per share of the Common Stock on any Trading Day means the volume weighted average price as displayed on
Bloomberg (or any successor service) page DLLR <EQUITY> AQR in respect of the period from 9:30 a.m. to 4:00 p.m., New York City time, on such Trading Day; or, if such price is not available, the market value per share of the Common Stock on
such day as determined by a nationally recognized independent investment banking firm retained for this purpose by the Company. VWAP will be determined without regard to after hours trading or any other trading outside of the regular trading session
trading hours. 
 Section 1.02. Other Definitions. 

 

			
	Terms:	  	Defined in Section:
	“Act”	  	1.05(a)
	“Additional Amounts Notice”	  	4.07
	“Agent Members”	  	2.12(e)(v)
	“Aggregate Share Cap”	  	10.03(c)
	“Applicable Conversion Rate”	  	10.02(a)
	“Bankruptcy Law”	  	6.01(i)
	“Conversion Agent”	  	2.03
	“Conversion Date”	  	10.02(d)
	“Conversion Notice”	  	10.02(c)
	“Conversion Obligation”	  	10.03(a)
	“Conversion Settlement Amount”	  	10.03(a)
	“Daily Settlement Amount”	  	10.03(a)(i)
	“Daily Share Amount”	  	10.03(a)(i)(B)
	“Daily Share Cap”	  	10.03(c)
	“Depositary”	  	2.01(b)
	“DTC”	  	2.01(b)
	“effective date”	  	10.01(c)
	“Event of Default”	  	6.01
	“Fundamental Change Repurchase Date”	  	3.02(a)
	“Fundamental Change Repurchase Notice”	  	3.02(c)
	“Fundamental Change Repurchase Price”	  	3.02(a)
	“Indemnitees”	  	7.07(c)

  
 8 

			
	Terms:	  	Defined in Section:
	“legal holiday”	  	12.08
	“Legend”	  	2.06(g)
	“Losses”	  	7.07(c)
	“Measurement Period”	  	10.01(a)(ii)
	“Merger Event”	  	10.06
	“Notice of Default”	  	6.01
	“Paying Agent”	  	2.03
	“QIBs”	  	2.01(b)
	“Reference Property”	  	10.06(a)
	“Registrar”	  	2.03
	“Rule 144A Information”	  	4.06
	“Share Cap”	  	10.03(c)
	“Spin Off”	  	10.04(c)
	“successor company”	  	5.01(a)
	“Trigger Event”	  	10.04(c)

 Section 1.03. Incorporation by Reference of Trust Indenture Act. Whenever this Indenture
refers to a provision of the TIA, the provision is incorporated by reference in and made a part of this Indenture. The following TIA terms used in this Indenture have the following meanings: 

“Commission” means the SEC. 
 “indenture securities” means the Securities. 
 “indenture
security holder” means a Securityholder. 
 “indenture to be qualified” means this Indenture.

 “indenture trustee” or “institutional trustee” means the Trustee. 

“obligor” on the indenture securities means the Company. 

All other TIA terms used in this Indenture that are defined by the TIA, defined by TIA reference to another statute or defined by SEC
rules have the meanings assigned to them by such definitions. 
 Section 1.04. Rules of Construction. Unless the
context otherwise requires: 
 (1) a term has the meaning assigned to it; 

(2) an accounting term not otherwise defined has the meaning assigned to it in accordance with generally accepted
accounting principles as in effect from time to time; 
 (3) “or” is not exclusive; 

(4) “including” means including, without limitation; 

  
 9 

 (5) words in the singular include the plural, and words in the plural
include the singular; and 
 (6) references to Sections and Articles are to references to Sections and Articles
of this Indenture. 
 Section 1.05. Acts of Holders. (a) Any request, demand, authorization, direction, notice,
consent, waiver or other action provided by this Indenture to be given or taken by Holders may be embodied in and evidenced by one or more instruments of substantially similar tenor signed by such Holders in person or by an agent duly appointed in
writing; and, except as herein otherwise expressly provided, such action shall become effective when such instrument or instruments are delivered to the Trustee and, where it is hereby expressly required, to the Company, as described in
Section 12.02. Such instrument or instruments (and the action embodied therein and evidenced thereby) are herein sometimes referred to as the “Act” of Holders signing such instrument or instruments. Proof of execution of any
such instrument or of a writing appointing any such agent shall be sufficient for any purpose of this Indenture and conclusive in favor of the Trustee and the Company, if made in the manner provided in this Section. 

(b) The fact and date of the execution by any person of any such instrument or writing may be proved by the affidavit of a witness of
such execution or by a certificate of a notary public or other officer authorized by law to take acknowledgments of deeds, certifying that the individual signing such instrument or writing acknowledged to such officer the execution thereof. Where
such execution is by a signer acting in a capacity other than such signer’s individual capacity, such certificate or affidavit shall also constitute sufficient proof of such signer’s authority. The fact and date of the execution of any
such instrument or writing, or the authority of the person executing the same, may also be proved in any other manner which the Trustee deems sufficient. 
 (c) The principal amount and serial number of any Security and the ownership of Securities shall be proved by the register for the Securities. 

(d) Any request, demand, authorization, direction, notice, consent, waiver or other Act of the Holder of any Security shall bind every
future Holder of the same Security, and the Holder of every Security issued upon the registration of transfer thereof or in exchange therefor or in lieu thereof, in respect of anything done, omitted or suffered to be done by the Trustee or the
Company in reliance thereon, whether or not notation of such action is made upon such Security. 
 (e) If the Company shall
solicit from the Holders any request, demand, authorization, direction, notice, consent, waiver or other Act, the Company may, at its option, by or pursuant to a Board Resolution, fix in advance a record date for the determination of Holders
entitled to give such request, demand, authorization, direction, notice, consent, waiver or other Act, but the Company shall have no obligation to do so. If such a record date is fixed, such request, demand, authorization, direction, notice,
consent, waiver or other Act may be given before or after such record date, but only the Holders of record at the close of business on such record date shall be deemed to be Holders for the purposes of determining whether Holders of the requisite

  
 10 

 
proportion of outstanding Securities have authorized or agreed or consented to such request, demand, authorization, direction, notice, consent, waiver or other Act, and for that purpose the
outstanding Securities shall be computed as of such record date; provided that no such authorization, agreement or consent by the Holders on such record date shall be deemed effective unless it shall become effective pursuant to the
provisions of this Indenture not later than six months after the record date. 
 ARTICLE 2 

THE SECURITIES 

Section 2.01. Form and Dating. (a) The Securities and the Trustee’s certificate of authentication shall be substantially
in the form of Exhibits A and B, which are a part of this Indenture. The Securities may have notations, legends or endorsements required by law, stock exchange rule or usage (provided that any such notation, legend or endorsement required by
usage is in a form acceptable to the Company). The Company shall provide any such notations, legends or endorsements to the Trustee in writing. Each Security shall be dated the date of its authentication. The Securities may, but need not, have the
corporate seal of the Company or a facsimile thereof affixed thereto or imprinted thereon. 
 (b) 144A Global Securities.
Securities offered and sold within the United States to qualified institutional buyers as defined in Rule 144A (“QIBs”) in reliance on Rule 144A shall be issued initially in the form of a 144A Global Security, which shall
be deposited with the Trustee at its Corporate Trust Office, as custodian for the Depositary (as defined below) and registered in the name of The Depository Trust Company (“DTC”) or the nominee thereof (DTC, or any successor
thereto, and any such nominee being hereinafter referred to as the “Depositary”), duly executed by the Company and authenticated by the Trustee as hereinafter provided. The aggregate principal amount of the 144A Global Securities
may from time to time be increased or decreased by adjustments made on the records of the Trustee and the Depositary as hereinafter provided. 
 (c) Global Securities in General. Each Global Security shall represent such of the outstanding Securities as shall be specified therein and each shall provide that it shall represent the aggregate amount
of outstanding Securities from time to time endorsed in the Schedule of Increases and Decreases of Global Security attached thereto and that the aggregate amount of outstanding Securities represented thereby may from time to time be reduced or
increased, as appropriate, to reflect exchanges, repurchases, redemptions and conversions. 
 Any adjustment of the aggregate
principal amount of a Global Security to reflect the amount of any increase or decrease in the amount of outstanding Securities represented thereby shall be made by the Trustee in accordance with instructions given by the Holder thereof as required
by Section 2.12 hereof, and shall be made on the records of the Trustee and the Depositary. 
 (d) Book-Entry Provisions.
This Section 2.01(d) shall apply only to Global Securities deposited with or on behalf of the Depositary. 

  
 11 

 The Company shall execute and the Trustee shall, in accordance with this
Section 2.01(d), authenticate and deliver initially one or more Global Securities that (i) shall be registered in the name of the Depositary or a nominee thereof, (ii) shall be delivered by the Trustee to the Depositary or held by the
Trustee pursuant to the Depositary’s instructions and (iii) shall be substantially in the form of Exhibit A attached hereto. 
 (e) Certificated Securities. Securities not issued as interests in the Global Securities shall be registered in the name of the Holder and issued in certificated form substantially in the form of Exhibit
B attached hereto. 
 Section 2.02. Execution and Authentication. The Securities shall be executed on behalf of the
Company by one Officer. The signature of such Officer on the Securities may be manual or facsimile. 
 Securities bearing the
manual or facsimile signature of an individual who was, at the time of the execution of the Securities, an Officer shall bind the Company, notwithstanding that such individual has ceased to hold such office prior to the authentication and delivery
of such Securities or did not hold such office at the date of authentication of such Securities. 
 No Security shall be
entitled to any benefit under this Indenture or be valid or obligatory for any purpose unless there appears on such Security a certificate of authentication substantially in the form provided for herein duly executed by the Trustee by manual
signature of an authorized signatory, and such certificate upon any Security shall be conclusive evidence, and the only evidence, that such Security has been duly authenticated and delivered hereunder. 

The Trustee shall authenticate and deliver the Securities for original issue in an aggregate principal amount of up to $200,000,000 (plus
up to an additional $30,000,000 upon exercise of the initial purchasers’ option to purchase additional Securities pursuant to the Purchase Agreement) upon one or more Company Orders without any further action by the Company. The aggregate
principal amount of the Securities due at the Stated Maturity thereof outstanding at any time may not exceed the amount set forth in the foregoing sentence. 
 The Securities shall be issued only in registered form without coupons and only in denominations of $1,000 of principal amount and any integral multiple of $1,000. 

Section 2.03. Registrar, Paying Agent, Bid Solicitation Agent and Conversion Agent. The Company shall maintain an office or
agency where Securities may be presented for registration of transfer or for exchange (“Registrar”), an office or agency where Securities may be presented for purchase or payment (“Paying Agent”) and an office or
agency where Securities may be presented for conversion (“Conversion Agent”). The Registrar shall keep a register of the Securities and of their transfer and exchange. The Company may have one or more co-registrars, one or more
additional paying agents, one or more additional bid solicitation agents and one or more additional conversion agents. The term Paying Agent includes any additional paying agent, including any named pursuant to Section 4.05. The term Conversion
Agent includes any additional conversion agent, including any named pursuant to Section 4.05. 
 The Company shall enter
into an appropriate agency agreement with any Registrar, Paying Agent, Conversion Agent, Bid Solicitation Agent or co-registrar (in each case, if such 

  
 12 

 
Registrar, agent or co-registrar is a person other than the Trustee). The agreement shall implement the provisions of this Indenture that relate to such agent. The Company shall promptly notify
the Trustee of the name and address of any such agent. If the Company fails to maintain a Registrar, Paying Agent, or Conversion Agent, the Trustee shall act as such and shall be entitled to appropriate compensation therefor pursuant to
Section 7.07. The Company or any Subsidiary or an Affiliate of either of them may act as Paying Agent, Registrar, Conversion Agent or co-registrar. 
 The Company initially appoints the Trustee as Registrar, Conversion Agent and Paying Agent in connection with the Securities. 
 Section 2.04. Paying Agent to Hold Money and Securities in Trust. Except as otherwise provided herein, on or prior to each due date of payments in respect of any Security, the Company shall
deposit with the Paying Agent a sum of money (in immediately available funds if deposited on the due date) or shares of Common Stock sufficient to make such payments when so becoming due. The Company shall require each Paying Agent (other than the
Trustee) to agree in writing that the Paying Agent shall hold in trust for the benefit of Securityholders or the Trustee all money and shares of Common Stock held by the Paying Agent for the making of payments in respect of the Securities and shall
promptly notify the Trustee of any Default by the Company in making any such payment. At any time during the continuance of any such Default, the Paying Agent shall, upon the written request of the Trustee, forthwith pay to the Trustee all money and
shares of Common Stock so held in trust. If the Company, a Subsidiary or an Affiliate of either of them acts as Paying Agent, it shall segregate the money and shares of Common Stock held by it as Paying Agent and hold it as a separate trust fund.
The Company at any time may require a Paying Agent to pay all money and shares of Common Stock held by it to the Trustee and to account for any funds and Common Stock disbursed by it. Upon doing so, the Paying Agent shall have no further liability
for the money or shares of Common Stock. 
 Section 2.05. Securityholder Lists. The Trustee shall preserve the most
recent list available to it of the names and addresses of Securityholders. If the Trustee is not the Registrar, the Company shall cause to be furnished to the Trustee at least semiannually on April 5 and October 5 a listing of
Securityholders dated as of the immediately preceding Interest Record Date, and at such other times as the Trustee may request in writing, a list in such form and as of such date as the Trustee may reasonably require of the names and addresses of
Securityholders. 
 Section 2.06. Transfer and Exchange. (a) Subject to Section 2.12 hereof, upon surrender for
registration of transfer of any Security, together with a written instrument of transfer satisfactory to the Registrar duly executed by the Securityholder or such Securityholder’s attorney duly authorized in writing, at the office or agency of
the Company designated as Registrar or co-registrar pursuant to Section 2.03, the Company shall execute, and the Trustee shall authenticate and deliver, in the name of the designated transferee or transferees, one or more new Securities of any
authorized denomination or denominations, of a like aggregate principal amount. The Company shall not charge a service charge for any registration of transfer or exchange, but the Company may require payment of a sum sufficient to pay all taxes,
assessments or other governmental charges that may be imposed in connection with the transfer or exchange of the Securities from the Securityholder requesting such transfer or exchange. 

  
 13 

 At the option of the Holder, Securities may be exchanged for other Securities of any
authorized denomination or denominations, of a like aggregate principal amount, upon surrender of the Securities to be exchanged, together with a written instrument of transfer satisfactory to the Registrar duly executed by the Securityholder or
such Securityholder’s attorney duly authorized in writing, at such office or agency. Whenever any Securities are so surrendered for exchange, the Company shall execute, and the Trustee shall authenticate and deliver, the Securities which the
Holder making the exchange is entitled to receive. 
 The Company shall not be required to make, and the Registrar need not
register, transfers or exchanges of Securities in respect of which a Fundamental Change Repurchase Notice has been given and not withdrawn by the Holder thereof in accordance with the terms of this Indenture (except, in the case of Securities to be
purchased in part, the portion thereof not to be purchased). 
 (b) Notwithstanding any provision to the contrary herein, so
long as a Global Security remains outstanding and is held by or on behalf of the Depositary, transfers of a Global Security, in whole or in part, shall be made only in accordance with Section 2.12 and this Section 2.06(b). Transfers of a
Global Security shall, except as set forth in Section 2.12, be limited to transfers of such Global Security in whole or in part, to the Depositary, to nominees of the Depositary or to a successor of the Depositary or such successor’s
nominee. 
 (c) Successive registrations and registrations of transfers and exchanges as aforesaid may be made from time to time
as desired, and each such registration shall be noted on the register for the Securities. 
 (d) Except as otherwise set forth
in this Indenture, any such action taken by a Holder shall be conclusive and binding upon such Holder and upon all future Holders and owners of such Security and of any Securities issued in exchange or substitution therefor, irrespective of whether
any notation in regard thereto is made upon such Security or any Security issued in exchange or substitution therefor. 
 (e)
Any Registrar appointed pursuant to Section 2.03 hereof shall provide to the Trustee such information as the Trustee may reasonably require in connection with the delivery by such Registrar of Securities upon transfer or exchange of Securities.

 (f) No Registrar shall be required to make registrations of transfer or exchange of Securities during any periods designated
in the text of the Securities or in this Indenture as periods during which such registrations of transfer and exchange need not be made. 
 (g) If Securities are issued upon the transfer, exchange or replacement of Securities subject to restrictions on transfer and bearing the legends relating to such restrictions imposed by the securities
laws set forth on the forms of Security attached hereto as Exhibits A and B setting forth such restrictions (collectively, the “Legend”), or if a request is made to remove the Legend on a Security, the Securities so issued shall
bear the Legend, or the Legend shall not be removed, as the case may be, unless there is delivered to the Company and the Registrar and the Trustee (if not the same person as the Registrar) such satisfactory evidence, which shall include an opinion
of counsel, as may be reasonably required by the Company and the Registrar and the Trustee (if 

  
 14 

 
not the same person as the Registrar), that neither the Legend nor the restrictions on transfer set forth therein are required to ensure that transfers thereof comply with the provisions of
Rule 144 under the Securities Act or that such Securities are not “restricted” within the meaning of Rule 144 under the Securities Act. Upon (i) provision of such satisfactory evidence, or (ii) notification by
the Company to the Trustee and Registrar of the sale of such Security pursuant to a registration statement that is effective at the time of such sale, the Trustee, at the written direction of the Company, shall authenticate and deliver a Security
that does not bear the Legend. If the Legend is removed from the face of a Security and the Security is subsequently held by the Company or an Affiliate of the Company, the Legend shall be reinstated. 

Section 2.07. Replacement Securities. If (a) any mutilated Security is surrendered to the Trustee, or (b) the
Company and the Trustee receive evidence to their satisfaction of the destruction, loss or theft of any Security, and there is delivered to the Company and the Trustee such security and/or indemnity as may be required by them to save each of them
harmless, then, in the absence of notice to the Company or the Trustee that such Security has been acquired by a bona fide purchaser, the Company shall execute and upon its written request the Trustee shall authenticate and deliver, in exchange for
any such mutilated Security or in lieu of any such destroyed, lost or stolen Security, a new Security of like tenor and principal amount, bearing a certificate number not contemporaneously outstanding. 

In case any such mutilated, destroyed, lost or stolen Security has become or is about to become due and payable, or is about to be
purchased by the Company pursuant to Article 3 hereof, the Company in its discretion may, instead of issuing a new Security, pay or purchase such Security, as the case may be. 

Upon the issuance of any new Securities under this Section 2.07, the Company may require the payment of a sum sufficient to cover
any tax or other governmental charge that may be imposed in relation thereto and any other expenses (including the fees and expenses of the Trustee) connected therewith. 
 Every new Security issued pursuant to this Section 2.07 in lieu of any mutilated, destroyed, lost or stolen Security shall constitute an additional obligation of the Company and shall be entitled to
all benefits of this Indenture equally and proportionately with any and all other Securities duly issued hereunder. 
 The
provisions of this Section 2.07 are exclusive and shall preclude (to the extent lawful) all other rights and remedies with respect to the replacement or payment of mutilated, destroyed, lost or stolen Securities. 

Section 2.08. Outstanding Securities; Determinations of Holders’ Action. Securities outstanding at any time are all the
Securities authenticated by the Trustee except for those cancelled by it, those purchased pursuant to Section 2.07, those delivered to it for cancellation and those described in this Section 2.08 as not outstanding. A Security does not
cease to be outstanding because the Company or an Affiliate thereof holds the Security; provided, however, that in determining whether the Holders of the requisite principal amount of Securities have given or concurred in any request,
demand, authorization, direction, notice, consent, waiver, or other Act hereunder, Securities owned by the Company or any other obligor upon the Securities 

  
 15 

 
or any Affiliate of the Company or such other obligor shall be disregarded and deemed not to be outstanding, except that, in determining whether the Trustee shall be protected in relying upon any
such request, demand, authorization, direction, notice, consent, waiver or other act, only Securities which a Responsible Officer of the Trustee actually knows to be so owned shall be so disregarded. Subject to the foregoing, only Securities
outstanding at the time of such determination shall be considered in any such determination (including, without limitation, determinations pursuant to Article 6 and Article 9). 

If a Security is replaced pursuant to Section 2.07, it ceases to be outstanding unless the Trustee receives proof satisfactory to it
that the replaced Security is held by a bona fide purchaser. 
 If the Paying Agent holds, in accordance with this Indenture, on
the Business Day immediately following a Fundamental Change Repurchase Date or on Stated Maturity, money or securities, if permitted hereunder, sufficient to pay Securities payable on that date, then from and after such Fundamental Change Repurchase
Date or Stated Maturity, as the case may be, such Securities shall cease to be outstanding, and Interest and any Additional Amounts on such Securities shall cease to accrue, whether or not book-entry transfer of the Securities has been made or the
Securities have been delivered to the Paying Agent, as the case may be. 
 If a Security is converted in accordance with
Article 10, then from and after the date of conversion, such Security shall cease to be outstanding, and Interest and any Additional Amounts shall cease to accrue and the rights of the Holders therein shall terminate (other than the right to
receive the Conversion Settlement Amount). 
 Section 2.09. Temporary Securities. Pending the preparation of
Certificated Securities, the Company may execute, and upon Company Order the Trustee shall authenticate and deliver, temporary Securities which are printed, lithographed, typewritten, mimeographed or otherwise produced, in any authorized
denomination, substantially of the tenor of the Certificated Securities in lieu of which they are issued and with such appropriate insertions, omissions, substitutions and other variations as the Officer executing such Securities may determine, as
conclusively evidenced by his or her execution of such Securities. 
 If temporary Securities are issued, the Company shall
cause Certificated Securities to be prepared without unreasonable delay. After the preparation of Certificated Securities, the temporary Securities shall be exchangeable for Certificated Securities upon surrender of the temporary Securities at the
office or agency of the Company designated for such purpose pursuant to Section 2.03, without charge to the Holder. Upon surrender for cancellation of any one or more temporary Securities, the Company shall execute and the Trustee shall
authenticate and deliver in exchange therefor a like principal amount of Certificated Securities of authorized denominations. Until so exchanged, the temporary Securities shall in all respects be entitled to the same benefits under this Indenture as
Certificated Securities. 
 Section 2.10. Cancellation. All Securities surrendered for payment, purchase by the
Company pursuant to Article 3, conversion or registration of transfer or exchange shall, if surrendered to any person other than the Trustee, be delivered to the Trustee and shall be promptly cancelled by it. The Company may at any time deliver
to the Trustee for cancellation 

  
 16 

 
any Securities previously authenticated and delivered hereunder which the Company may have acquired in any manner whatsoever, and all Securities so delivered shall be promptly cancelled by the
Trustee. The Company may not issue new Securities to replace Securities it has paid or delivered to the Trustee for cancellation other than in connection with registrations of transfer or exchange or that any Holder has converted pursuant to
Article 10. No Securities shall be authenticated in lieu of or in exchange for any Securities cancelled as provided in this Section, except as expressly permitted by this Indenture. All cancelled Securities held by the Trustee shall be disposed
of by the Trustee in accordance with the Trustee’s customary procedure. 
 Section 2.11. Persons Deemed Owners.
Prior to due presentment of a Security for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee may treat the person in whose name such Security is registered as the owner of such Security for the purpose of
receiving payment of the principal amount of the Security or any portion thereof, or the payment of any Fundamental Change Repurchase Price in respect thereof, and Interest or Additional Amounts thereon, for the purpose of conversion and for all
other purposes whatsoever, whether or not such Security be overdue, and neither the Company, the Trustee nor any agent of the Company or the Trustee shall be affected by notice to the contrary. 

Section 2.12. Global Securities. (a) Notwithstanding any other provisions of this Indenture or the Securities,
(A) transfers of a Global Security, in whole or in part, shall be made only in accordance with Section 2.06 and Section 2.12(a)(i) below, (B) transfers of a beneficial interest in a Global Security for a Certificated Security
shall comply with Section 2.06 and Section 2.12(a)(ii) below and Section 2.12(c) below, and (C) transfers of a Certificated Security shall comply with Section 2.06, Section 2.12(a)(iii) and Section 2.12(a)(iv)
below, as applicable. 
 (i) Transfer of Global Security. A Global Security may not be transferred, in
whole or in part, to any person other than the Depositary or a nominee or any successor thereof, and no such transfer to any such other person may be registered; provided that this Section 2.12(a)(i) shall not prohibit any transfer of a
Security that is issued in exchange for a Global Security but is not itself a Global Security. No transfer of a Security to any person shall be effective under this Indenture or the Securities unless and until such Security has been registered in
the name of such person. Nothing in this Section 2.12(a)(i) shall prohibit or render ineffective any transfer of a beneficial interest in a Global Security effected in accordance with the other provisions of this Section 2.12. 

(ii) Restrictions on Transfer of a Beneficial Interest in a Global Security for a Certificated Security. A
beneficial interest in a Global Security may not be exchanged for a Certificated Security except upon satisfaction of the requirements set forth in this clause (ii) and in Section 2.12(e) below. Upon receipt by the Trustee of a request to
transfer a beneficial interest in a Global Security in accordance with Applicable Procedures for a Certificated Security in the form satisfactory to the Trustee, together with: 

(A) so long as the Securities are Restricted Securities, a certification, in the form set forth in Exhibit C, that such
beneficial interest in a Global Security (1) is being transferred to a QIB in accordance with Rule 144A or (2) is being transferred pursuant to and in compliance with Rule 144 under the Securities Act or another exemption from
the securities laws (which is documented to the Company’s satisfaction); 

  
 17 

 (B) written instructions from the Holder to the Trustee to make, or direct
the Registrar to make, an adjustment on its books and records with respect to such Global Security to reflect a decrease in the aggregate principal amount of the Securities represented by the Global Security, such instructions to contain information
regarding the Depositary account to be decreased; and 
 (C) if the Company or the Trustee so requests, an
opinion of counsel or other evidence reasonably satisfactory to it as to the compliance with the restrictions set forth in the Legend, 
 then
the Trustee shall cause, or direct the Registrar to cause, in accordance with the standing instructions and procedures existing between the Depositary and the Registrar, the aggregate principal amount of the Securities represented by the Global
Security to be decreased by the aggregate principal amount of the Certificated Security to be issued, shall issue such Certificated Security and shall debit or cause to be debited to the account of the person specified in such instructions a
beneficial interest in the Global Security equal to the principal amount of the Certificated Security so issued. 

(iii) Transfer and Exchange of Certificated Securities. When Certificated Securities are presented to the Registrar
with a request: 
 (A) to register the transfer of such Certificated Securities; or 

(B) to exchange such Certificated Securities for an equal principal amount of Certificated Securities of other authorized
denominations, the Registrar shall register the transfer or make the exchange as requested if its reasonable requirements for such transaction are met; provided, however, that the Certificated Securities surrendered for transfer or
exchange: 
 (1) shall be duly endorsed or accompanied by a written instrument of transfer reasonably
satisfactory to the Company and the Registrar, duly executed by the Holder thereof or his attorney duly authorized in writing; and 
 (2) so long as such Securities are Restricted Securities, such Securities are being transferred or exchanged pursuant to an effective registration statement under the Securities Act or pursuant to
clause (x), (y) or (z) below, and are accompanied by the following additional information and documents, as applicable: 
 (x) if such Certificated Securities are being delivered to the Registrar by a Holder for registration in the name of such Holder, without transfer, a certification from such Holder to that effect; or

  
 18 

 (y) if such Certificated Securities are being transferred to the Company, a
certification to that effect (in the form set forth in Exhibit C); or 
 (z) if such Certificated Securities are
being transferred pursuant to an exemption from registration under the Securities Act, (i) a certification to that effect (in the form set forth in Exhibit C, if applicable) and (ii) if the Company or the Trustee so requests, an opinion of
counsel or other evidence reasonably satisfactory to it as to the compliance with the restrictions set forth in the Legend. 
 (iv) Restrictions on Transfer or Exchange of a Certificated Security for a Beneficial Interest in a Global Security. A Certificated Security may not be transferred or exchanged for a beneficial
interest in a Global Security except upon satisfaction of the requirements set forth below. 
 Upon receipt by the Trustee of a
Certificated Security, duly endorsed or accompanied by appropriate instruments of transfer, in form satisfactory to the Trustee, together with: 
 (A) so long as the Securities are Restricted Securities, a certification, in the form set forth in Exhibit C, that such Certificated Security (1) is being transferred to the Company, (2) is
being transferred to a QIB in accordance with Rule 144A or (3) is being transferred pursuant to and in compliance with Rule 144 under the Securities Act or another exemption from the securities laws (which is documented to the
Company’s satisfaction); 
 (B) written instructions from the Holder directing the Trustee to make, or to
direct the Registrar to make, an adjustment on its books and records with respect to such Global Security to reflect an increase in the aggregate principal amount of the Securities represented by the Global Security, such instructions to contain
information regarding the Depositary account to be credited with such increase; and 
 (C) if the Company or the
Trustee so requests, an opinion of counsel or other evidence reasonably satisfactory to it as to the compliance with the restrictions set forth in the Legend, 
 then the Trustee shall cancel such Certificated Security and cause, or direct the Registrar to cause, in accordance with the standing instructions and procedures existing between the Depositary and the
Registrar, the aggregate principal amount of Securities represented by the Global Security to be increased by the aggregate principal amount of the Certificated Security to be exchanged, and shall credit or cause to be credited to the account of the
person specified in such instructions a beneficial interest in the Global Security equal to the principal amount of the Certificated Security so cancelled. If no Global Securities are then outstanding, the Company shall issue and the Trustee shall
authenticate, upon written order of the Company in the form of an Officer’s Certificate, a new Global Security in the appropriate principal amount. 

  
 19 

 (b) Subject to the succeeding Section 2.12(c), every Security shall be subject to the
restrictions on transfer provided in the Legend, including the delivery of an opinion of counsel, if so required. Whenever any Restricted Security is presented or surrendered for registration of transfer or for exchange for a Security registered in
a name other than that of the Holder, such Security must be accompanied by a certificate in substantially the form set forth in Exhibit C, dated the date of such surrender and signed by the Holder of such Security, as to compliance with such
restrictions on transfer. The Registrar shall not be required to accept for such registration of transfer or exchange any Security not so accompanied by a properly completed certificate. 

(c) The restrictions imposed by the Legend upon the transferability of any Security shall cease and terminate when such Security has been
sold pursuant to an effective registration statement under the Securities Act or transferred in compliance with Rule 144 under the Securities Act (or any successor provision thereto) or, if earlier, upon the expiration of the holding period
applicable to sales thereof under Rule 144(k) under the Securities Act (or any successor provision thereto). Any Security as to which such restrictions on transfer shall have expired in accordance with their terms or shall have terminated
may, upon a surrender of such Security to the Registrar for exchange in accordance with the provisions of this Section 2.12 (accompanied, in the event that such restrictions on transfer have terminated by reason of a transfer in compliance with
Rule 144 under the Securities Act (or any successor provision thereto), by an opinion of counsel having substantial experience in practice under the Securities Act and otherwise reasonably acceptable to the Company and the Trustee, addressed to
the Company and the Trustee and in form acceptable to the Company and the Trustee, to the effect that the transfer of such Security has been made in compliance with Rule 144 under the Securities Act or such successor provision), be exchanged
for a new Security, of like tenor and aggregate principal amount, which shall not bear the restrictive Legend. The Company shall inform the Trustee of the effective date of any registration statement registering the Securities under the Securities
Act. The Trustee shall not be liable for any action taken or omitted to be taken by it in good faith in accordance with the aforementioned opinion of counsel or registration statement. 

(d) As used in the preceding two paragraphs of this Section 2.12, the term “transfer” includes any sale, pledge,
transfer, loan, hypothecation, or other disposition of any Security. 
 (e) The provisions of clauses (i), (ii), (iii), (iv),
(v) and (vi) below shall apply only to Global Securities: 
 (i) Notwithstanding any other provisions
of this Indenture or the Securities, a Global Security shall not be exchanged in whole or in part for a Security registered in the name of any person other than the Depositary or one or more nominees thereof; provided that a Global Security
may be exchanged for Securities registered in the names of any person designated by the Depositary in the event that (A) the Depositary has notified the Company that it is unwilling or unable to continue as Depositary for such Global Security,
or such Depositary has ceased to be a “clearing agency” registered under the Exchange Act, and a successor Depositary is not appointed by the Company within 60 days, or (B) an Event of Default has occurred and is continuing. Any
Global Security exchanged pursuant to clause (A) above shall be so exchanged in whole and not in part, 

  
 20 

 
and any Global Security exchanged pursuant to clause (B) above may be exchanged in whole or from time to time in part as directed by the Depositary. Any Security issued in exchange for a
Global Security or any portion thereof shall be a Global Security; provided that any such Security so issued that is registered in the name of a person other than the Depositary or a nominee thereof or any successor of either of the foregoing
pursuant to this paragraph shall not be a Global Security. 
 (ii) Securities issued in exchange for a Global
Security or any portion thereof shall be issued in definitive, fully registered form, shall have an aggregate principal amount equal to that of such Global Security or portion thereof to be so exchanged, shall be registered in such names and be in
such authorized denominations as the Depositary shall designate, and shall be substantially in the form of Exhibit B attached hereto and shall bear the applicable legends provided for therein. Any Global Security to be exchanged in whole shall be
surrendered by the Depositary to the Registrar. With regard to any Global Security to be exchanged in part, either such Global Security shall be so surrendered for exchange or, if the Trustee is acting as custodian for the Depositary or its nominee
with respect to such Global Security, the principal amount thereof shall be reduced by an amount equal to the portion thereof to be so exchanged, by means of an appropriate adjustment made on the records of the Trustee. Upon any such surrender or
adjustment, the Trustee shall authenticate and deliver the Security issuable on such exchange to or upon the order of the Depositary or an authorized representative thereof. 

(iii) Subject to the provisions of clause (v) below, the registered Holder may grant proxies and otherwise authorize
any person, including Agent Members (as defined below) and persons that may hold interests through Agent Members, to take any action which a Holder is entitled to take under this Indenture or the Securities. 

(iv) In the event of the occurrence of any of the events specified in clause (i) above, the Company shall
promptly make available to the Trustee a reasonable supply of Certificated Securities in definitive, fully registered form. 
 (v) Neither any members of, or participants in, the Depositary (collectively, the “Agent Members”) nor any other persons on whose behalf Agent Members may act shall have any rights under
this Indenture with respect to any Global Security registered in the name of the Depositary or any nominee thereof, or under any such Global Security, and the Depositary or such nominee, as the case may be, may be treated by the Company, the Trustee
and any agent of the Company or the Trustee as the absolute owner and Holder of such Global Security for all purposes whatsoever. Notwithstanding the foregoing, nothing herein shall prevent the Company, the Trustee or any agent of the Company or the
Trustee from giving effect to any written certification, proxy or other authorization furnished by the Depositary or such nominee, as the case may be, or impair, as between the Depositary, its Agent Members and any other person on whose behalf an
Agent Member may act, the operation of customary practices of such persons governing the exercise of the rights of a Holder of any Security. 
 (vi) Except as expressly set forth in this Indenture, including Sections 2.12(a)(ii) and 2.12(e), none of the Trustee, any Paying Agent, the Conversion

  
 21 

 
Agent, the Company or the Registrar shall have any responsibility or obligation to any beneficial owner in the Global Securities, a member of or a participant in the Depositary, or other person
with respect to the accuracy of the records of the Depositary or its nominee or of any participant or member thereof, with respect to any ownership interest in the Global Securities or with respect to the delivery to any participant, member,
beneficial owner or other person (other than the Depositary) of any notice or the payment of any amount under or with respect to such Global Securities. All notices and communications to be given to the Holders and all payments to be made to the
Holders under the Securities shall be given or made only to or upon the order of the registered Holders (which shall be, in the case of a Global Security, the Depositary or its nominee). The rights of beneficial owners in the Global Securities shall
be exercised only through the Depositary subject to the applicable rules and procedures of the Depositary. 
 Other than as set
forth in this Indenture, the Trustee, any Paying Agent, the Conversion Agent, the Company and the Registrar may rely upon, and shall be fully protected in relying upon, information furnished by the Depositary with respect to its members,
participants and any beneficial owners. Except as expressly set forth in this Indenture, including Sections 2.12(a)(ii) and 2.12(e), the Trustee, each Paying Agent, the Conversion Agent, the Company and the Registrar shall be entitled to deal
with any depositary (including the Depositary), and any nominee thereof, that is the Holder of any Global Securities as a Holder for all purposes of this Indenture relating to such Global Securities (including the payment of principal, Interest and
any Additional Amounts and the giving of instructions or directions by or to the owner or Holder of a beneficial ownership interest in such Global Securities) as the sole Holder of such Global Securities, and shall have no obligations to the
beneficial owners thereof. None of the Trustee, any Paying Agent, the Conversion Agent, the Company or the Registrar shall have any responsibility or liability for any acts or omissions of any such depositary with respect to such Global Securities,
for the records of any such depositary, including records in respect of beneficial ownership interests in respect of any such Global Securities, for any transactions between such depositary and any participant in such depositary or between or among
any such depositary, any such participant and/or any holder or owner of a beneficial interest in such Global Securities, or for any transfers of beneficial interests in any such Global Securities. 

(f) The Trustee and the Registrar shall have no obligation or duty to monitor, determine or inquire as to compliance with any
restrictions on transfer imposed under this Indenture or under applicable law with respect to any transfer of any interest in any Security (including any transfers between or among Agent Members or beneficial owners of interests in any Global
Security) other than to require delivery of such certificates and other documentation or evidence as are expressly required by, and to do so if and when expressly required by the terms of, this Indenture, and to examine the same to determine
substantial compliance as to form with the express requirements hereof. 
 The Trustee shall have no responsibility for the
actions or omissions of the Depositary, or the accuracy of the books and records of the Depositary. 
 Section 2.13.
CUSIP Numbers. The Company may issue the Securities with one or more “CUSIP”, “ISIN” or other similar numbers (if then generally in use), and, if it does so, the Trustee shall use “CUSIP”, “ISIN” or
other similar numbers in notices as a convenience to 

  
 22 

 
Holders; provided that any such notice may state that no representation is made as to the correctness of such numbers either as printed on the Securities or as contained in any notice of a
purchase and that reliance may be placed only on the other identification numbers printed on the Securities. The Company shall promptly notify the Trustee of any change in the CUSIP, ISIN or other similar numbers. 

Section 2.14. Payment. If any Interest Payment Date, Stated Maturity, Fundamental Change Repurchase Date, Conversion
Settlement Date or other date when payment is required to be made under this Indenture falls on a day that is not a Business Day, then the required payment will be made on the next succeeding Business Day with the same force and effect as if made on
the date that the payment was due, and no additional Interest will accrue on that payment for the period from and after the Interest Payment Date, Stated Maturity, Fundamental Change Repurchase Date, Conversion Settlement Date or other payment date,
as the case may be, to that next succeeding Business Day. 
 ARTICLE 3 

REPURCHASES 

Section 3.01. [Reserved] 
 Section 3.02. Repurchase of Securities at Option of the Holder Upon a Fundamental Change. (a) If a Fundamental Change occurs, each Holder shall have the right, at such Holder’s option, to
require the Company to repurchase for cash all of such Holder’s Securities, or any portion thereof that is equal to or an integral multiple of $1,000 principal amount, at a repurchase price equal to 100% of the principal amount of the
Securities repurchased, plus accrued and unpaid Interest and any accrued and unpaid Additional Amounts on those Securities (the “Fundamental Change Repurchase Price”) to, but not including, a date specified by the Company in the
notice of a Fundamental Change mailed by the Company pursuant to Section 3.02(b) that is not less than 20 nor more than 35 calendar days following the date of such notice (the “Fundamental Change Repurchase Date”), subject to
satisfaction by or on behalf of the Holder of the requirements set forth in Section 3.02(c). If the Fundamental Change Repurchase Date is on a date that is after an Interest Record Date and on or prior to the corresponding Interest Payment
Date, the Fundamental Change Repurchase Price shall be 100% of the principal amount of the Securities repurchased. 
 (b) No
later than 15 calendar days after the occurrence of a Fundamental Change, the Company shall mail a Company Notice of the Fundamental Change (substantially in the form of Exhibit D) to the Trustee, the Paying Agent and each Holder (and beneficial
owners if required by applicable law) on the date of the Fundamental Change. The Company Notice shall include a form of Fundamental Change Repurchase Notice to be completed by the Holder, and shall state: 

(i) briefly, the events causing a Fundamental Change and the date of such Fundamental Change; 

(ii) the date by which the Fundamental Change Repurchase Notice pursuant to this Section 3.02 must be delivered to
the Paying Agent in order for a Holder to exercise the repurchase rights; 

  
 23 

 (iii) the Fundamental Change Repurchase Date; 

(iv) the Fundamental Change Repurchase Price; 

(v) the name and address of the Paying Agent and the Conversion Agent; 

(vi) the Applicable Conversion Rate, including any increase in the Conversion Rate pursuant to Section 10.01(c);

 (vii) that the Securities as to which a Fundamental Change Repurchase Notice has been given may be converted
if they are otherwise convertible pursuant to Article 10 hereof only if the Fundamental Change Repurchase Notice has been withdrawn in accordance with the terms of this Indenture; 

(viii) that the Securities must be surrendered to the Paying Agent (by effecting book-entry transfer of the Securities or
delivering Certificated Securities, together with necessary endorsements, as the case may be) to collect payment; 
 (ix) that the Fundamental Change Repurchase Price for any Security as to which a Fundamental Change Repurchase Notice has been duly given and not withdrawn shall be paid promptly following the later of
the Business Day immediately following the Fundamental Change Repurchase Date and the time of surrender of such Security as described in clause (viii); 
 (x) briefly, the procedures the Holder must follow to exercise rights under this Section 3.02; 
 (xi) briefly, the conversion rights, if any, that exist on the Securities at the date of the Company Notice and as a result of such Fundamental Change; 

(xii) the procedures for withdrawing a Fundamental Change Repurchase Notice; 

(xiii) that, unless the Company defaults in making payment of such Fundamental Change Repurchase Price, Interest and any
Additional Amounts on such Securities covered by any Fundamental Change Repurchase Notice shall cease to accrue from and after the Fundamental Change Repurchase Date; and 

(xiv) the CUSIP, “ISIN” or other similar number(s), as the case may be, of the Securities. 

At the Company’s request, the Trustee shall give such Company Notice to each Holder in the Company’s name and at the
Company’s expense; provided, however, that, in all cases, the text of such Company Notice shall be prepared by the Company. 
 (c) A Holder may exercise its rights specified in this Section 3.02 upon delivery of a written notice of repurchase (a “Fundamental Change Repurchase Notice”) to the Paying Agent at
any time prior to the close of business on the Business Day immediately preceding the Fundamental Change Repurchase Date, stating: 
 (i) if Certificated Securities have been issued, the certificate number(s) of the Securities which the Holder shall deliver to be repurchased or, if Certificated Securities have not been issued, the
Fundamental Change Repurchase Notice shall comply with the appropriate Depositary procedures for book-entry transfer; 

  
 24 

 (ii) the portion of the principal amount of the Security which the Holder
shall deliver to be repurchased, which portion must be $1,000 or an integral multiple of $1,000; and 
 (iii)
that such Security shall be repurchased pursuant to the terms and conditions specified in Section 4 of the Securities and in this Indenture. 
 The delivery of such Security (together with all necessary endorsements) and the Fundamental Change Repurchase Notice to the Paying Agent at the offices of the Paying Agent shall be a condition to the
receipt by the Holder of the Fundamental Change Repurchase Price therefor; provided, however, that such Fundamental Change Repurchase Price shall be so paid pursuant to this Section 3.02 only if the Security (together with all
necessary endorsements) so delivered to the Paying Agent shall conform in all respects to the description thereof set forth in the related Fundamental Change Repurchase Notice. 

The Company shall repurchase from the Holder thereof, pursuant to this Section 3.02, a portion of a Security if the principal amount
of such portion is $1,000 or an integral multiple of $1,000. Provisions of this Indenture that apply to the repurchase of all of a Security also apply to the repurchase of such portion of such Security. 

Any repurchase by the Company contemplated pursuant to the provisions of this Section 3.02 shall be consummated by the delivery of
the Fundamental Change Repurchase Price promptly following the later of the Fundamental Change Repurchase Date or the time of delivery of such Security (together with all necessary endorsements or notifications of book-entry transfer). 

Notwithstanding anything herein to the contrary, any Holder delivering to the Paying Agent the Fundamental Change Repurchase Notice
contemplated by this Section 3.02(c) shall have the right to withdraw such Fundamental Change Repurchase Notice by delivery of a written notice of withdrawal to the Paying Agent in accordance with Section 3.03(b) at any time prior to the
close of business on the Business Day immediately preceding the Fundamental Change Repurchase Date. 
 The Paying Agent shall
promptly notify the Company of the receipt by it of any Fundamental Change Repurchase Notice or written withdrawal thereof. 

Section 3.03. Effect of Fundamental Change Repurchase Notice. (a) Upon receipt by the Paying Agent of the Fundamental Change
Repurchase Notice specified in Section 3.02, the Holder of the Security in respect of which such Fundamental Change Repurchase Notice was given shall (unless such Fundamental Change Repurchase Notice is withdrawn as specified in

  
 25 

 
Section 3.03(b)) thereafter be entitled solely to receive the Fundamental Change Repurchase Price with respect to such Security whether or not the Security is, in fact, properly delivered.
Such Fundamental Change Repurchase Price shall be paid to such Holder, subject to receipt of funds and/or securities by the Paying Agent, promptly following the later of (x) the Fundamental Change Repurchase Date with respect to such Security
(provided the conditions in Section 3.02 have been satisfied) and (y) the time of delivery of such Security to the Paying Agent by the Holder thereof in the manner required by Section 3.02. Securities in respect of which a
Fundamental Change Repurchase Notice has been given by the Holder thereof may not be converted pursuant to and to the extent permitted by Article 10 hereof on or after the date of the delivery of such Fundamental Change Repurchase Notice unless
such Fundamental Change Repurchase Notice has first been validly withdrawn as specified in Section 3.03(b). 
 (b) A
Fundamental Change Repurchase Notice may be withdrawn by means of a written notice of withdrawal delivered to the office of the Paying Agent at any time, if received by the Paying Agent prior to the close of business on the Business Day immediately
preceding the Fundamental Change Repurchase Date specifying: 
 (i) the principal amount, if any, of such
Security which remains subject to the original Fundamental Change Repurchase Notice and which has been or shall be delivered for purchase by the Company; 
 (ii) if Certificated Securities have been issued, the certificate number, if any, of the Security in respect of which such notice of withdrawal is being submitted (or, if Certificated Securities have not
been issued, that such withdrawal notice shall comply with the appropriate Depositary procedures); and 
 (iii)
the principal amount of the Security with respect to which such notice of withdrawal is being submitted. 
 Section 3.04.
Deposit of Fundamental Change Repurchase Price. Prior to 11:00 a.m. (local time in the City of New York) on the Fundamental Change Repurchase Date, the Company shall deposit with the Paying Agent (or, if the Company or a Subsidiary or an
Affiliate of either of them is acting as the Paying Agent, shall segregate and hold in trust as provided in Section 2.04) an amount of cash in immediately available funds sufficient to pay the aggregate Fundamental Change Repurchase Price of
all the Securities or portions thereof which are to be purchased as of the Fundamental Change Repurchase Date. 

Section 3.05. Securities Purchased in Part. Any Certificated Security which is to be purchased only in part (but any such
partial purchase shall be in minimum principal amounts equal to $1,000 or an integral multiple of $1,000) shall be surrendered at the office of the Paying Agent (with, if the Company or the Trustee so requires, due endorsement by, or a written
instrument of transfer satisfactory to the Company and the Trustee duly executed by, the Holder thereof or such Holder’s attorney duly authorized in writing), and the Company shall execute and the Trustee shall authenticate and deliver to the
Holder of such Security, without service charge, a new Security or Securities of any authorized denomination as requested by such Holder in aggregate principal amount equal to, and in exchange for, the portion of the principal amount of the Security
so surrendered which is not purchased. 

  
 26 

 Section 3.06. Covenant to Comply with Securities Laws Upon Purchase of
Securities. When complying with the provisions of Section 3.02 hereof (provided that such offer or purchase constitutes an “issuer tender offer” for purposes of Rule 13e-4 (which term, as used herein, includes any successor
provision thereto) under the Exchange Act at the time of such offer or purchase), and subject to any exemptions available under applicable law, the Company shall, if then applicable, (i) comply with Rule 13e-4 and Rule 14e-1 (or any
successor provisions) and any other applicable tender offer rules under the Exchange Act, (ii) file a Schedule TO (or any successor schedule, form or report) or any other schedule required under the Exchange Act, and (iii) otherwise comply
with all federal and state securities laws so as to permit the rights and obligations under Section 3.02 to be exercised in the time and in the manner specified in Section 3.02. 

Section 3.07. Repayment to the Company. The Trustee and the Paying Agent shall return to the Company any cash that remains
unclaimed as provided in Section 10 of the Securities, together with interest, if any, thereon (subject to the provisions of Section 7.01(f)), held by them for the payment of the Fundamental Change Repurchase Price. 

ARTICLE 4 

COVENANTS 

Section 4.01. Payment of Securities. The Company shall make all payments in respect of the Securities on the dates and in the
manner provided in the Securities or pursuant to this Indenture. Any amounts of cash in immediately available funds or shares of Common Stock to be given to the Trustee or Paying Agent shall be deposited with the Trustee or Paying Agent by 11:00
a.m., New York City time, by the Company on the applicable payment date. The principal amount of, and Interest and any Additional Amounts on, the Securities, and the Fundamental Change Repurchase Price and amounts payable on conversion shall be
considered paid on the applicable date due if on such date (which, in the case of a Fundamental Change Repurchase Price, shall be on the Business Day immediately following the applicable Fundamental Change Repurchase Date) the Trustee or the Paying
Agent holds, in accordance with this Indenture, cash or securities, if permitted hereunder, sufficient to pay all such amounts then due. 
 Section 4.02. SEC and Other Reports. The Company shall deliver to the Trustee copies of its annual report and of the information, documents and other reports (or copies of such portions of any
of the foregoing as the SEC may by rules and regulations prescribe) which the Company is required to file with the SEC pursuant to Section 13 or 15(d) of the Exchange Act within 15 days after it is required to file such annual and quarterly
reports, information, documents and other reports with the SEC; provided, however, that, to the extent permitted by law, any such document, information and other reports filed and publicly available through the SEC’s EDGAR filing system shall
be deemed to have been received by the Trustee. The Company shall also comply with the other provisions of TIA Section 314(a). Delivery of such reports, information and documents to the Trustee is for informational purposes only, and the
Trustee’s receipt of such shall not constitute constructive notice of any information contained therein or determinable from information contained therein, including the Company’s compliance with any of its covenants hereunder (as to which
the Trustee is entitled to rely exclusively on Officer’s Certificates). 

  
 27 

 Section 4.03. Compliance Certificate. The Company shall deliver to the Trustee
within 120 days after the end of each fiscal year of the Company (beginning with the Company’s fiscal year ending June 30, 2012) an Officer’s Certificate, stating whether or not, to the knowledge of the signer thereof, the Company is
in default in the performance and observance of any of the terms, provisions and conditions of this Indenture (without regard to any period of grace or requirement of notice provided hereunder), and if the Company shall be in default, specifying all
such defaults and the nature and status thereof of which such Officer may have knowledge, and shall otherwise comply with Section 314(a)(4) of the TIA. 
 The Company shall, so long as any of the Securities are outstanding, deliver to the Trustee, promptly upon any executive officer of the Company becoming aware of any Default or Event of Default, an
Officer’s Certificate specifying such Default or Event of Default, and what action the Company is taking or proposes to take with respect thereto. 
 Section 4.04. Further Instruments and Acts. The Company shall execute and deliver such further instruments and do such further acts as may be reasonably necessary or proper to carry out
more effectively the purposes of this Indenture. 
 Section 4.05. Maintenance of Office or Agency. The Company shall
maintain in the Borough of Manhattan, the City of New York, an office or agency of the Trustee, Registrar, Paying Agent and Conversion Agent where Securities may be presented or surrendered for payment, where Securities may be surrendered for
registration of transfer, exchange, purchase or conversion, and where notices and demands to or upon the Company in respect of the Securities and this Indenture may be served. The office of the Trustee, located at 100 Wall Street, Suite 1600, New
York, New York 10005, shall initially be such office or agency for all of the aforesaid purposes. Such office or agency need not be the principal securities clearance or processing office of the Trustee. The Company shall give prompt written notice
to the Trustee of the location, and of any change in the location, of any such office or agency (other than a change in the location of the office of the Trustee). If at any time the Company shall fail to maintain any such required office or agency
or shall fail to furnish the Trustee with the address thereof, such presentations, surrenders, notices and demands may be made or served at the address of the Trustee set forth in Section 12.02. 

The Company may also from time to time designate one or more other offices or agencies where the Securities may be presented or
surrendered for any or all such purposes, and may from time to time rescind such designations; provided, however, that no such designation or rescission shall in any manner relieve the Company of its obligation to maintain an office or
agency in the Borough of Manhattan, the City of New York, for such purposes. 
 Section 4.06. Delivery of Certain
Information. At any time when the Company is not subject to Section 13 or 15(d) of the Exchange Act until such time as neither the Securities nor any shares of Common Stock issued upon conversion of the Securities are “restricted
securities” within the meaning of Rule 144 of the Securities Act, the Company shall promptly furnish or cause to be furnished Rule 144A Information (as defined below) upon the written request of a Holder or any beneficial owner of
Securities or Holder or beneficial owner of shares of Common Stock issued upon conversion thereof, to such Holder or any beneficial owner of Securities or Holder or beneficial owner of shares of Common Stock issued upon conversion

  
 28 

 
thereof, or to a prospective purchaser of any such security designated by any such Holder or beneficial owner, as the case may be, to the extent required to permit compliance by such Holder or
beneficial owner with Rule 144A in connection with the resale of any such security. “Rule 144A Information” shall be such information as is specified pursuant to Rule 144A(d)(4) under the Securities Act. Whether
a person is a beneficial owner shall be determined by the Company to the Company’s reasonable satisfaction. 

Section 4.07. Additional Amounts Notice. In the event that the Company is required to pay Additional Amounts to Holders of
Securities pursuant to Section 4.09 or Section 6.01, the Company shall provide written notice (“Additional Amounts Notice”) to the Trustee of its obligation to pay Additional Amounts prior to the required payment date for
the Additional Amounts, and the Additional Amounts Notice shall set forth the amount of Additional Amounts to be paid by the Company on such payment date. The Trustee shall not at any time be under any duty to any Holder of Securities to determine
the Additional Amounts, or with respect to the nature, extent or calculation of the amount of Additional Amounts when made, or with respect to the method employed in such calculation of the Additional Amounts. 

Section 4.08. Resale of the Securities. During the period of two years after the last date of original issuance of the
Securities, the Company shall not, and shall not permit any of its Affiliates to, resell any of the Securities that constitute “restricted securities” under Rule 144 under the Securities Act that have been reacquired by any of
them. 
 Section 4.09. No Registration Rights; Additional Interest. 

(a) If, at any time during the six-month period beginning on, and including, the date which is six months after the last date of original
issuance of the Securities, the Company either (i) fails to timely file any document or report that the Company is required to file with the SEC pursuant to Section 13 or l5(d) of the Exchange Act, as applicable (after giving effect to all
applicable grace periods thereunder and other than current reports on Form 8-K), or (ii) the Securities are not otherwise freely tradable by holders other than Affiliates or the Company (as a result of restrictions pursuant to U.S. securities
law or the terms of this Indenture or the Securities) (each an “Additional Interest Event”), the Company will pay additional interest on the Securities. Additional interest will accrue on the Securities at the rate of 0.50% per
annum of the principal amount of Securities outstanding for each day during which an Additional Interest Event has occurred and is continuing. 
 (b) The Company will use its reasonable best efforts to have an unrestricted CUSIP assigned to the Securities and to have the Legend on the Securities removed as of the 365th day after the last date of
original issuance of the Securities. 
 (c) Until such time as the Company notifies the Trustee to remove the Legend from the
Securities, the applicable restricted CUSIP number will be the CUSIP number for the Securities. At such time as the Company notifies the Trustee to remove the restrictive legend from the Securities, such legend will be deemed removed from any Global
Security and the unrestricted CUSIP number for the Securities will be deemed to be the CUSIP number for the Securities. 

  
 29 

 (d) Additional interest payable pursuant to Section 4.09(a) will be payable in arrears
on each Interest Payment Date following accrual in the same manner as regular Interest on the Securities. 
 ARTICLE 5

 SUCCESSOR COMPANY 
 Section 5.01. When Company May Merge or Transfer Assets. The Company shall not consolidate with or merge with or into any other person or convey, transfer or lease all or substantially all its
assets to another person, unless: 
 (a) the resulting, surviving or transferee person (the “successor
company”) shall be a corporation organized and existing under (i) the laws of the United States of America, any state thereof or the District of Columbia, or (ii) any other jurisdiction so long as the successor company agrees to
submit to service of process in any state in the United States of America or the District of Columbia and, in the case of clause (ii) above, the successor company provides a full and unconditional indemnity and provision for additional
amounts for any incremental amounts required to be withheld from payments or deliveries to Holders or beneficial owners of the Securities under applicable United States or foreign laws, rules, regulations or authorities, and any other incremental
tax liabilities or costs of such Holders or beneficial owners as a result of such merger or other transaction, and in each case the successor company (if not the Company) will expressly assume, by a supplemental indenture, executed and delivered to
the Trustee, in form reasonably satisfactory to the Trustee, all of the Company’s obligations under the Securities and this Indenture; 
 (b) immediately after giving effect to such transaction, no Default or Event of Default shall have occurred and be continuing; 
 (c) the Company shall have delivered to the Trustee an Officer’s Certificate and an Opinion of Counsel, each stating that such consolidation, merger or transfer and, if a supplemental indenture is
required in connection with such transaction, such supplemental indenture, comply with this Article 5; and 
 (d) the
Company shall have delivered to the Trustee an Opinion of Counsel to the effect that the Holders or beneficial owners of the Securities will not recognize income, gain or loss for U.S. federal income tax purposes as a result of such transaction and
will be subject to U.S. federal income tax in no greater amount, in substantially the same manner and at no earlier times as would have been the case if the transaction had not occurred, except where any of the foregoing are subject to the
indemnification provided for in Section 5.01(a) above. 
 For purposes of the foregoing, the transfer (by lease,
assignment, sale or otherwise) of the properties and assets of one or more Subsidiaries (other than to the Company or another Subsidiary), which, if such assets were owned by the Company, would constitute all or substantially all of the properties
and assets of the Company and its Subsidiaries, taken as a whole, shall be deemed to be the transfer of all or substantially all of the properties and assets of the Company. 

  
 30 

 The successor company formed by such consolidation or into which the Company is merged or
the successor company to which such conveyance, transfer, lease or other disposition is made shall succeed to, and be substituted for, and may exercise every right and power of, the Company under this Indenture with the same effect as if such
successor had been named as the Company herein; and thereafter, except in the case of a conveyance, transfer or lease of all or substantially all the Company’s assets (in which case the Company will not be discharged from the obligation to pay
the principal amount of the Securities and Interest, including any Additional Amounts) and except for obligations, if any, that the Company may have under a supplemental indenture, the Company shall be discharged from all obligations and covenants
under this Indenture and the Securities. Subject to Section 9.06, the Company, the Trustee and the successor company shall enter into a supplemental indenture to evidence the succession and substitution of such successor company and such
discharge and release of the Company. 
 ARTICLE 6 
 DEFAULTS AND REMEDIES 
 Section 6.01. Events of Default. So long as
any Securities are outstanding, each of the following shall be an “Event of Default”: 
 (a) following the
exercise by the Holder of the right to convert a Security in accordance with Article 10 hereof, the Company fails to comply with its obligations to deliver the cash and shares of Common Stock, if any, required to be delivered as part of the
applicable Conversion Settlement Amount on the applicable Conversion Settlement Date; 
 (b) the Company defaults in its
obligation to provide timely notice of a Fundamental Change to the Trustee and each Holder as required under Section 3.02(b); 
 (c) the Company defaults in the payment of the principal amount of any Security when due at maturity, upon redemption, repurchase or otherwise (including, without limitation, upon the exercise by a Holder
of its right to require the Company to repurchase such Securities pursuant to and in accordance with Section 3.02 hereof); 

(d) the Company defaults in the payment of any Interest, including any Additional Amounts, when due and payable, and continuance of such
default for a period of 30 days past the applicable due date; 
 (e) the Company fails to comply with its obligation to
repurchase the Securities at the option of a Holder pursuant to Section 3.02 hereof; 
 (f) the Company fails to perform or
observe any other term, covenant or warranty or agreement in the Securities or this Indenture (other than those referred to in clause (a) through clause (e) above) and such failure continues for 60 days after receipt by the Company of a
Notice of Default; 
 (g) the Company fails to make any payment by the end of any applicable grace period after maturity or
acceleration of indebtedness for borrowed money of the Company or its Subsidiaries in an amount in excess of $20,000,000 and continuance of such failure; 

  
 31 

 (h) the Company or any of its Significant Subsidiaries fails to pay final judgments
aggregating in excess of $20,000,000, which judgments are not paid, discharged or stayed for a period of 60 days; 
 (i) the
entry by a court having jurisdiction in the premises of (i) a decree or order for relief in respect of the Company or any of its Significant Subsidiaries, in an involuntary case or proceeding under any applicable bankruptcy, insolvency,
reorganization or other similar law (any “Bankruptcy Law”) or (ii) a decree or order adjudging the Company or any Significant Subsidiary, a bankrupt or insolvent, or approving as properly filed a petition seeking
reorganization, arrangement, adjustment or composition of or in respect of the Company or any Significant Subsidiary, under any applicable Bankruptcy Law, or appointing a custodian, receiver, liquidator, assignee, trustee, sequestrator or other
similar official of the Company or any Significant Subsidiary or of any substantial part of any of their property, or ordering the winding up or liquidation of its affairs, and the continuance of any such decree or order for relief or any such other
decree or order described in clause (i) or (ii) above is unstayed and in effect for a period of 60 consecutive days; and 
 (j) (i) the commencement by the Company or any Significant Subsidiary, of a voluntary case or proceeding under any applicable Bankruptcy Law or of any other case or proceeding to be adjudicated a
bankrupt or insolvent, or (ii) the consent by the Company or any Significant Subsidiary, to the entry of a decree or order for relief in respect of the Company or any Significant Subsidiary, in an involuntary case or proceeding under any
applicable Bankruptcy Law or to the commencement of any bankruptcy or insolvency case or proceeding against the Company or any Significant Subsidiary, or (iii) the filing by the Company or any Significant Subsidiary, of a petition or answer or
consent seeking reorganization or relief under any applicable Bankruptcy Law, or (iv) the consent by the Company or any Significant Subsidiary to the filing of such petition or to the appointment of or the taking possession by a custodian,
receiver, liquidator, assignee, trustee, sequestrator or other similar official of the Company or any Significant Subsidiary or of any substantial part of any of their property, or (v) the making by the Company or any Significant Subsidiary, of
a general assignment for the benefit of creditors, or the admission by the Company or any Significant Subsidiary, in writing of its inability to pay its debts generally as they become due. 

The foregoing shall constitute Events of Default whatever the reason for any such Event of Default and whether it is voluntary or
involuntary or is effected by operation of law or pursuant to any judgment, decree or order of any court or any order, rule or regulation of any administrative or governmental body. 

Notwithstanding the foregoing, clause (f) above shall not constitute an Event of Default until the Trustee notifies the
Company, or the Holders of at least 25% in aggregate principal amount of the Securities at the time outstanding notify the Company and the Trustee, of such default and the Company does not cure such default (and such default is not waived) within
the time specified in clause (f) above (subject to the provisions of Section 6.01(k) below) after actual receipt of such notice. Any such notice must specify the default, demand that it be remedied and state that such notice is a
“Notice of Default.” 

  
 32 

 (k) Notwithstanding anything to the contrary in this Indenture, to the extent elected by the
Company in its sole discretion, the sole remedy for an Event of Default described in clause (f) above relating to the failure to comply with Section 4.02 hereof or the failure to comply with Section 314(a)(1) of the TIA, if
applicable, will for the first 180 days after the occurrence of such an Event of Default consist exclusively of the right to receive additional interest on the Securities at an annual rate equal to 0.25% of the principal amount of the Securities.
This additional interest will be in addition to any Additional Amounts on the Securities that may accrue as a result of Section 4.09 and will be payable on the same dates and in the same manner as Interest accruing on the Securities. The
additional interest will accrue on all outstanding Securities from and including the date on which an Event of Default relating to the failure to comply with Section 4.02 hereof or the failure to comply with Section 314(a)(1) of the TIA
first occurs, to but not including, the 180th day thereafter (or such earlier date on which the Event of Default relating to the failure to comply with Section 4.02 or the failure to comply with Section 314(a)(1) of the TIA shall have been
cured or waived). On such 180th day (or earlier, if the Event of Default relating to the failure to comply with Section 4.02 or the failure to comply with Section 314(a)(1) of the TIA is cured or waived prior to such 180th day), such
additional interest will cease to accrue and, if the Event of Default relating to the failure to comply with Section 4.02 or the failure to comply with Section 314(a)(1) of the TIA has not been cured or waived prior to such 180th day, the
Securities will be subject to acceleration as provided in Section 6.02 hereof. The provisions of this paragraph will not affect the rights of Holders of Securities in the event of the occurrence of any other Event of Default. In the event the
Company does not timely elect to pay the additional interest upon an Event of Default relating to the failure to comply with Section 4.02 or the failure to comply with Section 314(a)(1) of the TIA in accordance with this paragraph, the
Securities will be subject to acceleration as provided in Section 6.02 hereof. To make such election, the Company must notify the Holders, the Trustee and the Paying Agent of such election on or prior to the date such failure to comply with
Section 4.02 or the failure to comply with Section 314(a)(1) of the TIA becomes an Event of Default. 

Section 6.02. Acceleration. If an Event of Default (other than an Event of Default specified in Section 6.01(i) or
Section 6.01(j) with respect to the Company) occurs and is continuing (the Event of Default not having been cured or waived), the Trustee by notice to the Company, or the Holders of at least 25% in aggregate principal amount of the Securities
at the time outstanding by notice to the Company and the Trustee, may declare the principal amount of the Securities and any accrued and unpaid Interest and any accrued and unpaid Additional Amounts on all the Securities to be immediately due and
payable. Upon such a declaration, such accelerated amount shall be due and payable immediately. If an Event of Default specified in Section 6.01(i) or Section 6.01(j) with respect to the Company occurs and is continuing, the principal
amount of the Securities and any accrued and unpaid Interest and any accrued and unpaid Additional Amounts on all the Securities shall become and be immediately due and payable without any declaration or other act on the part of the Trustee or any
Securityholders. The Holders of a majority in aggregate principal amount of the Securities at the time outstanding, by notice to the Trustee and the Company (and without notice to any other Securityholder), may rescind an acceleration and its
consequences, and thereby waive the Events of Default giving rise to such acceleration, if (a) no judgment or decree for payment of amounts due has been obtained by the Trustee; (b) the Company has paid (or deposited with the Trustee a sum
sufficient to pay) (1) all overdue Interest, including any Additional Amounts, on all Securities; (2) the principal 

  
 33 

 
amount of any Securities that have become due otherwise than by such declaration of acceleration; (3) to the extent that payment of such Interest, including any Additional Amounts, is
lawful, Interest upon overdue Interest, including any Additional Amounts; and (4) all sums paid or advanced by the Trustee under this Indenture and the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and
counsel; and (c) all existing Events of Default have been cured or waived except nonpayment of the principal amount of the Securities and any accrued and unpaid interest and any accrued and any unpaid Additional Amounts that have become due
solely as a result of acceleration, which amounts, if such rescission is effective, shall no longer be payable as a result of acceleration. No such rescission shall affect any subsequent Event of Default or impair any right consequent thereto.

 Section 6.03. Other Remedies. If an Event of Default occurs and is continuing, the Trustee may pursue any
available remedy to collect the payment of the principal amount of the Securities and any accrued and unpaid Interest and any accrued and unpaid Additional Amounts on the Securities or to enforce the performance of any provision of the Securities or
this Indenture. 
 The Trustee may maintain a proceeding even if the Trustee does not possess any of the Securities or does not
produce any of the Securities in the proceeding. A delay or omission by the Trustee or any Securityholder in exercising any right or remedy accruing upon an Event of Default shall not impair the right or remedy or constitute a waiver of, or
acquiescence in, the Event of Default. No remedy is exclusive of any other remedy. All available remedies are cumulative. 

Section 6.04. Waiver of Past Defaults. The Holders of a majority in aggregate principal amount of the Securities at the time
outstanding, by notice to the Trustee (and without notice to any other Securityholder), may, on behalf of the Holders of all the Securities, waive any existing or past Default and its consequences except (1) an Event of Default described in
clauses (a), (c), (d) and (e) of Section 6.01 or (2) an Event of Default in respect of a provision that under Section 9.02 cannot be amended without the consent of each Securityholder affected, which, in each case may be
waived only upon the written consent of each affected Holder. When a Default is waived, it is deemed cured, but no such waiver shall extend to any subsequent or other Default or impair any consequent right. This Section 6.04 shall be in lieu of
Section 316(a)(1)(B) of the TIA and such Section 316(a)(1)(B) is hereby expressly excluded from this Indenture, as permitted by the TIA. 
 Section 6.05. Control by Majority. The Holders of a majority in aggregate principal amount of the Securities at the time outstanding may direct the time, method and place of conducting any
proceeding for any remedy available to the Trustee or of exercising any trust or power conferred on the Trustee. However, the Trustee may refuse to follow any direction that conflicts with law or this Indenture or that the Trustee determines is
unduly prejudicial to the rights of other Securityholders or would involve the Trustee in personal liability; provided, that the Trustee may take any other action deemed proper by the Trustee which is not inconsistent with such direction
or this Indenture. Prior to taking any action under this Indenture, the Trustee may require indemnity satisfactory to it in its sole discretion against all losses and expenses caused by taking or not taking such action. 

  
 34 

 Section 6.06. Limitation on Suits. A Securityholder may not pursue any remedy
with respect to this Indenture or the Securities, except in the case of a Default due to the non-payment of the principal amount of the Securities, any accrued and unpaid Interest, any accrued and unpaid Additional Amounts or any unpaid Conversion
Settlement Amounts, unless: 
 (1) the Holder gives to the Trustee written notice stating that a Default is
continuing; 
 (2) the Holders of at least 25% in aggregate principal amount of the Securities at the time
outstanding make a written request to the Trustee to pursue the remedy, and offer reasonable security or indemnity against any costs, liability or expense of the Trustee; 

(3) the Trustee does not comply with the request within 60 days after receipt of such notice, request and offer of
security or indemnity; and 
 (4) the Holders of a majority in aggregate principal amount of the Securities at
the time outstanding do not give the Trustee a direction inconsistent with the request during such 60-day period. 
 A Securityholder may not
use this Indenture to prejudice the rights of any other Securityholder or to obtain a preference or priority over any other Securityholder. 
 Section 6.07. Rights of Holders to Receive Payment. Notwithstanding any other provision of this Indenture, the right of any Holder to receive payment of the principal amount of the Securities
and any accrued and unpaid Interest and any accrued and unpaid Additional Amounts in respect of the Securities held by such Holder, on or after the respective due dates expressed in the Securities or any Fundamental Change Repurchase Date, and to
convert the Securities in accordance with Article 10, or to bring suit for the enforcement of any such payment or the right to convert on or after such respective dates, shall not be impaired or affected adversely without the consent of such
Holder. 
 Section 6.08. Collection Suit by Trustee. If an Event of Default described in Section 6.01 clauses
(a) through (d) (other than (b)) occurs and is continuing, the Trustee may recover judgment in its own name and as trustee of an express trust against the Company for the whole amount owing with respect to the Securities and the amounts
provided for in Section 7.07. 
 Section 6.09. Trustee May File Proofs of Claim. In case of the pendency of any
receivership, insolvency, liquidation, bankruptcy, reorganization, arrangement, adjustment, composition or other judicial proceeding relative to the Company or any other obligor upon the Securities or the property of the Company or of such other
obligor or their creditors, the Trustee (irrespective of whether the principal amount of the Securities and any accrued and unpaid Interest and accrued and unpaid Additional Amounts in respect of the Securities shall then be due and payable as
therein expressed or by declaration or otherwise and irrespective of whether the Trustee shall have made any demand on the Company for the payment of any such amount) shall be entitled and empowered, by intervention in such proceeding or otherwise:

 (a) to file and prove a claim for the whole principal amount of the Securities and any accrued and unpaid
Interest and any accrued and unpaid Additional Amounts and to file such other papers or documents as may be necessary or advisable in order to have the claims of the Trustee (including any claim for the reasonable compensation, expenses,
disbursements and advances of the Trustee, its agents and counsel or any other amounts due the Trustee under Section 7.07) and of the Holders allowed in such judicial proceeding, and 

  
 35 

 (b) to collect and receive any moneys or other property payable or
deliverable on any such claims and to distribute the same; and any custodian, receiver, assignee, trustee, liquidator, sequestrator or similar official in any such judicial proceeding is hereby authorized by each Holder to make such payments to the
Trustee and, in the event that the Trustee shall consent to the making of such payments directly to the Holders, to pay the Trustee any amount due it for the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents
and counsel, and any other amounts due the Trustee under Section 7.07. 
 Nothing herein contained shall be deemed to
authorize the Trustee to authorize or consent to or accept or adopt on behalf of any Holder any plan of reorganization, arrangement, adjustment or composition affecting the Securities or the rights of any Holder thereof, or to authorize the Trustee
to vote in respect of the claim of any Holder in any such proceeding. 
 The Company agrees not to object to the Trustee
participating as a member of any official committee of creditors of the Company as it deems necessary or advisable. 

Section 6.10. Priorities. Any money collected by the Trustee pursuant to this Article 6 and, after an Event of Default,
any money or other property distributable in respect of the Company’s obligations under this Indenture, shall be paid out in the following order: 
 FIRST: to the Trustee (including any predecessor Trustee) for amounts due under Section 7.07; 
 SECOND: to Securityholders for amounts due and unpaid on the Securities for the principal amount of the Securities and any accrued and unpaid Interest and accrued and any unpaid Additional Amounts, as the
case may be, ratably, without preference or priority of any kind, according to such amounts due and payable on the Securities; and 
 THIRD: the balance, if any, to the Company. 
 The Trustee may fix a record date
and payment date for any payment to Securityholders pursuant to this Section 6.10. At least 15 days before such record date, the Trustee shall mail to each Securityholder and the Company a notice that states the record date, the payment date
and the amount to be paid. 
 Section 6.11. Undertaking for Costs. In any suit for the enforcement of any right or
remedy under this Indenture or in any suit against the Trustee for any action taken or omitted by it as Trustee, a court in its discretion may require the filing by any party litigant (other than the Trustee) in the suit of an undertaking to pay the
costs of the suit, and the court in its discretion 

  
 36 

 
may assess reasonable costs, including reasonable attorneys’ fees and expenses, against any party litigant in the suit, having due regard to the merits and good faith of the claims or
defenses made by the party litigant. This Section 6.11 does not apply to a suit by the Trustee, a suit by a Holder pursuant to Section 6.07 or a suit by Holders of more than 10% in aggregate principal amount of the Securities at the time
outstanding. This Section 6.11 shall be in lieu of Section 315(e) of the TIA and such Section 315(e) is hereby expressly excluded from this Indenture, as permitted by the TIA. 

Section 6.12. Waiver of Stay, Extension or Usury Laws. The Company covenants (to the extent that it may lawfully do so) that
it shall not at any time insist upon, or plead, or in any manner whatsoever claim or take the benefit or advantage of, any stay or extension law or any usury or other law wherever enacted, now or at any time hereafter in force, which would prohibit
or forgive the Company from paying all or any portion of the principal amount of the Securities and any accrued and unpaid Interest and any accrued and unpaid Additional Amounts on Securities, as contemplated herein, or which may affect the
covenants or the performance of this Indenture; and the Company (to the extent that it may lawfully do so) hereby expressly waives all benefit or advantage of any such law, and covenants that it shall not hinder, delay or impede the execution of any
power herein granted to the Trustee, but shall suffer and permit the execution of every such power as though no such law had been enacted. 
 ARTICLE 7 
 TRUSTEE 

Section 7.01. Duties of Trustee. (a) If an Event of Default has occurred and is continuing, the Trustee shall exercise such
of the rights and powers vested in it by this Indenture and use the same degree of care and skill in their exercise as a prudent person would exercise or use under the circumstances in the conduct of such person’s own affairs. 

(b) Except during the continuance of an Event of Default: 

(i) the Trustee need perform only those duties that are specifically set forth in this Indenture and no others, and no
implied duties shall be read into this Indenture against the Trustee; and 
 (ii) in the absence of bad faith on
its part, the Trustee may conclusively rely, as to the truth of the statements and the correctness of the opinions expressed therein, upon certificates or opinions furnished to the Trustee and conforming to the requirements of this Indenture, but in
the case of any such certificates or opinions which by any provision hereof are specifically required to be furnished to the Trustee, the Trustee shall be under a duty to examine such certificates and opinions to determine whether or not they
conform to the requirements of this Indenture, but need not confirm or investigate the accuracy of mathematical calculations or other facts stated therein. This Section 7.01(b) shall be in lieu of Section 315(a) of the TIA and such
Section 315(a) is hereby expressly excluded from this Indenture, as permitted by the TIA. 
 (c) The Trustee may not be
relieved from liability for its own negligent action, its own negligent failure to act or its own willful misconduct, except that: 
 (i) this Section 7.01(c) does not limit the effect of Sections 7.01(b) and 7.01(g); 

  
 37 

 (ii) the Trustee shall not be liable for any error of judgment made in good
faith by a Responsible Officer unless it is proved that the Trustee was negligent in ascertaining the pertinent facts; and 
 (iii) the Trustee shall not be liable with respect to any action it takes or omits to take in good faith in accordance with a direction received by it pursuant to Section 6.05. 

Subparagraphs (c)(i), (ii) and (iii) shall be in lieu of Sections 315(d)(1), 315(d)(2) and 315(d)(3) of the TIA and such Sections
315(d)(1), 315(d)(2) and 315(d)(3) are hereby expressly excluded from this Indenture, as permitted by the TIA. 
 (d) Every
provision of this Indenture that in any way relates to the Trustee is subject to this Section 7.01. 
 (e) The Trustee may
refuse to perform any duty or exercise any right or power unless it receives indemnity satisfactory to it against any loss, liability or expense. 
 (f) Money held by the Trustee in trust hereunder need not be segregated from other funds except to the extent required by law. The Trustee (acting in any capacity hereunder) shall be under no liability
for interest on any money received by it hereunder unless otherwise agreed in writing with the Company (provided that any interest earned on money held by the Trustee in trust hereunder shall be the property of the Company). 

(g) No provision of this Indenture shall require the Trustee to expend or risk its own funds or otherwise incur any financial liability
in the performance of any of its duties hereunder, or in the exercise of any of its rights or powers, if it shall have reasonable grounds for believing that repayment of such funds or adequate indemnity against such risk or liability is not
reasonably assured to it. 
 Section 7.02. Rights of Trustee. Subject to the provisions of Section 7.01:

 (a) the Trustee may conclusively rely and shall be protected in acting or refraining from acting upon any resolution,
certificate, statement, instrument, opinion, report, notice, request, direction, consent, order, bond, debenture, note, other evidence of indebtedness or other paper or document (whether in original or facsimile form) believed by it to be
genuine and to have been signed or presented by the proper party or parties; 
 (b) whenever in the administration of this
Indenture the Trustee shall deem it desirable that a matter be proved or established prior to taking, suffering or omitting any action hereunder, the Trustee (unless other evidence be herein specifically prescribed) may, in the absence of bad faith
on its part, conclusively rely upon an Officer’s Certificate; 
 (c) the Trustee may execute any of the trusts or powers
hereunder or perform any duties hereunder either directly or by or through agents or attorneys and the Trustee shall not be responsible for any misconduct or negligence on the part of any agent or attorney appointed with due care by it hereunder;

  
 38 

 (d) the Trustee shall not be liable for any action taken, suffered, or omitted to be taken
by it in good faith which it believes to be authorized or within its rights or powers conferred under this Indenture; 
 (e) the
Trustee may consult with counsel selected by it and any advice or Opinion of Counsel shall be full and complete authorization and protection in respect of any action taken or suffered or omitted by it hereunder in good faith and in accordance with
such advice or Opinion of Counsel; 
 (f) the Trustee shall be under no obligation to exercise any of the rights or powers
vested in it by this Indenture at the request, order or direction of any of the Holders, pursuant to the provisions of this Indenture, unless such Holders shall have offered to the Trustee security or indemnity satisfactory to it against the costs,
expenses and liabilities which may be incurred therein or thereby; 
 (g) any request or direction of the Company mentioned
herein shall be sufficiently evidenced by a Company Request or Company Order and any resolution of the Board of Directors may be sufficiently evidenced by a Board Resolution; 
 (h) the Trustee shall not be bound to make any investigation into the facts or matters stated in any resolution, certificate, statement, instrument, opinion, report, notice, request, direction, consent,
order, bond, debenture, note, other evidence of indebtedness or other paper or document, but the Trustee, in its discretion, may make such further inquiry or investigation into such facts or matters as it may see fit, and, if the Trustee shall
determine to make such further inquiry or investigation, it shall be entitled to, during regular business hours, examine the books, records and premises of the Company, personally or by agent or attorney at the sole cost of the Company and shall
incur no liability or additional liability of any kind by reason of such inquiry or investigation; 
 (i) Except with respect to
Section 4.01, the Trustee shall have no duty to inquire as to the performance of the Company with respect to the covenants contained in Article 4. In addition, the Trustee shall not be deemed to have knowledge of an Event of Default except
(i) any Default or Event of Default occurring pursuant to Section 6.01(a), 6.01(c) or 6.01(d) or (ii) any Default or Event of Default of which the Trustee shall have received written notification from the Company or the Holders of at
least 25% in aggregate principal amount of the Securities, which notice specifically references this Indenture and the Securities. 
 (j) the rights, privileges, protections, immunities and benefits given to the Trustee, including, without limitation, its right to be indemnified, are extended to, and shall be enforceable by, the Trustee
in each of its capacities hereunder, and to each agent, custodian and other person employed to act hereunder; 
 (k) the Trustee
may request that the Company deliver an Officer’s Certificate setting forth the names of individuals and/or titles of officers authorized at such time to take specified actions pursuant to this Indenture, which Officer’s Certificate may be
signed by any person authorized to sign an Officer’s Certificate, including any person specified as so authorized in any such certificate previously delivered and not superseded; 

  
 39 

 (l) the permissive rights of the Trustee to take certain actions under this Indenture shall
not be construed as a duty unless so specified herein; and 
 (m) the Company or its agents shall be required to deliver to the
Trustee a schedule of its calculations and the Trustee shall be entitled to conclusively rely upon the accuracy of such calculations without independent verification. 
 Section 7.03. Individual Rights of Trustee. The Trustee in its individual or any other capacity may become the owner or pledgee of Securities and may otherwise deal with the Company or its
Affiliates with the same rights it would have if it were not a Trustee. Any Paying Agent, Registrar, Conversion Agent or co-registrar may do the same with like rights. However, the Trustee must comply with Sections 7.10 and 7.11. 

Section 7.04. Trustee’s Disclaimer. The Trustee makes no representation as to, and shall have no responsibility for, the
validity or adequacy of this Indenture or the Securities, it shall not be accountable for the Company’s use or application by the Company of the Securities or of the proceeds from the Securities, it shall not be responsible for the correctness
of any statement in the registration statement for the Securities under the Securities Act or in any offering document for the Securities, the Indenture or the Securities (other than its certificate of authentication), or the determination as to
which beneficial owners are entitled to receive any notices hereunder. 
 Section 7.05. Notice of Defaults. If a
Default or Event of Default occurs and if it is known to the Trustee, the Trustee shall give to each Securityholder notice of the Default or Event of Default within 90 days after it occurs, unless such Default or Event of Default shall have been
cured or waived before the giving of such notice. Notwithstanding the preceding sentence, except in the case of a Default or Event of Default described in clauses (c) and (d) of Section 6.01, the Trustee may withhold the notice if and
so long as a committee of its Responsible Officers in good faith determines that withholding the notice is in the interest of the Securityholders. The preceding sentence shall be in lieu of the proviso to Section 315(b) of the TIA and such
proviso is hereby expressly excluded from this Indenture, as permitted by the TIA. The Trustee shall not be deemed to have knowledge of a Default or Event of Default unless a Responsible Officer of the Trustee has received written notice from the
Company or the Holders of at least 25% in aggregate principal amount of the Securities of such Default or Event of Default, which notice specifically references this Indenture and the Securities. 

Section 7.06. Reports by Trustee to Holders. Within 120 calendar days after each December 31 beginning with
December 31, 2012, the Trustee shall mail to each Securityholder a brief report dated as of such December 31 that complies with TIA Section 313(a), if required by such Section 313(a). The Trustee also shall comply with TIA
Section 313(b). Any reports required by this Section 7.06 shall be transmitted by mail to Securityholders pursuant to TIA Section 313(c). 

  
 40 

 A copy of each report at the time of its mailing to Securityholders shall be filed with the
SEC and each securities exchange, if any, on which the Securities are listed. The Company agrees to notify the Trustee promptly whenever the Securities become listed on any securities exchange and of any delisting thereof. 

Section 7.07. Compensation and Indemnity. The Company agrees: 

(a) to pay to the Trustee from time to time such compensation as the Company and the Trustee shall from time to time agree in writing,
for all services rendered by it hereunder (which compensation shall not be limited (to the extent permitted by law) by any provision of law in regard to the compensation of a trustee of an express trust); 

(b) to reimburse the Trustee upon its request for all reasonable expenses, disbursements and advances incurred or made by the Trustee in
accordance with any provision of this Indenture (including the reasonable compensation and the expenses, advances and disbursements of its agents and counsel), except any such expense, disbursement or advance as may be attributable to its own
negligence, willful misconduct or bad faith; and 
 (c) to indemnify and hold the Trustee and its directors, officers, agents
and employees (collectively, the “Indemnitees”) harmless from and against any and all claims, liabilities, losses, damages, fines, penalties and expenses, including out-of-pocket, incidental expenses, legal fees and expenses and the
allocated costs and expenses of in-house counsel and legal staff (“Losses”) that may be imposed on, incurred by or asserted against the Indemnitees or any of them for following any instruction or other direction upon which the
Trustee is authorized to rely pursuant to the terms of this Indenture. In addition to and not in limitation of the immediately preceding sentence, the Company also agrees to indemnify and hold the Indemnitees and each of them harmless from and
against any and all Losses that may be imposed on, incurred by or asserted against the Indemnitees or any of them in connection with or arising out of the Trustee’s performance under this Indenture, provided the Trustee has not acted
with negligence or engaged in willful misconduct. 
 To secure the Company’s payment obligations in this Section 7.07,
the Trustee shall have a lien prior to the Securities on all money or property held or collected by the Trustee, except that held in trust to pay the principal amount of, or the Fundamental Change Repurchase Price, Interest or any Additional Amounts
as the case may be, on particular Securities. 
 The Company’s payment, reimbursement and indemnity obligations pursuant to
this Section 7.07 shall survive the satisfaction and discharge of this Indenture, the resignation or removal of the Trustee and the termination of this Indenture for any reason. In addition to and without prejudice to its rights hereunder, when
the Trustee incurs expenses or renders services in connection with an Event of Default specified in Section 6.01(i) or Section 6.01(j), the expenses, including the reasonable charges and expenses of its counsel and the compensation for
services payable pursuant to Section 7.07(a), are intended to constitute expenses of administration under any applicable federal or state bankruptcy, insolvency or similar laws. 

For the purposes of this Section 7.07, the “Trustee” shall include any predecessor Trustee; provided,
however, that except as may be otherwise agreed among the parties, the negligence, willful misconduct or bad faith of any Trustee hereunder shall not affect the rights of any other Trustee hereunder. 

  
 41 

 Section 7.08. Replacement of Trustee. The Trustee may resign at any time by so
notifying the Company; provided, however, that no such resignation shall be effective until a successor Trustee has accepted its appointment pursuant to this Section 7.08. The Holders of a majority in aggregate principal amount of
the Securities at the time outstanding may remove the Trustee by so notifying the Trustee and the Company in writing. The Company shall remove the Trustee if: 
 (a) the Trustee fails to comply with Section 7.10; 
 (b) the Trustee is
adjudged bankrupt or insolvent; 
 (c) a receiver or public officer takes charge of the Trustee or its property; or 

(d) the Trustee otherwise becomes incapable of acting. 
 If the Trustee resigns or is removed or if a vacancy exists in the office of the Trustee for any reason, the Company shall promptly appoint, by resolution of its Board of Directors, a successor Trustee.

 A successor Trustee shall deliver a written acceptance of its appointment to the retiring Trustee and to the Company
satisfactory in form and substance to the retiring Trustee and the Company. Thereupon the resignation or removal of the retiring Trustee shall become effective, and the successor Trustee shall have all the rights, powers and duties of the Trustee
under this Indenture. The successor Trustee shall mail a notice of its succession to Securityholders. The retiring Trustee shall promptly transfer all property held by it as Trustee to the successor Trustee, subject to the lien provided for in
Section 7.07. 
 If a successor Trustee does not take office within 30 days after the retiring Trustee resigns or is
removed, the retiring Trustee, the Company or the Holders of a majority in aggregate principal amount of the Securities at the time outstanding may petition any court of competent jurisdiction at the expense of the Company for the appointment of a
successor Trustee. 
 If the Trustee fails to comply with Section 7.10, any Securityholder may petition any court of
competent jurisdiction for the removal of the Trustee and the appointment of a successor Trustee. 
 So long as no Default or
Event of Default shall have occurred and be continuing, if the Company shall have delivered to the Trustee (i) a Board Resolution appointing a successor Trustee, effective as of a date at least 30 days after delivery of such Resolution to the
Trustee, and (ii) an instrument of acceptance of such appointment, effective as of such date, by such successor Trustee in accordance with this Indenture, the Trustee shall be deemed to have resigned as contemplated in this Section 7.08,
the successor Trustee shall be deemed to have been accepted as contemplated in this Indenture, all as of such date, and all other provisions of this Indenture shall be applicable to such resignation, appointment and acceptance. 

  
 42 

 Section 7.09. Successor Trustee by Merger. Any corporation or association into
which the Trustee in its individual capacity may be merged or converted or with which it may be consolidated or to which it transfers all or substantially all of its corporate trust business or assets, or any corporation or association resulting
from any merger, conversion or consolidation to which the Trustee in its individual capacity may be sold or otherwise transferred, shall be the Trustee hereunder without further act. 

Section 7.10. Eligibility; Disqualification. The Trustee shall at all times satisfy the requirements of TIA Sections
310(a)(1) and 310(b). The Trustee (or any parent holding company) shall have a combined capital and surplus of at least $50,000,000 as set forth in its most recent published annual report of condition. Nothing herein contained shall prevent the
Trustee from filing with the Commission the application referred to in the penultimate paragraph of TIA Section 310(b). 

Section 7.11. Preferential Collection of Claims Against Company. The Trustee shall comply with TIA Section 311(a),
excluding any creditor relationship listed in TIA Section 311(b). A Trustee who has resigned or been removed shall be subject to TIA Section 311(a) to the extent indicated therein. 

ARTICLE 8 

DISCHARGE OF INDENTURE 
 Section 8.01. Discharge of Liability on Securities. When (i) the Company causes to be delivered to the Trustee all outstanding Securities (other than Securities replaced or repaid
pursuant to Section 2.07) for cancellation or (ii) all outstanding Securities have become due and payable (whether on conversion, maturity, repurchase or otherwise) and the Company deposits with the Trustee cash and, if applicable, shares
of Common Stock sufficient to pay all amounts due and owing on all outstanding Securities (other than Securities replaced pursuant to Section 2.07), and if in either case the Company pays all other sums payable hereunder by the Company, then
this Indenture shall, subject to Section 7.07, cease to be of further effect. The Trustee shall join in the execution of a document prepared by the Company acknowledging satisfaction and discharge of this Indenture on demand of the Company
accompanied by an Officer’s Certificate and Opinion of Counsel and at the cost and expense of the Company. 

Section 8.02. Repayment to the Company. The Trustee and the Paying Agent shall return to the Company upon written request any
money or securities held by them for the payment of any amount with respect to the Securities that remains unclaimed for one year, subject to applicable abandoned property law. 

After return to the Company, Holders entitled to the money or securities must look to the Company for payment as general creditors unless
an applicable abandoned property law designates another person and the Trustee and the Paying Agent shall have no further liability to the Securityholders with respect to such money or securities for that period commencing after the return thereof.

 Section 8.03. Application of Trust Money. The Trustee shall hold in trust all money and other consideration
deposited with it pursuant to Section 8.01 and shall apply such deposited 

  
 43 

 
money and other consideration through the Paying Agent and in accordance with this Indenture to the payment of amounts due on the Securities. Money and other consideration so held in trust is
subject to the Trustee’s rights under Section 7.07. 
 ARTICLE 9 

AMENDMENTS 

Section 9.01. Without Consent of Holders. The Company and the Trustee may modify or amend this Indenture or the Securities
without the consent of any Securityholder to: 
 (a) add guarantees with respect to the Securities or secure the Securities;

 (b) conform, as necessary, this Indenture and the Securities to the “Description of the Notes” as set forth in the
Offering Memorandum; 
 (c) add to the covenants of the Company or Events of Default for the benefit of the Holders of
Securities; 
 (d) surrender any right or power herein conferred upon the Company; 

(e) provide for the assumption by a successor company of the Company’s obligations to the Holders of Securities in the case of a
merger, consolidation, conveyance, transfer, sale or lease pursuant to Article 5 and Section 10.06 hereof; 
 (f)
comply with the requirements of the SEC in order to effect or maintain the qualification of this Indenture or any supplemental indenture under the TIA; 
 (g) cure any ambiguity or to correct or supplement any provision herein which may be inconsistent with any other provision herein; 
 (h) make other changes to this Indenture or forms or terms of the Securities so long as no such change individually or in the aggregate with all other such changes has or will have a material adverse
effect on the interests of the Holders of the Securities; 
 (i) establish the terms or form of Securities (substantially in the
form of Exhibit A) 
 (j) evidence and provide for the acceptance of the appointment under this Indenture of a successor Trustee
in accordance with the terms of this Indenture; 
 (k) increase the Applicable Conversion Rate; or 

(l) provide for the right of the Holders of the Securities to convert any Security and the obligation of the Company to repurchase
Securities in connection with any Fundamental Change or any event described in Section 10.06. 
 Section 9.02. With
Consent of Holders. Except as provided in Section 9.01 and this Section 9.02, this Indenture or the Securities may be amended, modified or supplemented, and noncompliance in any particular instance with any provision of this Indenture
or the Securities may be waived, in each case with the written consent of the Holders of at least a majority of the principal amount of the Securities at the time outstanding. 

  
 44 

 Without the written consent or the affirmative vote of each Holder of Securities affected
thereby, an amendment, supplement or waiver under this Section 9.02 may not: 
 (a) reduce the principal amount of or
change the Stated Maturity of any Security; 
 (b) reduce the Fundamental Change Repurchase Price; 

(c) change the Company’s obligation to repurchase the Securities upon a Fundamental Change in a manner adverse to the Holders of the
Securities; 
 (d) change the currency in which any Security or Interest, including any Additional Amounts thereon, or the
Fundamental Change Repurchase Price thereof is payable; 
 (e) reduce the rate of accrual for, or extend the time for payment of
Interest, including any Additional Amounts on any Security; 
 (f) impair the right of any Holder to institute suit for the
enforcement of any payment on or with respect to any Security; 
 (g) impair the right of the Holders of the Securities to
convert any Security as provided in Article 10 or reduce the number of shares or other consideration due upon conversion, except as otherwise permitted pursuant to Article 5 or Section 10.06 hereof; 

(h) change the Company’s obligation to maintain an office or agency in the places and for the purposes specified in this Indenture;

 (i) amend or modify any of the provisions of this Section 9.02, or reduce the percentage of the aggregate principal
amount of outstanding Securities required to amend, modify, supplement or waive a provision of the Indenture or the Securities, except to provide that certain other provisions of this Indenture cannot be modified or waived without the consent of the
Holder of each outstanding Security affected thereby; or 
 (j) reduce the percentage of the aggregate principal amount of the
outstanding Securities the consent of whose Holders is required for any such supplemental indenture entered into in accordance with this Section 9.02 or the consent of whose Holders is required for any waiver provided for in this Indenture.

 It shall not be necessary for the consent of the Holders under this Section 9.02 to approve the particular form of any
proposed amendment, but it shall be sufficient if such consent approves the substance thereof. 
 After an amendment under this
Section 9.02 becomes effective, the Company shall mail to each Holder a notice briefly describing the amendment. However, the failure to give such notice to all the Holders, or any defect in the notice, will not impair or affect the validity of
the amendment. 

  
 45 

 Section 9.03. Compliance with Trust Indenture Act. Every supplemental indenture
executed pursuant to this Article shall comply with the TIA as then in effect. 
 Section 9.04. Revocation and Effect of
Consents, Waivers and Actions. Until an amendment, waiver or other action by Holders becomes effective, a consent thereto by a Holder of a Security hereunder is a continuing consent by the Holder and every subsequent Holder of that Security or
portion of the Security that evidences the same obligation as the consenting Holder’s Security, even if notation of the consent, waiver or action is not made on the Security. However, any such Holder or subsequent Holder may revoke the consent,
waiver or action as to such Holder’s Security or portion of the Security if the Trustee receives the notice of revocation before the date the amendment, waiver or action becomes effective. After an amendment, waiver or action becomes effective,
it shall bind every Securityholder. 
 Section 9.05. Notice of Amendments, Notation on or Exchange of Securities.
Securities authenticated and delivered after the execution of any supplemental indenture pursuant to this Article 9 may, and shall if required by the Company, bear a notation in form approved by the Company as to any matter provided for in such
supplemental indenture. If the Company shall so determine, new Securities so modified as to conform, in the opinion of the Trustee and the Board of Directors, to any such supplemental indenture may be prepared and executed by the Company and
authenticated and delivered by the Trustee in exchange for outstanding Securities. 
 Section 9.06. Trustee to Sign
Supplemental Indentures. The Trustee shall sign any supplemental indenture authorized pursuant to this Article 9 if the amendment contained therein does not affect the rights, duties, liabilities or immunities of the Trustee. If it does,
the Trustee may, but need not, sign such supplemental indenture. In signing such supplemental indenture the Trustee shall receive, and, subject to the provisions of Section 7.01, shall be fully protected in relying upon, an Officer’s
Certificate and an Opinion of Counsel stating that such amendment is authorized or permitted by this Indenture. 

Section 9.07. Effect of Supplemental Indentures. Upon the execution of any supplemental indenture under this Article, this
Indenture shall be modified in accordance therewith, and such supplemental indenture shall form a part of this Indenture for all purposes; and every Holder of Securities theretofore or thereafter authenticated and delivered hereunder shall be bound
thereby. 
 ARTICLE 10 
 CONVERSIONS 
 Section 10.01. Conversion Privilege. (a) Subject to and
upon compliance with the provisions of this Article 10, a Holder of a Security shall have the right, at such Holder’s option, to convert all or any portion (if the portion to be converted is $1,000 principal amount or an integral multiple
thereof) of such Security prior to the close of business on the second Scheduled Trading Day immediately preceding Stated Maturity into cash and shares of Common Stock, if any and subject to the Share Cap, based on the Applicable Conversion Rate
only as follows: 
 (i) before October 15, 2016, on any date during any calendar quarter of the Company (a
“Calendar Quarter”) commencing after the calendar quarter ending June 30, 2012 

  
 46 

 
(and only during such Calendar Quarter) if the Closing Sale Price of the Common Stock for at least 20 Trading Days during the period of 30 consecutive Trading Days ending on the last Trading Day
of the immediately preceding Calendar Quarter is more than 130% of the Applicable Conversion Price in effect on each such Trading Day; 
 (ii) during the five consecutive Business Days immediately following any five consecutive Trading Day period (the “Measurement Period”) in which the Trading Price per $1,000 original
principal amount of the Securities (as determined following a request by a Holder of the Securities in accordance with the procedures described below) for each day of such Measurement Period was less than 98% of the product of the Closing Sale Price
of the Common Stock and the Applicable Conversion Rate on each such day. The Trustee or another party appointed by the Trustee will, on the Company’s behalf, determine if the Securities are convertible as a result of the Trading Price of the
Securities and notify the Company and the Trustee if the Trustee has appointed another party to determine if the Securities are convertible pursuant to this clause (ii); provided, that the Trustee or such other person appointed by the
Trustee shall have no obligation to determine the Trading Price of the Securities unless the Company has requested such determination and the Company shall have no obligation to make such request unless requested to do so in writing by a Holder of
the Security. If a Holder provides such request, the Company shall instruct the Trustee to determine the Trading Price of the Securities for each Trading Day until the Trading Price is 98% or more of the product of the Closing Sale Price of the
Common Stock and the Applicable Conversion Rate on such Trading Day. If the Company does not so instruct the Trustee to obtain bids when required, or if the Trustee does not obtain bids when directed by the Company, the Trading Price per $1,000
principal amount of the Securities will be deemed to be less than 98% of the product of the Closing Sale Price of the Common Stock and the Applicable Conversion Rate on each Trading Day such failure occurs; 

(iii) any time on or after October 15, 2016 and on or prior to the close of business on the second Scheduled Trading
Day immediately preceding Stated Maturity, without regard to the foregoing conditions; 
 (iv) as provided in
clause (b) of this Section 10.01. 
 The Company or, if applicable, the Conversion Agent (in the case of a
conversion pursuant to clause (i) above) or the Trustee (in the case of a conversion pursuant to clause (ii) above) on behalf of the Company, shall determine on a daily basis during the time periods specified in
Section 10.01(a)(i) or, following a request by a Holder of Securities in accordance with the procedures specified in Section 10.01(a)(ii), whether the Securities shall be convertible as a result of the occurrence of an event specified in
such Sections and, if the Securities shall be so convertible, the Company, the Conversion Agent or the Trustee, as applicable, shall promptly deliver to the Conversion Agent, the Trustee or the Company, as applicable, written notice thereof.
Whenever the Securities shall become convertible pursuant to this Section 10.01 (as determined in accordance with this Section 10.01), the Company or, at the Company’s request, the Trustee in the name and at the expense of the
Company, shall promptly notify the Holders of the event triggering such convertibility in the manner provided in Section 12.02, or the Company shall promptly disseminate a press release and use its reasonable

  
 47 

 
efforts to post the information on its website or otherwise publicly disclose the information. Any notice so given shall be conclusively presumed to have been duly given, whether or not the
Holder receives such notice. 
 (b) In the event that: 

(1) (A) the Company distributes to all or substantially all holders of Common Stock rights or warrants entitling them
to purchase, for a period expiring within 60 days after the date of such distribution, Common Stock at less than the average of the Closing Sale Prices of the Common Stock for the 10 consecutive Trading Days ending on the Trading Day immediately
preceding the declaration date for such distribution; or (B) the Company distributes to all or substantially all holders of Common Stock cash or other assets, securities or rights to purchase the Company’s securities (excluding dividends
or distributions described in Section 10.04(a)), which distribution has a per share value as determined by the Board of Directors exceeding 10% of the Closing Sale Price of the Common Stock on the Trading Day immediately preceding the
declaration date of such distribution, then, in either case, the Securities may be surrendered for conversion at any time on and after the date that the Company gives notice to the Holders of such distribution, which shall be not less than
45 Business Days prior to the Ex-Dividend Date for such distribution, until the earlier of (x) the close of business on the Business Day immediately preceding the Ex-Dividend Date for such distribution or (y) the date on which the
Company announces that such distribution shall not take place; provided that no Holder of a Security shall have the right to convert its Securities if the Holder is entitled to participate in such distribution (based on the Applicable
Conversion Rate) without conversion; or 
 (2) (A) the Company is a party to a consolidation, merger,
binding share exchange or sale or conveyance of all or substantially all of its property and assets that does not constitute a Fundamental Change, pursuant to which the Common Stock would be converted into cash, securities and/or other property or
(B) a Fundamental Change occurs prior to Stated Maturity (regardless of whether Holders have a right to require the Company to repurchase the Securities upon such Fundamental Change as set forth in Article 3), then the Securities may be
surrendered for conversion at any time from and after the date that is 45 Business Days prior to the anticipated effective date of such transaction until and including the date that is 45 calendar days after the actual effective date of
such transaction (or, if such transaction also constitutes a Fundamental Change pursuant to which Holders have a right to require the Company to repurchase the Securities pursuant to Section 3.02, until the close of business on the Business Day
immediately preceding the applicable Fundamental Change Repurchase Date). The Company shall notify Holders and the Trustee as promptly as practicable following the date that it publicly announces the Fundamental Change transaction giving rise to the
above conversion right (but in no event less than 45 Business Days prior to the anticipated effective date of such transaction). 
 (c) If a Fundamental Change occurs and a Holder elects to convert its Securities in connection with such Fundamental Change (regardless of whether such Holder has the right to require the Company to
repurchase its Securities as set forth in Article 3), the Company will pay, 

  
 48 

 
to the extent set forth in this Section 10.01(c), a make whole premium (the “make whole premium”) by increasing the Applicable Conversion Rate of such
Securities; provided that if the Stock Price paid in connection with such Fundamental Change is greater than $70.00 or less than $16.53 (subject in each case to adjustment as described below), no make whole premium shall be added to the
Applicable Conversion Rate. A conversion of the Securities will be deemed for these purposes to be “in connection with” a Fundamental Change if the Conversion Notice is received by the Conversion Agent on or following the effective
date of the Fundamental Change but before the close of business on the Business Day immediately preceding the related Fundamental Change Repurchase Date. 
 The increase in the Applicable Conversion Rate as described in the immediately preceding paragraph shall be determined by reference to the table attached as Schedule I hereto, based on the effective
date of such Fundamental Change transaction and the Stock Price paid in connection with such transaction; provided that if the Stock Price is between two Stock Price amounts in the table or such effective date is between two effective dates
in the table, the make whole premium shall be determined by a straight-line interpolation between the make whole premium set forth for the higher and lower Stock Price amounts and the two dates, as applicable, based on a 365-day year. The
“effective date” with respect to a Fundamental Change transaction means the date that a Fundamental Change becomes effective. 
 The Stock Prices set forth in the first row of the table in Schedule I hereto shall be adjusted as of any date on which the Applicable Conversion Rate of the Securities is adjusted pursuant to
Section 10.04. The adjusted Stock Prices shall equal the Stock Prices applicable immediately prior to such adjustment, multiplied by a fraction, the numerator of which is the Applicable Conversion Rate immediately prior to the adjustment giving
rise to the Stock Price adjustment and the denominator of which is the Applicable Conversion Rate as so adjusted. The make whole premium shall be adjusted in the same manner as the Applicable Conversion Rate as set forth in Section 10.04.

 Notwithstanding the foregoing, in no event shall the Applicable Conversion Rate pursuant to this clause (c) exceed
60.4960 shares of Common Stock for each $1,000 principal amount of Securities, subject to adjustments in the same manner as the Applicable Conversion Rate as set forth in Section 10.04, and the number of shares of the Common Stock issuable upon
a conversion in connection with a Fundamental Change shall be subject to the Share Cap; provided, however, that if a Holder will receive units of Reference Property rather than shares of Common Stock upon conversion in connection with a
Fundamental Change, the Share Cap shall not apply to the calculation of the number of units of Reference Property to which a Holder is entitled upon conversion. 
 Section 10.02. Conversion Procedure; Applicable Conversion Rate; Fractional Shares. (a) Subject to Section 10.01 and Section 10.03, each Security shall be convertible at the office
of the Conversion Agent into a combination of cash and fully paid and nonassessable shares (calculated to the nearest 1/10,000th of a share) of Common Stock, if any, at a rate (the “Applicable Conversion Rate”) equal to, initially,
46.8962 shares of Common Stock for each $1,000 principal amount of Securities. The Applicable Conversion Rate shall be adjusted in certain instances as provided in Section 10.01(c) and Section 10.04 hereof, but shall not be adjusted for
any accrued and unpaid Interest or any Additional Amounts. Upon conversion, no 

  
 49 

 
payment shall be made by the Company with respect to any accrued and unpaid Interest, including any Additional Amounts, unless, as described below, such conversion occurs between an Interest
Record Date and the Interest Payment Date to which such Interest Record Date relates, in which case the Holders of the Securities on the Interest Record Date shall receive accrued and unpaid interest, including any Additional Amounts, payable on the
Securities on the applicable Interest Payment Date. Instead, such amount shall be deemed paid by the applicable Conversion Settlement Amount delivered upon conversion of any Security. In addition, no payment shall be made in respect of dividends on
the Common Stock with a record date prior to the Conversion Date. The Company shall not issue any fraction of a share of Common Stock in connection with any conversion of Securities, but instead shall, subject to Section 10.03 hereof, make a
cash payment (calculated to the nearest cent) equal to such fraction multiplied by the Closing Sale Price of the Common Stock on the final Trading Day of the Applicable Conversion Period. 

(b) [Reserved] 

(c) Before any Holder of a Security shall be entitled to convert the same, such Holder shall (1) in the case of Global Securities,
comply with the Applicable Procedures in effect at that time for converting a beneficial interest in a Global Security, and in the case of Certificated Securities, surrender such Securities, duly endorsed to the Company or in blank, at the office of
the Conversion Agent, and (2) give written notice to the Company in the form on the reverse of such Certificated Security (the “Conversion Notice”) at said office or place that such Holder elects to convert the same and shall
state in writing therein the principal amount of Securities to be converted (which shall be equal to or an integral multiple of $1,000 principal amount) and the name or names (with addresses) in which such Holder wishes the certificate or
certificates for the shares of Common Stock included in the Conversion Settlement Amount, if any, to be registered. 
 Before
any such conversion, a Holder also shall pay all taxes or duties, if any, as provided in Section 10.07 and any amount payable pursuant to Section 10.02(h). 
 If more than one Security shall be surrendered for conversion at one time by the same Holder, the number of full shares of Common Stock, if any, that shall be deliverable upon conversion shall be computed
on the basis of the aggregate principal amount of the Securities (or specified portions thereof to the extent permitted thereby) so surrendered. 
 (d) A Security shall be deemed to have been converted as of the close of business on the date (the “Conversion Date”) that the Holder has complied with Section 10.02(c). 

(e) The Company shall, on the Conversion Settlement Date, to the extent applicable as set forth in Section 10.03, (i) pay the
cash component (including cash in lieu of any fraction of a share to which such Holder would otherwise be entitled) of the Conversion Obligation determined pursuant to Section 10.03 to the Holder of a Security surrendered for conversion, or
such Holder’s nominee or nominees, and (ii) issue, or cause to be issued, and deliver to the Conversion Agent or to such Holder, or such Holder’s nominee or nominees, certificates for the number of full shares of Common Stock, if any,
to which such Holder shall be entitled as part of such Conversion Obligation. The Company shall not be required to deliver certificates for shares of Common Stock while the stock transfer books for such Common Stock or the security register

  
 50 

 
are duly closed for any purpose, but certificates for shares of Common Stock shall be issued and delivered as soon as practicable after the opening of such books or security register, and the
person or persons entitled to receive the Common Stock as part of the applicable Conversion Settlement Amount upon such conversion shall be treated for all purposes as the record holder or holders of such Common Stock, as of the close of business on
the last Trading Day of the Applicable Conversion Period. 
 (f) In case any Security shall be surrendered for partial
conversion, the Company shall execute and the Trustee shall authenticate and deliver to or upon the written order of the Holder of the Security so surrendered, without charge to such Holder (subject to the provisions of Section 10.07 hereof), a
new Security or Securities in authorized denominations in an aggregate principal amount equal to the unconverted portion of the surrendered Securities. 
 (g) By delivering the combination of cash and shares of Common Stock, if any, together with a cash payment in lieu of any fractional shares to the Conversion Agent or to the Holder or such Holder’s
nominee or nominees, the Company shall have satisfied in full its Conversion Obligation with respect to such Security, and upon such delivery, accrued and unpaid Interest, if any, and any Additional Amounts, with respect to such Security shall be
deemed to be paid in full rather than canceled, extinguished or forfeited, and such amounts shall no longer accrue. 
 (h) If a
Securityholder delivers a Conversion Notice after the Interest Record Date for a payment of Interest (including any Additional Amounts) but prior to the corresponding Interest Payment Date, such Securityholder must pay to the Company, at the time
such Securityholder surrenders Securities for conversion, an amount equal to the Interest (but not including any Additional Amounts), that has accrued and shall be paid on the related Interest Payment Date. The preceding sentence shall not apply
(1) if the Company has specified a Fundamental Change Repurchase Date that is after the close of business on an Interest Record Date but on or prior to the corresponding Interest Payment Date, (2) to the extent of overdue Interest if any
overdue Interest exists at the time of conversion with respect to the Securities converted or (3) if a Holder converts its Securities after the close of business on or after April 1, 2017. 

Section 10.03. Payment Upon Conversion. (a) Subject to 10.03(c), upon conversion of Securities, the Company shall satisfy its
obligation to convert the Securities (the “Conversion Obligation”) by delivering to Holders surrendering Securities for conversion, for each $1,000 principal amount of Securities, a settlement amount (the “Conversion
Settlement Amount”) equal to the sum of the Daily Settlement Amounts for each of the 40 consecutive Trading Days of the Applicable Conversion Period. 
 (i) The “Daily Settlement Amount” for each of the 40 consecutive Trading Days of the Applicable Conversion Period, shall consist of: 

(A) cash equal to the lesser of $25 and the Daily Conversion Value on such Trading Day; and 

(B) to the extent the Daily Conversion Value on such Trading Day exceeds $25, a number of shares of Common Stock (the
“Daily Share Amount”) equal to (x) the difference between such Daily Conversion Value and $25 divided by (y) the VWAP for such Trading Day. 

  
 51 

 (ii) The Conversion Settlement Amount will be delivered on the Conversion
Settlement Date. 
 (b) [Reserved] 
 (c) Notwithstanding anything to the contrary, unless the Company obtains stockholder approval in accordance with applicable listing standards of NASDAQ, in no event will the Company issue more than the
number of shares equal to 19.99% of the shares of Common Stock outstanding immediately prior to the issuance of the Securities upon conversion of the Securities (the “Aggregate Share Cap”). The share cap will be applied for each
individual day of the Applicable Conversion Period (the “Daily Share Cap,” and together with the Aggregate Share Cap, the “Share Cap”). The Daily Share Cap will be calculated as (1) a number of shares of Common
Stock equal to the Aggregate Share Cap divided by (2) the product of (A) the aggregate principal amount of Securities (expressed in thousands) issued in the offering contemplated by the Offering Memorandum (including any Securities issued
pursuant to the initial purchasers’ option to purchase additional Securities pursuant to the Purchase Agreement), and (B) 40. The Daily Share Cap will be rounded to the nearest ten-thousandth, with any one hundred-thousandths rounded
downward. The Share Cap will not be adjusted for any increase in the Applicable Conversion Rate. The Share Cap will cease to apply at any time that either (1) the elimination of the Share Cap has been approved by the Holders of Company Common
Stock in accordance with the listing standards of NASDAQ or (2) the Share Cap is otherwise no longer required for the Company to be in compliance with applicable listing standards of NASDAQ. The Company shall not be required to conduct any such
stockholder vote and shall not undertake any such stockholder vote if such vote would be inconsistent with applicable listing standards of NASDAQ. 
 Section 10.04. Adjustment of Applicable Conversion Rate. The Applicable Conversion Rate shall be adjusted, without duplication, from time to time by the Company in accordance with this
Section 10.04, except that the Company will not make any adjustment if Holders of Securities are entitled to participate on the relevant distribution or payment date, as a result of holding the Securities, in the transactions described in
Sections 10.04(b), 10.04(c) and 10.04(d) below without having to convert their Securities as if each Holder held a number of shares of the Common Stock equal to the Applicable Conversion Rate in effect immediately before the relevant
Ex-Dividend Date multiplied by the principal amount of Securities held by such Holder: 
 (a) If the Company, at
any time or from time to time while any of the Securities are outstanding, issues shares of Common Stock as a dividend or distribution on shares of Common Stock, or if the Company effects a share split or share combination, then the Applicable
Conversion Rate will be adjusted based on the following formula: 
  

													
		 	 CR1
	 	 =
	 	CR0	 	×	 	 OS1
	 	
	 	 	 	 	 	OS0	 	

  
 52 

 where 

 

							
	
CR1
	 	 	=	  	  	the Applicable Conversion Rate in effect immediately after the opening of business on the Ex-Dividend Date for such dividend or distribution or the effective date of such share
split or share combination, as applicable;
			
	
CR0
	 	 	=	  	  	the Applicable Conversion Rate in effect immediately prior to the opening of business on the Ex-Dividend Date for such dividend or distribution, or the effective date of such
share split or share combination, as applicable;
			
	
OS0
	 	 	=	  	  	the number of shares of Common Stock outstanding immediately prior to the opening of business on the Ex-Dividend Date for such dividend or distribution or the effective date of
such share split or share combination; and
			
	
OS1
	 	 	=	  	  	the number of shares of Common Stock that would be outstanding immediately after, and solely as a result of, such dividend, distribution, share split or share combination, as
applicable.

 Any adjustment to the Applicable Conversion Rate under this Section 10.04(a) shall become
effective immediately after the opening of business on the Ex-Dividend Date for such dividend or distribution, or immediately after the opening of business on the effective date for such share split or share combination, as applicable. If any
dividend or distribution of the type described in this Section 10.04(a) is declared but not so paid or made, the Applicable Conversion Rate shall again be adjusted effective as of the date the Board of Directors determines not to pay such
dividend or distribution, to the Applicable Conversion Rate which would then be in effect if such dividend or distribution had not been declared. 
 (b) If the Company, at any time or from time to time while any of the Securities are outstanding, distributes to all or substantially all holders of Common Stock any rights, options or warrants entitling
them to purchase for a period of 60 calendar days or less from the date of issuance of such distribution, shares of Common Stock at an exercise price per share of Common Stock less than the average of the Closing Sales Prices of the Common Stock for
the 10 Trading Day period immediately preceding the declaration date of such distribution, the Applicable Conversion Rate shall be increased based on the following formula: 

 

													
		 	 CR1
	 	=	 	CR0	 	×	 	 OS0 + X
	 	
	 	 	 	 	 	OS0 + Y	 	

 where 

 

							
	
CR1
	 	 	=	  	  	the Applicable Conversion Rate in effect immediately after the opening of business on the Ex-Dividend Date for such distribution;
			
	
CR0
	 	 	=	  	  	the Applicable Conversion Rate in effect immediately prior to the opening of business on the Ex-Dividend Date for such distribution;

  
 53 

 
							
	
OS0
	 	 	=	  	  	the number of shares of Common Stock outstanding immediately prior to the opening of business on the Ex-Dividend Date for such distribution;
			
	 X
	 	 	=	  	  	the total number of shares of Common Stock issuable pursuant to such rights, options or warrants; and
			
	 Y
	 	 	=	  	  	the number of shares of Common Stock equal to the aggregate price payable to exercise such rights, options or warrants, divided by the average of the Closing Sale Prices
of the Common Stock over the 10 consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the declaration date for such distribution.

 Any adjustment to the Applicable Conversion Rate under this Section 10.04(b) shall be made
successively whenever any such rights, options or warrants are distributed and shall become effective immediately after the opening of business on the Ex-Dividend Date for such distribution. To the extent that shares of Common Stock are not
delivered after the expiration of such rights, options or warrants, the Applicable Conversion Rate shall be decreased to the Applicable Conversion Rate that would then be in effect had the increase with respect to the distribution of such rights,
options or warrants been made on the basis of delivery of only the number of shares of Common Stock actually delivered. If such rights, options or warrants are not so distributed, the Applicable Conversion Rate shall be decreased to the Applicable
Conversion Rate that would then be in effect if such Ex-Dividend Date for such distribution had not occurred. For purposes of Section 10.01(b)(1) and this Section 10.04(b), in determining whether any rights, warrants or options entitle the
Holders to purchase shares of Common Stock at less than the average of the Closing Sale Prices of the Common Stock for the 10 consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the declaration date for
such distribution, and in determining the aggregate offering price of such shares of Common Stock, there shall be taken into account any consideration received for such rights, options or warrants and any amount payable on exercise or conversion
thereof, the value of such consideration, if other than cash, as shall be determined in good faith by the Board of Directors. 
 (c) If the Company, at any time or from time to time while the Securities are outstanding, distributes shares of any class of Capital Stock of the Company, evidences of indebtedness or other assets or
property of the Company to all or substantially all holders of its Common Stock, excluding: 
 (i) dividends or
distributions as to which the Applicable Conversion Rate is adjusted pursuant to Section 10.04(a); 
 (ii)
rights, options or warrants as to which the Applicable Conversion Rate is adjusted pursuant to Section 10.04(b); 
 (iii) dividends or distributions paid exclusively in cash; and 

(iv) Spin-Offs (as defined below) to which the provisions set forth below in this Section 10.04(c) shall apply;

  
 54 

 then the Applicable Conversion Rate will be adjusted based on the following formula:

  

													
		 	 CR1
	 	=	 	CR0	 	×	 	 SP0
	 	
	 	 	 	 	 	SP0 – FMV	 

 where 

 

							
	
CR1
	 	 	=	  	  	the Applicable Conversion Rate in effect immediately after the opening of business on such Ex-Dividend Date for such distribution;
			
	
CR0
	 	 	=	  	  	the Applicable Conversion Rate in effect immediately prior to the opening of business on the Ex-Dividend Date for such distribution;
			
	
SP0
	 	 	=	  	  	the average of the Closing Sale Prices of the Common Stock over the 10 consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the
Ex-Dividend Date for such distribution; and
			
	 FMV
	 	 	=	  	  	the Fair Market Value (as determined in good faith by the Board of Directors) of the shares of Capital Stock, evidences of indebtedness, assets or property distributed with
respect to each outstanding share of the Common Stock immediately prior to the opening of business on the Ex-Dividend Date for such distribution.

 Any adjustment to the Applicable Conversion Rate under the preceding paragraph of this
Section 10.04(c) shall become effective immediately after the opening of business on the Ex-Dividend Date for such distribution. If such distribution is not so paid or made, the Applicable Conversion Rate shall be decreased to be the Applicable
Conversion Rate that would then be in effect if such distribution had not been declared. 
 Notwithstanding
the foregoing, if “FMV” (as defined above) is equal to or greater than “SP0” (as defined above), or if the difference between “SP0” and “FMV” is less than $1.00, in lieu of the foregoing increase, the Company shall deliver to each Holder of a Security, in respect of each $1,000 principal amount thereof, at the same
time and upon the same terms as it delivers to holders of shares of the Common Stock without having to convert its Securities, the amount and kind of Company Capital Stock, evidences of indebtedness, securities or other assets or property that such
Holder would have received as if such Holder owned a number of shares of Common Stock equal to the Applicable Conversion Rate on the Ex-Dividend Date for such distribution. 
 Where there has been a payment of a dividend or other distribution on the Common Stock of shares of Capital Stock of any class or series, or similar equity interest, of or relating to a Subsidiary or
other business unit that are listed on a U.S. national or regional securities exchange (a “Spin-Off”), the Applicable Conversion Rate shall be increased based on the following formula: 

 

													
		 	 CR1
	 	=	 	CR0	 	×	 	 FMV + MP0
	 	
	 	 	 	 	 	MP0	 

  
 55 

 where 

 

							
	
CR1
	 	 	=	  	  	the Applicable Conversion Rate in effect immediately after the opening of business on the effective date of the Spin-Off;
			
	
CR0
	 	 	=	  	  	the Applicable Conversion Rate in effect immediately prior to the opening of business on the effective date of the Spin-Off;
			
	 FMV
	 	 	=	  	  	the average of the Closing Sale Prices of the Capital Stock or similar equity interest distributed to holders of Common Stock applicable to one share of Common Stock over the
first 10 consecutive Trading Day period immediately following, and including, the third Trading Day after the effective date of the Spin-Off (the “valuation period”); and
			
	
MP0
	 	 	=	  	  	the average of the Closing Sale Prices of the Common Stock over the valuation period.

 Any adjustment to the Applicable Conversion Rate under the preceding paragraph of this
Section 10.04(c) will occur immediately after the close of business on the last day of the valuation period, but will be given effect as of the opening of business on the Ex-Dividend Date for the Spin-Off. With respect to the conversion of any
Securities where the final day of the Applicable Conversion Period occurs during the valuation period, the Company will pay the cash and deliver any shares of Common Stock due upon conversion (based on the Adjusted Conversion Rate as determined
above) on the third Business Day immediately following the last day of the valuation period. 
 For the purposes of this
Section 10.04(c), rights, options or warrants distributed by the Company to all holders of Common Stock entitling them to subscribe for or purchase shares of the Company’s Capital Stock (either initially or under certain circumstances),
which rights, warrants or options until the occurrence of a specified event or events (a “Trigger Event”): (1) are deemed to be transferred with such shares of Common Stock; (2) are not exercisable; and
(3) are also issued in respect of future issuances of Common Stock, shall be deemed not to have been distributed for purposes of this Section 10.04(c), (and no adjustment to the Applicable Conversion Rate under this Section 10.04(c)
will be required) until the occurrence of the earliest Trigger Event, whereupon such rights and warrants shall be deemed to have been distributed and an appropriate adjustment (if any is required) to the Applicable Conversion Rate shall be made
under this Section 10.04(c). If any such right, warrant or option, including any such existing rights, warrants or options distributed prior to the date of this Indenture, are subject to events, upon the occurrence of which such rights,
warrants or options become exercisable to purchase different securities, evidences of indebtedness or other assets, then the date of the occurrence of any and each such event shall be deemed to be the date of distribution and record date with
respect to new rights, warrants or options with such rights (and a termination or expiration of the existing rights, warrants or options without exercise by any of the holders thereof). In addition, in the event of any distribution (or deemed
distribution) of rights, warrants or options or any Trigger Event or other event (of the type described in the preceding sentence) with respect thereto that was counted for 

  
 56 

 
purposes of calculating a distribution amount for which an adjustment to the Applicable Conversion Rate under this Section 10.04(c) was made, (1) in the case of any such rights,
warrants or options which shall all have been redeemed or purchased without exercise by any Holders thereof, the Applicable Conversion Rate shall be readjusted upon such final purchase to give effect to such distribution or Trigger Event, as the
case may be, as though it were a cash distribution, equal to the per share redemption or purchase price received by a holder of Common Stock with respect to such rights, warrants or options (assuming such holder had retained such rights,
warrants or options), made to all applicable holders of Common Stock as of the date of such redemption or purchase, and (2) in the case of such rights, warrants or options which shall have expired or been terminated without exercise by any
holders thereof, the Applicable Conversion Rate shall be readjusted as if such rights, warrants or options had not been issued. 
 (d) If any cash dividend or other distribution exclusively in cash is made to all or substantially all holders of the Common Stock (other than dividends or distributions made in connection with the
Company’s liquidation, dissolution or winding-up), the Applicable Conversion Rate shall be adjusted based on the following formula: 
  

													
		 	 CR1
	 	 =
	 	CR0	 	×	 	 SP0
	 	
	 	 	 	 	 	SP0 – C	 	

 where 
  

							
	
CR1
	 	 	=	  	  	the Applicable Conversion Rate in effect immediately after the opening of business on the Ex-Dividend Date for such dividend or distribution;
			
	
CR0
	 	 	=	  	  	the Applicable Conversion Rate in effect immediately prior to the opening of business on the Ex-Dividend Date for such dividend or distribution;
			
	
SP0
	 	 	=	  	  	the average of the Closing Sale Prices of the Common Stock over the 10 consecutive Trading Day period on, and including, the Trading Day immediately preceding the Ex-Dividend
Date for such distribution; and
			
	 C
	 	 	=	  	  	the amount in cash per share the Company distributes to holders of Common Stock.

 Any increase made under this clause (d) shall become effective immediately after the opening
of business on the Ex-Dividend Date for such dividend or distribution. If such dividend or distribution is not so paid or made, the Applicable Conversion Rate shall be decreased, effective as of the date the Board of Directors determines not to make
or pay such dividend or distribution, to the Applicable Conversion Rate that would then be in effect if such dividend or distribution had not been declared. 
 Notwithstanding the foregoing, if “C” (as defined above) is equal to or greater than “SP0” (as defined above), or if the difference between “SP0” and “C” is less than $1.00, in lieu of the foregoing increase, the Company shall deliver to each Holder of
a Security, in respect of each $1,000 principal amount thereof, at the same time and upon the same terms as it delivers to holders of shares of Common Stock without having to convert its 

  
 57 

 
Securities, the amount of cash that such Holder would have received as if such Holder owned a number of shares of Common Stock equal to the Applicable Conversion Rate on the Ex-Dividend Date for
such cash dividend or distribution. 
 (e) If the Company or any Subsidiary makes a payment in respect of a
tender offer or exchange offer for Common Stock, to the extent that the cash and value (which will be, except for the value of traded securities, determined by the Board of Directors) of any other consideration included in the payment per share
of Common Stock exceeds the Closing Sale Price of the Common Stock on the Trading Day next succeeding the last date on which tenders or exchanges may be made pursuant to such tender or exchange offer, the Applicable Conversion Rate shall be
increased based on the following formula: 
  

													
		 	 CR1
	 	 =
	 	CR0	 	×	 	 AC + ( SP1 × OS1 )
	 	
	 	 	 	 	 	OS0 × SP1
	 	

 where 
  

							
	
CR1
	 	 	=	  	  	the Applicable Conversion Rate in effect immediately after the close of business on the Trading Day immediately following the date such tender offer or exchange offer
expires;
			
	
CR0
	 	 	=	  	  	the Applicable Conversion Rate in effect immediately prior to the close of business on the Trading Day immediately following the date such tender or exchange offer
expires;
			
	 AC
	 	 	=	  	  	the aggregate value of all cash and any other consideration (as determined by the Board of Directors) paid or payable for shares purchased in such tender or exchange
offer;
			
	
SP1
	 	 	=	  	  	the average of the Closing Sale Prices of the Common Stock over the 10 consecutive Trading Day period commencing on, and including, the Trading Day next succeeding the date such
tender or exchange offer expires (the “averaging period”);
			
	
OS1
	 	 	=	  	  	the number of shares of Common Stock outstanding immediately after the close of business on the date such tender or exchange offer expires (after giving effect to such tender
offer or exchange offer); and
			
	
OS0
	 	 	=	  	  	the number of shares of Common Stock outstanding immediately prior to the date such tender or exchange offer expires (prior to giving effect to such tender offer or exchange
offer).

 Any adjustment to the Applicable Conversion Rate under this Section 10.04(e) shall become
effective immediately after the close of business on the last day of the averaging period, but will be given effect as of the opening of business on the Trading Day next succeeding the date such tender offer or exchange offer expires. With respect
to the conversion of any Securities where the final day of the Applicable Conversion Period occurs during the averaging period, the Company will pay the cash and deliver any shares of Common Stock due upon conversion (based on the Adjusted
Conversion Rate as determined above) on the third Business Day immediately following the last day of the averaging period. 

  
 58 

 If the Company is obligated to purchase shares pursuant to any such tender
or exchange offer, but the Company is permanently prevented by applicable law from effecting any such purchases or all such purchases are rescinded, the Applicable Conversion Rate shall again be adjusted to be the Applicable Conversion Rate that
would then be in effect if such tender or exchange had not been made. 
 (f) No adjustment to the Applicable
Conversion Rate will be required unless the adjustment would require an increase or decrease of at least 1% of the Applicable Conversion Rate. If any adjustment is not made because the adjustment does not change the Applicable Conversion Rate by at
least 1%, then such adjustment will be carried forward and taken into account in any future adjustments. In addition, the Company will make any carry forward adjustments not otherwise effected, without duplication, prior to any Fundamental Change
Repurchase Date, upon any conversion of the Securities on each Trading Day of the Applicable Conversion Period and on every one year anniversary from the original issue date of the Securities. Adjustments to the Applicable Conversion Rate will be
rounded to the nearest ten-thousandth, with five one-hundred-thousandths rounded upward (e.g., 0.76545 would be rounded up to 0.7655). 
 (g) The Company from time to time may, to the extent permitted by applicable law, increase the Applicable Conversion Rate by any amount for a period of at least 20 Business Days if either (i) the
Board of Directors shall have made a determination that such increase would be in the best interests of the Company, which determination shall be conclusive or (ii) as the Board of Directors considers to be advisable to avoid or diminish income
tax to holders of the Common Stock or rights to purchase shares of Common Stock in connection with any dividend or distribution of shares (or rights to acquire shares) or from any event treated as such for income tax purposes. Whenever the
Applicable Conversion Rate is increased pursuant to this Section 10.04(g), the Company shall mail to Holders of record of the Securities a notice of the increase at least 15 days prior to the date the increased Applicable Conversion Rate takes
effect, and such notice shall state the increased Applicable Conversion Rate and the period during which it will be in effect. 
 (h) Except as otherwise provided in this Indenture, all calculations under this Article 10 shall be made by the Company. No adjustment shall be made for the Company’s issuance of Common Stock or
securities convertible into or exchangeable for shares of Common Stock or rights to purchase Common Stock or convertible or exchangeable securities, other than as provided in this Section 10.04. The Company shall make such calculations in good
faith and, absent manifest error, such calculations shall be binding on the Holders. 
 (i) Whenever the
Applicable Conversion Rate is adjusted as herein provided, the Company shall promptly file with the Trustee and any Conversion Agent an Officer’s Certificate setting forth the Applicable Conversion Rate after such adjustment and setting forth a
brief statement of the facts requiring such adjustment. Unless and until a 

  
 59 

 
Responsible Officer of the Trustee shall have received such Officer’s Certificate, the Trustee shall not be deemed to have knowledge of any adjustment of the Applicable Conversion Rate and
may assume without inquiry that the last Applicable Conversion Rate of which it has knowledge is still in effect. Promptly after delivery of such certificate, the Company shall issue a press release through Business Wire containing the relevant
information and make this information available on its website or through another public medium as it may use at that time. 
 (j) For purposes of this Section 10.04, the number of shares of Common Stock at any time outstanding shall not include shares held in the treasury of the Company so long as the Company does not pay
any dividend or make any distribution on shares of Common Stock held in the treasury of the Company, but shall include shares issuable in respect of scrip certificates issued in lieu of fractions of shares of Common Stock. 

(k) Notwithstanding anything to the contrary in this Article 10, no adjustment to the Applicable Conversion Rate
shall be made: 
 (i) upon the issuance of any shares of Common Stock pursuant to any present or future plan
providing for the reinvestment of dividends or interest payable on the Company’s securities and the investment of additional optional amounts in shares of Common Stock under any plan; 

(ii) upon the issuance of any shares of Common Stock or options or rights to purchase those shares pursuant to any present
or future employee, director or consultant benefit plan or program of or assumed by the Company or any Subsidiary; 
 (iii) upon the issuance of any shares of Common Stock pursuant to any option, warrant, right or exercisable, exchangeable or convertible security not described in (ii) above outstanding as of the
date the Securities were first issued; 
 (iv) for a change in the par value of the Common Stock; or 

(v) for accrued and unpaid Interest, including any Additional Amounts. 

Section 10.05. Conditions to Voluntary Conversion Rate Adjustments. If the Company is required to increase the
Applicable Conversion Rate pursuant to Section 10.01(c) as a result of a Fundamental Change that is approved by the Board of Directors prior to the effective date of such Fundamental Change or pursuant to Section 10.04 and such increase in
the Applicable Conversion Rate could result in the Securities, in the aggregate, becoming convertible into shares of the Common Stock in excess of the Share Cap, the Company shall, at its option, either obtain stockholder approval of the issuance of
such shares of Common Stock or deliver cash in lieu of any shares otherwise deliverable upon conversion of Securities in excess of the Daily Share Cap based on the VWAP on each Trading Day of the Applicable Conversion Period in respect of which, in
lieu of delivering shares of the Common Stock, the Company delivers cash pursuant to this Section 10.05. If the Company obtains such stockholder approval, upon conversion of any 

  
 60 

 
Security, the Company shall deliver the full amount of shares of the Common Stock as calculated using the increased Applicable Conversion Rate. Notwithstanding the foregoing, the Company shall
not be required to conduct any such shareholder vote and shall not undertake any such shareholder vote if such vote would be inconsistent with applicable listing standards of NASDAQ. 

Section 10.06. Effect of Reclassification, Consolidation, Merger or Sale. (a) In the case of: 

(i) any recapitalization, reclassification or change of the Common Stock (other than changes resulting from a share split
or share combination), 
 (ii) any consolidation, merger or combination involving the Company, 

(iii) any sale, lease or other transfer to a third party of the consolidated assets of the Company substantially as an
entirety or 
 (iv) any statutory share exchange, 
 in each case as a result of which the Common Stock would be converted into, or exchanged for, stock, other securities or other property or assets (including cash or any combination thereof) (any such
event, a “Merger Event”), then, at and after the effective time of such Merger Event, the Share Cap shall not apply and the right to convert each $1,000 principal amount of Securities shall be changed into a right to convert such
principal amount of Securities into the kind and amount of shares of stock or other securities or other property or assets (including cash or any combination thereof) that a holder of a number of shares of Common Stock equal to the Applicable
Conversion Rate (without giving effect to the Share Cap) immediately prior to such Merger Event would have owned or been entitled to receive (the “Reference Property”, with each “unit of Reference Property” meaning
the kind and amount of Reference Property that a holder of one share of Common Stock is entitled to receive) upon such Merger Event and, prior to or at the effective time of such Merger Event, the Company or the successor or purchasing person, as
the case may be, shall execute with the Trustee a supplemental indenture providing for such change in the right to convert each $1,000 principal amount of Securities. 
 (b) If such Merger Event causes the Common Stock to be converted into, or exchanged for, the right to receive more than a single type of consideration (determined based in part upon any form of
stockholder election), then (i) the Reference Property that will be used to calculate the VWAP and that will be payable upon conversion of any Securities shall be deemed to be the kind and amount of consideration actually received by the
holders of a majority of the Common Stock that affirmatively make such an election (if electing between two types of consideration) or the holders of a plurality of the Common Stock that affirmatively make such an election (if electing between more
than two types of consideration), and (ii) the unit of Reference Property for purposes of Section 10.06(a) shall refer to the consideration referred to in clause (i) attributable to one share of Common Stock. 

(c) The Conversion Obligation in respect of any Securities converted following the effective date of any Merger Event (other than a
Merger Event in which the holders of Common Stock receive only cash) shall be computed in the same manner as set forth in Section 10.03(a) 

  
 61 

 
except that VWAP of the Common Stock shall be deemed to equal the sum of (A) 100% of the value of any portion of a unit of Reference Property that consists of cash, (B) the VWAP of any
portion of a unit of Reference Property that consists of securities that are traded on a U.S. national or regional securities exchange and (C) the Fair Market Value of any portion of a unit of Reference Property that consists of any other type
of property, as determined by an independent nationally recognized investment bank selected by the Company for this purpose. If the foregoing calculations would require the Company to deliver a fractional share of any security comprising a portion
of a unit of Reference Property to a Holder of Securities being converted, the Company shall deliver cash in lieu of such fractional share or unit based on the Closing Sale Price of such security on the last Trading Day of the Applicable Conversion
Period. If the holders receive only cash in such Merger Event, then for all conversions that occur after the effective date of such Merger Event (x) the consideration due upon conversion of each $1,000 principal amount of Securities shall be
solely cash in an amount equal to the Applicable Conversion Rate in effect on the Applicable Conversion Date (as may be increased by any make-whole premium pursuant to Section 10.01(c)), multiplied by the price per share of Common Stock
in such Merger Event and (y) the Company shall satisfy the Conversion Obligation by paying cash to converting Holders on the third Business Day immediately following the Conversion Date. The Company shall notify in writing all Holders, the
Trustee and the Conversion Agent (if other than the Trustee) of the components of a unit of Reference Property as soon as practicable after such determination is made. Such supplemental indenture required by Section 10.06(a) shall provide for
adjustments that shall be as nearly equivalent as is possible to the adjustments provided for in this Article 10. If, in the case of any Merger Event, the Reference Property includes shares of stock, securities or other property or assets
(including cash or any combination thereof) of a person other than the successor or purchasing corporation, as the case may be, in such Merger Event, then such supplemental indenture shall also be executed by such other person and shall contain such
additional provisions to protect the interests of the Holders of the Securities as the Board of Directors shall reasonably consider necessary by reason of the foregoing, including to the extent required by the Board of Directors and practicable the
provisions providing for the purchase rights set forth in Article 3. 
 (d) The Company shall not become a party to any
Merger Event unless its terms are consistent with this Section 10.06. None of the foregoing provisions shall affect any right that a Holder of Securities may have to convert its Securities into cash and shares of Common Stock, if any, as set
forth in Section 10.01 prior to the effective date of such Merger Event. 
 (e) The Company shall cause notice of the
execution of such supplemental indenture to be mailed to each Holder of Securities, at its address appearing on the Security register provided for in Section 2.03 of this Indenture, within 20 days after execution thereof. Failure to deliver
such notice shall not affect the legality or validity of such supplemental indenture. 
 (f) The above provisions of this
Section 10.06 shall similarly apply to successive reclassifications, changes, consolidations, mergers, statutory share exchanges, combinations, sales and conveyances. 
 If this Section 10.06 applies to any event or occurrence, Section 10.04 shall not apply to such event or occurrence. 

  
 62 

 Section 10.07. Taxes on Shares Issued. The issue of stock certificates on
conversions of Securities shall be made without charge to the converting Holder for any tax in respect of the issue thereof, except for applicable withholding, if any. The Company shall not, however, be required to pay any tax or duty which may be
payable in respect of any transfer involved in the issue and delivery of stock in any name other than that of the Holder or beneficial owner of any Securities converted, and the Company shall not be required to issue or deliver any such stock
certificate unless and until the person or persons requesting the issue thereof shall have paid to the Company the amount of such tax or shall have established to the satisfaction of the Company that such tax has been paid or that none is due.

 Section 10.08. Reservation of Shares, Shares to Be Fully Paid; Compliance with Governmental Requirements. (a) The
Company shall provide, free from preemptive rights, out of its authorized but unissued shares or shares held in treasury, sufficient shares of Common Stock for the conversion of the Securities from time to time as such Securities are presented for
conversion. 
 (b) Before taking any action which would cause an adjustment increasing the Applicable Conversion Rate to an
amount that would cause the Applicable Conversion Price to be reduced below the then par value, if any, of the shares of Common Stock issuable upon conversion of the Securities, the Company shall take all corporate action which may, in the opinion
of its counsel, be necessary in order that the Company may validly and legally issue shares of such Common Stock at such adjusted Applicable Conversion Rate. 
 (c) (i) The Company covenants that all shares of Common Stock which may be issued upon conversion of Securities shall upon issue be fully paid and nonassessable by the Company and free from all taxes,
liens and charges with respect to the issue thereof. 
 (ii) The Company covenants that, if any shares of Common
Stock to be provided for the purpose of conversion of Securities hereunder require registration with or approval of any governmental authority under any federal or state law before such shares may be validly issued upon conversion, the Company shall
in good faith and as expeditiously as possible, to the extent then permitted by the rules and interpretations of the SEC (or any successor thereto), endeavor to secure such registration or approval, as the case may be. 

Section 10.09. Adjustments of Prices. Whenever any provision of this Indenture requires the Company to calculate the Closing
Sale Prices, the VWAPs, the Daily Conversion Values or the Daily Share Amounts over a span of multiple days (including an Applicable Conversion Period and the period for determining the Stock Price for purposes of a Fundamental Change), the Board of
Directors shall make appropriate adjustments to each to account for any adjustment to the Applicable Conversion Rate that becomes effective, or any event requiring an adjustment to the Applicable Conversion Rate where the Ex-Dividend Date of the
event occurs, at any time during the period when the Closing Sale Prices, the VWAPs, the Daily Conversion Values or the Daily Share Amounts are to be calculated. 
 Section 10.10. Responsibility of Trustee. The Trustee and any other Conversion Agent shall not at any time be under any duty or responsibility to any Holder of Securities to determine

  
 63 

 
the Applicable Conversion Rate or whether any facts exist which may require any adjustment of the Applicable Conversion Rate, or with respect to the nature or extent or calculation of any such
adjustment when made, or with respect to the method employed, or herein or in any supplemental indenture provided to be employed, in making the same. The Trustee and any other Conversion Agent shall not be accountable with respect to the validity or
value (or the kind or amount) of any shares of Common Stock, or of any securities or property, which may at any time be issued or delivered upon the conversion of any Security; and the Trustee and any other Conversion Agent make no representations
with respect thereto. Neither the Trustee nor any Conversion Agent shall be responsible for any failure of the Company to issue, transfer or deliver any shares of Common Stock or stock certificates or other securities or property or cash upon the
surrender of any Security for the purpose of conversion or to comply with any of the duties, responsibilities or covenants of the Company contained in this Article 10. Without limiting the generality of the foregoing, neither the Trustee nor
any Conversion Agent shall be under any responsibility to determine the correctness of any provisions contained in any supplemental indenture entered into pursuant to Section 10.06 relating either to the kind or amount of shares of stock or
securities or property (including cash) receivable by Holders upon the conversion of their Securities after any event referred to in such Section 10.06 or to any adjustment to be made with respect thereto, but, subject to the provisions of
Section 7.01, may accept as conclusive evidence of the correctness of any such provisions, and shall be protected in relying upon the Officer’s Certificate (which the Company shall be obligated to file with the Trustee prior to the
execution of any such supplemental indenture) with respect thereto. 
 ARTICLE 11 

REDEMPTION 

Section 11.01. Redemption. The Company shall not have the right to redeem any Securities prior to the Stated Maturity and no
sinking fund is provided for the Securities. 
 ARTICLE 12 

MISCELLANEOUS 

Section 12.01. Trust Indenture Act Controls. If any provision of this Indenture limits, qualifies, or conflicts with another
provision which is required to be included in this Indenture by the TIA, the required provision shall control. 

Section 12.02. Notices. Any request, demand, authorization, notice, waiver, consent or communication by the Company or the
Trustee to the other is duly given if in writing and delivered in person or mailed by first-class mail, postage prepaid, addressed as follows or transmitted by facsimile transmission to the following facsimile numbers: 

if to the Company: 
 DFC Global Corp.

 1436 Lancaster Avenue 
 Berwyn, PA
19312 
 Attn: Randy Underwood 

Facsimile: (610) 296-7844 

  
 64 

 With a copy to (which shall not constitute notice): 

Roy Hibberd, General Counsel 
 DFC Global Corp.

 1436 Lancaster Avenue 
 Berwyn, PA
19312 
 Facsimile: (610) 296-7844 

and 
 Pepper Hamilton LLP 

3000 Two Logan Square 
 Eighteenth and Arch
Streets 
 Philadelphia, PA 19103 

Attn: Brian M. Katz 
 Facsimile:
(215) 981-4750 
 if to the Trustee: 
 U.S. Bank National Association 
 225 Asylum Street 

23rd
 Floor 
 Hartford, CT 06103 
 Attn: Kathy Mitchell 
 Facsimile: (860) 241-6897 

The Company or the Trustee by notice given to the other in the manner provided above may designate additional or different addresses for
subsequent notices or communications. 
 Any notice or communication given to a Securityholder shall be delivered to the
Securityholder, in accordance with the procedures of the Registrar or by first-class mail, postage prepaid, at the Securityholder’s address as it appears on the registration books of the Registrar and shall be sufficiently given if so mailed
within the time prescribed. 
 Failure to mail a notice or communication to a Securityholder or any defect in it shall not
affect its sufficiency with respect to other Securityholders. If a notice or communication is mailed in the manner provided above, it is duly given, whether or not received by the addressee; provided, however, that no notice to the
Trustee shall be deemed to be duly given unless and until the Trustee actually receives same at the address given above. 
 If
the Company mails a notice or communication to the Securityholders, it shall mail a copy to the Trustee and each Registrar, Paying Agent, Conversion Agent or co-registrar. 
 Section 12.03. Communication by Holders with Other Holders. Securityholders may communicate pursuant to TIA Section 312(b) with other Securityholders with respect to their rights under
this Indenture or the Securities. The Company, the Trustee, the Registrar, the Paying Agent, the Conversion Agent and anyone else shall have the protection of TIA Section 312(c). 

  
 65 

 Section 12.04. Certificate and Opinion as to Conditions Precedent. Upon any
request or application by the Company to the Trustee to take any action under this Indenture (other than to authenticate the Securities under Section 2.02), the Company shall furnish to the Trustee: 

(a) an Officer’s Certificate stating that, in the opinion of the signer, all conditions precedent, if any, provided for in this
Indenture relating to the proposed action have been complied with; and 
 (b) an Opinion of Counsel stating that, in the opinion
of such counsel, all such conditions precedent, if any, have been complied with. 
 Section 12.05. Statements Required
in Certificate or Opinion. Each Officer’s Certificate or Opinion of Counsel delivered pursuant to Section 12.04 with respect to compliance with a covenant or condition provided for in this Indenture shall include: 

(a) a statement that each person making such Officer’s Certificate or Opinion of Counsel has read such covenant or condition;

 (b) a brief statement as to the nature and scope of the examination or investigation upon which the statements or opinions
contained in such Officer’s Certificate or Opinion of Counsel are based; 
 (c) a statement that, in the opinion of each
such person, he has made such examination or investigation as is necessary to enable such person to express an informed opinion as to whether or not such covenant or condition has been complied with; and 

(d) a statement that, in the opinion of such person, such covenant or condition has been complied with. 

Section 12.06. Separability Clause. In case any provision in this Indenture or in the Securities shall be invalid, illegal or
unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby. 
 Section 12.07. Rules by Trustee, Paying Agent, Conversion Agent and Registrar. The Trustee may make reasonable rules for action by or a meeting of Securityholders. The Registrar, the
Conversion Agent, the Bid Solicitation Agent and the Paying Agent may make reasonable rules for their functions. 

Section 12.08. Legal Holidays. A “legal holiday” is any day other than a Business Day. If any specified date
(including a date for giving notice) is a legal holiday, the action shall be taken on the next succeeding day that is not a legal holiday, and, if the action to be taken on such date is a payment in respect of the Securities, no interest shall
accrue with respect to such payment for the intervening period. 
 Section 12.09. Governing Law. THIS INDENTURE
SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK WITHOUT GIVING EFFECT TO THE CONFLICT OF LAWS RULES THEREOF. 

  
 66 

 Section 12.10. No Recourse Against Others. A director, officer, employee or
stockholder, as such, of the Company shall not have any liability for any obligations of the Company under the Securities or this Indenture or for any claim based on, in respect of or by reason of such obligations or their creation. By accepting a
Security, each Securityholder shall waive and release all such liability. The waiver and release shall be part of the consideration for the issue of the Securities. 
 Section 12.11. Successors. All agreements of the Company in this Indenture and the Securities shall bind its successor. All agreements of the Trustee in this Indenture shall bind its
successor. 
 Section 12.12. Multiple Originals. The parties may sign any number of copies of this Indenture. Each
signed copy shall be an original, but all of them together represent the same agreement. One signed copy is enough to prove this Indenture. 

  
 67 

 IN WITNESS WHEREOF, the undersigned, being duly authorized, have executed this Indenture on
behalf of the respective parties hereto as of the date first above written. 
  

			
	DFC Global Corp.
		
	By:	 	 /s/ William M. Athas

		
		 	Name: William M. Athas
		
		 	Title: Senior Vice President, Finance, Chief Accounting Officer and Corporate Controller

 [Signature Page to Indenture] 

			
	U.S. BANK NATIONAL ASSOCIATION, as Trustee
		
	By:	 	  

		
		 	Name: K. Mitchell
		
		 	Title: Authorized Officer

 [Signature Page to Indenture] 

 EXHIBIT A 
 [FORM OF FACE OF GLOBAL SECURITY] 
 UNLESS THIS CERTIFICATE IS PRESENTED BY AN
AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED
BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (AND ANY PAYMENT HEREON IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY), ANY TRANSFER, PLEDGE OR
OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL SINCE THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN. 
 TRANSFERS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS TO NOMINEES OF THE DEPOSITORY TRUST COMPANY, OR TO A SUCCESSOR THEREOF OR SUCH SUCCESSOR’S NOMINEE AND TRANSFERS OF PORTIONS OF THIS
GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE RESTRICTIONS SET FORTH IN ARTICLE TWO OF THE INDENTURE REFERRED TO ON THE REVERSE HEREOF. 
 THE SECURITY EVIDENCED BY THIS CERTIFICATE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT OF 1933”), OR ANY STATE SECURITIES LAWS, AND MAY NOT BE
OFFERED, SOLD OR OTHERWISE TRANSFERRED, EXCEPT AS SET FORTH IN THE FOLLOWING TWO SENTENCES. EACH PURCHASER OF THIS NOTE IS HEREBY NOTIFIED THAT THE SELLER OF THIS NOTE MAY BE RELYING ON THE EXEMPTION FROM THE PROVISIONS OF SECTION 5 OF THE
SECURITIES ACT OF 1933 PROVIDED BY RULE 144A THEREUNDER. BY ACQUISITION HEREOF OR A BENEFICIAL INTEREST HEREIN, THE HOLDER: 

(1) REPRESENTS THAT IT IS A “QUALIFIED INSTITUTIONAL BUYER” AS DEFINED IN RULE 144A UNDER THE SECURITIES ACT OF 1933;

 (2) AGREES THAT IT WILL NOT PRIOR TO THE DATE ONE YEAR, OR SUCH SHORTER PERIOD OF TIME AS PERMITTED BY RULE 144 UNDER THE
SECURITIES ACT OR ANY SUCCESSOR PROVISION THEREUNDER, AFTER THE LAST DATE OF ORIGINAL ISSUANCE OF THE [    ]% SENIOR CONVERTIBLE NOTES DUE 2017 OF DFC GLOBAL CORP. (THE “COMPANY”) RESELL OR OTHERWISE TRANSFER THE
SECURITY EVIDENCED HEREBY OR ANY COMMON STOCK THAT MAY BE ISSUABLE UPON CONVERSION OF SUCH SECURITY EXCEPT (A) TO THE COMPANY OR ANY SUBSIDIARY THEREOF, (B) TO A PERSON IT REASONABLY BELIEVES IS A QUALIFIED INSTITUTIONAL BUYER IN
COMPLIANCE WITH RULE 144A UNDER THE SECURITIES ACT OF 1933, (C) PURSUANT TO A REGISTRATION STATEMENT WHICH HAS BEEN DECLARED EFFECTIVE UNDER THE SECURITIES 

  
 A-1

 
ACT OF 1933 AND THAT CONTINUES TO BE EFFECTIVE AT THE TIME OF SUCH TRANSFER OR (D) PURSUANT TO ANY OTHER EXEMPTION FROM THE REGISTRATION REQUIREMENTS UNDER THE SECURITIES ACT, INCLUDING
UNDER RULE 144, IF AVAILABLE, SUBJECT (IN THE CASE OF CLAUSE (D)) TO THE COMPANY’S AND THE TRUSTEE’S RIGHT PRIOR TO ANY SUCH TRANSFER, TO REQUIRE THE DELIVERY OF AN OPINION OF COUNSEL, CERTIFICATIONS AND/OR OTHER INFORMATION SATISFACTORY
TO THE COMPANY AND THE TRUSTEE; AND 
 (3) AGREES THAT IT WILL DELIVER TO EACH PERSON TO WHOM THE SECURITY EVIDENCED HEREBY IS
TRANSFERRED PURSUANT TO CLAUSE 2(B) OR CLAUSE 2(D) (EXCEPT A TRANSFER PURSUANT TO RULE 144 UNDER THE SECURITIES ACT ABOVE) A NOTICE SUBSTANTIALLY TO THE EFFECT OF THIS LEGEND. 

  
 A-2

 DFC Global Corp. 
 3.25% Senior Convertible Notes Due 2017 
  

			
	CUSIP: [—]	  	
	ISSUE DATE: April [—], 2012	  	Principal Amount: $[—]

 No. 
 DFC Global Corp., a Delaware corporation, promises to pay to Cede & Co. or registered assigns, the principal amount of [—] Dollars, on
April 15, 2017. 
 Interest Rate: 3.25% per year. 
 Interest Payment Dates: April 15 and October 15 of each year, commencing October 15, 2012. 
 Interest Record Date: April 1 and October 1 of each year. 
 Reference is
hereby made to the further provisions of this Security set forth on the reverse side of this Security, which further provisions shall for all purposes have the same effect as if set forth at this place. 

  
 A-3

 IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed. 

 

							
	Dated: April [—], 2012	 		 	DFC Global Corp.
				
		 		 	By:	 	  

				
		 		 	Name:	 	  

				
		 		 	Title:	 	  

  
 A-4

			
	 TRUSTEE’S CERTIFICATE OF AUTHENTICATION
 U.S. BANK NATIONAL ASSOCIATION,
 as Trustee, certifies that this is one of the Securities referred
to in the within-mentioned Indenture.

		
	By	 	  

		 	Authorized Officer

 Dated: April [—], 2012 

  
 A-5

 [FORM OF REVERSE OF GLOBAL SECURITY] 

3.25% Senior Convertible Notes Due 2017 
 This Security is one of a duly authorized issue of 3.25% Senior Convertible Notes Due 2017 (the “Securities”) of DFC Global Corp., Inc., a Delaware corporation (including any successor
corporation under the Indenture hereinafter referred to, the “Company”), issued under an Indenture, dated as of April 16, 2012 (the “Indenture”), between the Company and U.S. Bank National Association, as
trustee (the “Trustee”). The terms of the Security include those stated in the Indenture, those made part of the Indenture by reference to the Trust Indenture Act of 1939, as amended (“TIA”), and those set forth in
this Security. This Security is subject to all such terms, and Holders are referred to the Indenture and the TIA for a statement of all such terms. To the extent permitted by applicable law, in the event of any inconsistency between the terms of
this Security and the terms of the Indenture, the terms of the Indenture shall control. Capitalized terms used but not defined herein have the meanings assigned to them in the Indenture unless otherwise indicated. 

 

	1.	Interest. 

 The
Securities shall bear Interest on the principal amount thereof at a rate of 3.25% per year. The Company shall also pay any Additional Amounts as set forth in the Indenture. 

Interest shall be payable semi-annually in arrears on each Interest Payment Date to Holders at the close of business on the preceding
Interest Record Date. Interest shall be computed on the basis of a 360-day year comprised of twelve 30 day months and will accrue from April 16, 2012 or from the most recent date to which Interest has been paid or duly provided for. 

If the principal amount of any Security, or any accrued and unpaid Interest or any Additional Amounts are not paid when due (whether upon
acceleration pursuant to Section 6.02 of the Indenture, upon the date set for payment of the Fundamental Change Repurchase Price pursuant to Section 4.01 of the Indenture, upon the Stated Maturity of the Securities, upon the Interest
Payment Dates or otherwise), then in each such case the overdue amount shall, to the extent permitted by law, bear cash interest at the rate of 3.25% per annum, compounded semi-annually, which interest shall accrue from the date such overdue
amount was originally due to the date payment of such amount, including interest thereon, has been made or duly provided for. All such interest shall be payable in cash on demand but if not so demanded shall be paid quarterly to the Holders on the
last day of each quarter. 
  

	2.	Method of Payment. 

Except as provided below, the Company shall pay Interest, including any Additional Amounts on (i) Global Securities to DTC by wire
transfer in immediately available funds, (ii) any Certificated Security having an aggregate principal amount of $2,000,000 or less, by check mailed, or wire transfer in immediately available funds paid, to the Holder of such Security and
(iii) any Certificated Security having a principal amount of more than $2,000,000, by wire transfer in immediately available funds if requested by the Holder of any such Security duly delivered to the Trustee at least five business days prior
to the relevant Interest Payment Date. 

  
 A-6

 At Stated Maturity, the Company shall pay Interest on Certificated Securities at the
Company’s office or agency maintained for that purpose, which initially shall be the office or agency of the Trustee located at 60 Livingston Avenue, St. Paul, MN 55107. 
 Subject to the terms and conditions of the Indenture, the Company shall make payments in cash in respect of Fundamental Change Repurchase Prices and at Stated Maturity to Holders who surrender Securities
to a Paying Agent to collect such payments in respect of the Securities. The Company shall pay cash amounts in money of the United States that at the time of payment is legal tender for payment of public and private debts. However, the Company may
make such cash payments by check payable in such money. 
  

	3.	Indenture. 

 The
Securities are general unsecured obligations of the Company limited to $230,000,000 aggregate principal amount. The Indenture does not limit other indebtedness of the Company, secured or unsecured. 

 

	4.	Repurchase by the Company at the Option of the Holder. 

 At the option of any Holder and subject to the terms and conditions of the Indenture, the Company shall become obligated to repurchase the Securities held by such Holder after the occurrence of a
Fundamental Change for a Fundamental Change Repurchase Price equal to 100% of the principal amount of those Securities plus accrued and unpaid Interest and any accrued and unpaid Additional Amounts, on those Securities up to, but not including, the
Fundamental Change Repurchase Date; provided, however that if the Fundamental Change Repurchase Date is on a date that is after an Interest Record Date and on or prior to the corresponding Interest Payment Date, the Fundamental Change Repurchase
Price shall be 100% of the principal amount of the Securities repurchased. To exercise such right, a Holder shall deliver to the Paying Agent a Fundamental Change Repurchase Notice containing the information set forth in the Indenture at any time on
or prior to the close of business on the Business Day immediately preceding the Fundamental Change Repurchase Date and shall deliver the Securities to the Paying Agent as set forth in the Indenture. 

Holders have the right to withdraw any Fundamental Change Repurchase Notice by delivering to the Paying Agent a written notice of
withdrawal in accordance with the provisions of the Indenture. 
 If cash sufficient to pay the Fundamental Change Repurchase
Price of all Securities or portions thereof to be purchased as of the Fundamental Change Repurchase Date is deposited with the Paying Agent, prior to or on the Fundamental Change Repurchase Date, Interest and any Additional Amounts shall cease to
accrue on such Securities (or portions thereof) on and following such Fundamental Change Repurchase Date, and the Holder thereof shall have no other rights as such other than the right to receive the Fundamental Change Repurchase Price upon
surrender of such Security. 

  
 A-7

	5.	Redemption by the Company. 

 The Company shall not have the right to redeem any Securities prior to Stated Maturity. 
  

	6.	Conversion. 

 Subject to
the occurrence of certain events and in compliance with the provisions of the Indenture (including, without limitation, the conditions to conversion of this Security set forth in Section 10.01 thereof), a Holder is entitled, at such
Holder’s option, to convert the Holder’s Security (or any portion of the principal amount thereof that is $1,000 or an integral multiple of $1,000) at the Applicable Conversion Rate in effect at the time of conversion. 

The Company shall notify Holders of any event triggering the right to convert the Securities as specified in the Indenture. 

A Security in respect of which a Holder has delivered a Fundamental Change Repurchase Notice exercising the option of such Holder to
require the Company to purchase such Security, may be converted only if such Fundamental Change Repurchase Notice is withdrawn in accordance with the terms of the Indenture. 
 The initial Applicable Conversion Rate is 46.8962 shares of Common Stock per $1,000 principal amount, subject to adjustment in certain events described in the Indenture. The Applicable Conversion
Rate shall not be adjusted for any accrued and unpaid Interest or any accrued and unpaid Additional Amounts. Upon conversion, no payment shall be made by the Company with respect to accrued and unpaid Interest and any accrued and unpaid Additional
Amounts. Instead, such amount shall be deemed paid by the cash and shares of Common Stock, if any, delivered upon conversion of any Security. In addition, no payment or adjustment shall be made in respect of dividends on the Common Stock, except as
set forth in the Indenture. 
 In addition, following certain corporate transactions as set forth in Section 10.01(b) of
the Indenture that constitute a Fundamental Change, a Holder who elects to convert its Securities in connection with such corporate transaction shall be entitled to receive a make whole premium upon conversion, subject to the terms and conditions
set forth in Section 10.01(c) and Section 10.02(c) of the Indenture. 
 To surrender a Security for conversion, a
Holder must (1) complete and manually sign the Conversion Notice attached hereto (or complete and manually sign a facsimile of such notice) and deliver such notice to the Conversion Agent, (2) surrender the Security to the Conversion
Agent, (3) if required, furnish appropriate endorsements and transfer documents, (4) if required by Section 10.02(h) of the Indenture, pay Interest and (5) pay any transfer or similar tax, if required. 

No fractional shares of Common Stock shall be issued upon conversion of any Security. Instead of any fractional share of Common Stock
that would otherwise be issued upon conversion of such Security, the Company shall pay a cash adjustment as provided in the Indenture. 

  
 A-8

 If the Company engages in any recapitalization, reclassification or change of the Common
Stock (other than a subdivision or combination of its outstanding Common Stock, or a change in par value, or from par value to no par value, or from no par value to par value), is party to a consolidation, merger, combination or transfer of all or
substantially all of its assets or undergoes a statutory share exchange and as a result of any such event the Holders of Common Stock would be entitled to receive Reference Property for their Common Stock, upon conversion of the Securities after the
effective date of such event, the Share Cap will cease to apply and the Conversion Obligation and the Conversion Settlement Amount shall be based on the Applicable Conversion Rate and the Reference Property, in each case in accordance with the
Indenture (without giving effect to the Share Cap). If the transaction also constitutes a Fundamental Change that would lead to the payment of a make whole premium as set forth in Section 10.01(c) of the Indenture, if a Holder elects to convert
all or a portion of its Securities, such Holder shall receive a make whole premium upon conversion pursuant to Section 10.01(c) of the Indenture, subject to the terms and conditions set forth in such Section. 

 

	7.	Paying Agent, Conversion Agent, Bid Solicitation Agent and Registrar. 

 Initially, the Trustee shall act as Paying Agent, Conversion Agent and Registrar. The Company may appoint and change any Paying Agent, Conversion Agent or Registrar without notice, other than notice to
the Trustee. The Company or any of its Subsidiaries or any of their Affiliates may act as Paying Agent, Conversion Agent or Registrar. 
  

	8.	Denominations; Transfer; Exchange. 

 The Securities are in fully registered form, without coupons, in denominations of $1,000 of principal amount and integral multiples of $1,000. A Holder may transfer or exchange Securities in accordance
with the Indenture. The Registrar may require a Holder, among other things, to furnish appropriate endorsements and transfer documents and to pay any taxes and fees required by law or permitted by the Indenture. The Registrar need not transfer or
exchange any Securities in respect of which a Fundamental Change Repurchase Notice has been given and not withdrawn (except, in the case of a Security to be purchased in part, the portion of the Security not to be purchased). 

 

	9.	Persons Deemed Owners. 

Except as otherwise provided in the Indenture, the registered Holder of this Security will be treated as the owner of this Security for
all purposes. 
  

	10.	Unclaimed Money or Securities. 

 The Trustee and the Paying Agent shall return to the Company upon written request any money or securities held by them for the payment of any amount with respect to the Securities that remains unclaimed
for one year, subject to applicable abandoned property law. After return to the Company, Holders entitled to the money or securities must look to the Company for payment as general creditors unless an applicable abandoned property law designates
another person. 

  
 A-9

	11.	Amendment; Waiver. 

Subject to certain exceptions set forth in the Indenture, (a) the Indenture or the Securities may be amended with the written
consent of the Holders of at least a majority in aggregate principal amount of the outstanding Securities and (b) certain Events of Defaults may be waived with the written consent of the Holders of a majority in aggregate principal amount of
the outstanding Securities. Subject to certain exceptions set forth in the Indenture, without the consent of any Securityholder, the Company and the Trustee may amend the Indenture or the Securities (i) to add guarantees with respect to the
Securities or secure the Securities, (ii) to conform as necessary, the Indenture and this Security to the “Description of the Notes” as set forth in the Offering Memorandum, (iii) to add to the covenants of the Company for
the benefit of the Holders of Securities, (iv) to surrender any right or power conferred upon the Company in the Indenture, (v) to provide for the assumption by a successor company of the Company’s obligations to the Holders of
Securities in the case of a merger, consolidation, sale conveyance, transfer, sale or lease as provided under the Indenture, (vi) to comply with the requirements of the SEC in order to effect or maintain the qualification of the Indenture under
the TIA, (vii) to cure any ambiguity or to correct or supplement any provision in the Indenture which may be inconsistent with any other provision in the Indenture, (viii) to make other changes to the Indenture or forms or terms of the
Securities so long as no such change individually or in the aggregate with all other such changes has or will have a material adverse effect on the interests of the Holders of the Securities, (ix) to establish the form of Securities
substantially in the form of Exhibit A to the Indenture, (x) to evidence and provide for the acceptance of the appointment under the Indenture of a successor Trustee in accordance with the terms of the Indenture, (xi) to increase the
Applicable Conversion Rate and (xii) to provide for the right of the Holders of the Securities to convert any Security, including following any Merger Event, and the obligation of the Company to repurchase the Securities in connection with any
Fundamental Change. 
  

	12.	Defaults and Remedies. 

As set forth in the Indenture, subject to certain exceptions, if any Event of Default with respect to Securities shall occur and be
continuing, the principal amount of the Securities and any accrued and unpaid Interest and any accrued and unpaid Additional Amounts on all the Securities may be declared due and payable in the manner and with the effect provided in the Indenture.

  

	13.	Trustee Dealings with the Company. 

 Subject to certain limitations imposed by the TIA, the Trustee under the Indenture, in its individual or any other capacity, may become the owner or pledgee of Securities and may otherwise deal with and
collect obligations owed to it by the Company or its Affiliates and may otherwise deal with the Company or its Affiliates with the same rights it would have if it were not Trustee. 

 

	14.	Calculations in Respect of Securities. 

 Except as otherwise provided in the Indenture, the Company or its agents shall be responsible for making all calculations called for under the Securities including, but not limited to, determination of
the market prices for the Securities and of the Common Stock and any Additional Amounts accrued on the Securities. Any calculations made in good faith and without 

  
 A-10

 
manifest error shall be final and binding on Holders of the Securities. The Company or its agents shall be required to deliver to the Trustee a schedule of its calculations and the Trustee shall
be entitled to conclusively rely upon the accuracy of such calculations without independent verification. 
  

	15.	No Recourse Against Others. 

 A director, officer, employee or shareholder, as such, of the Company shall not have any liability for any obligations of the Company under the Securities or the Indenture or for any claim based on, in
respect of or by reason of such obligations or their creation. By accepting a Security, each Securityholder waives and releases all such liability. The waiver and release are part of the consideration for the issue of the Securities. 

 

	16.	Authentication. 

 This
Security shall not be valid until an authorized signatory of the Trustee manually signs the Trustee’s Certificate of Authentication on the other side of this Security. 

 

	17.	Abbreviations. 

Customary abbreviations may be used in the name of a Securityholder or an assignee, such as TEN COM (=tenants in common), TEN ENT
(=tenants by the entireties), JT TEN (=joint tenants with right of survivorship and not as tenants in common), CUST (=custodian) and U/G/M/A (=Uniform Gift to Minors Act). 

 

	18.	Governing Law. 

 THE LAWS
OF THE STATE OF NEW YORK SHALL GOVERN THE INDENTURE AND THIS SECURITY, WITHOUT GIVING EFFECT TO THE CONFLICT OF LAWS RULES THEREOF. 
  

	19.	Copy of Indenture. 

 The
Company shall furnish to any Securityholder upon written request and without charge a copy of the Indenture which has in it the text of this Security in larger type. Requests may be made to: 

DFC Global Corp. 

1436 Lancaster Avenue 
 Berwyn, PA 19312 
 Attn: Randy Underwood 

Facsimile: (610) 296-7844 

  
 A-11

							
	ASSIGNMENT FORM	  		  	CONVERSION NOTICE	  	
		
	To assign this Security, fill in the form below:	  	To convert this Security, check the box [    ]
		
	I or we assign and transfer this Security to	  	To convert only part of this Security, state the principal
	  
	  		  	amount to be converted (which must be $1,000 or an
	  
	  		  	integral multiple of $1,000):
	(Insert assignee’s soc. sec. or tax ID no.)	  		  	
	  
	  		  	If you want the stock certificate made out in another person’s
	  
	  		  	name fill in the form below:
	  
	  		  	  
	  	
	(Print or type assignee’s name, address and zip code)	  	  
	  	
		  	(Insert the other person’s soc. sec. tax ID no.)
			
		  	  
	  	
	and irrevocably appoint	  	  
	  	
	                            
agent to transfer this Security on the books of the	  	  
	  	
	Company. The agent may substitute another to act for him.	  	  
	  	
		  	  
	  	
		  	(Print or type other person’s name, address and zip code)

  

									
	Date:	  		  	Your Signature:	  	  
	  	
		
	  
	  	
		
	(Sign exactly as your name appears on the other side of this Security)	  	

  

					
	
	Signature Guaranteed
	
	  

	
	Participant in a Recognized Signature
	
	Guarantee Medallion Program
		
	By:	 	  

		 	Authorized Signatory

  
 A-12

 SCHEDULE OF INCREASES AND DECREASES 

OF GLOBAL SECURITY 
 Initial
Principal Amount of Global Security:
                                        

 ($        ). 
  

									
	 Date
	  	Amount of
Increase in
Principal
Amount of
Global Security	  	Amount of
Decrease in
Principal
Amount of
Global Security	  	Principal
Amount of
Global Security
After Increase or
Decrease	  	Notation by
Registrar or
Security
Custodian
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	

  
 A-13

 EXHIBIT B 
 [FORM OF FACE OF CERTIFICATED SECURITY] 
 THE SECURITY EVIDENCED BY THIS
CERTIFICATE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT OF 1933”), OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, EXCEPT AS SET FORTH IN THE FOLLOWING TWO
SENTENCES. EACH PURCHASER OF THIS NOTE IS HEREBY NOTIFIED THAT THE SELLER OF THIS NOTE MAY BE RELYING ON THE EXEMPTION FROM THE PROVISIONS OF SECTION 5 OF THE SECURITIES ACT OF 1933 PROVIDED BY RULE 144A THEREUNDER. BY ACQUISITION HEREOF OR A
BENEFICIAL INTEREST HEREIN, THE HOLDER: 
 (1) REPRESENTS THAT IT IS A “QUALIFIED INSTITUTIONAL BUYER” AS DEFINED IN
RULE 144A UNDER THE SECURITIES ACT OF 1933; 
 (2) AGREES THAT IT WILL NOT PRIOR TO THE DATE ONE YEAR, OR SUCH SHORTER PERIOD OF
TIME AS PERMITTED BY RULE 144 UNDER THE SECURITIES ACT OR ANY SUCCESSOR PROVISION THEREUNDER, AFTER THE LAST DATE OF ORIGINAL ISSUANCE OF THE 3.25% SENIOR CONVERTIBLE NOTES DUE 2017 OF DFC GLOBAL CORP. (THE “COMPANY”) RESELL OR OTHERWISE
TRANSFER THE SECURITY EVIDENCED HEREBY OR ANY COMMON STOCK THAT MAY BE ISSUABLE UPON CONVERSION OF SUCH SECURITY EXCEPT (A) TO THE COMPANY OR ANY SUBSIDIARY THEREOF, (B) TO A PERSON IT REASONABLY BELIEVES IS A QUALIFIED INSTITUTIONAL BUYER
IN COMPLIANCE WITH RULE 144A UNDER THE SECURITIES ACT OF 1933, (C) PURSUANT TO A REGISTRATION STATEMENT WHICH HAS BEEN DECLARED EFFECTIVE UNDER THE SECURITIES ACT OF 1933 AND THAT CONTINUES TO BE EFFECTIVE AT THE TIME OF SUCH TRANSFER OR
(D) PURSUANT TO ANY OTHER EXEMPTION FROM THE REGISTRATION REQUIREMENTS UNDER THE SECURITIES ACT, INCLUDING UNDER RULE 144, IF AVAILABLE, SUBJECT (IN THE CASE OF CLAUSE (D)) TO THE COMPANY’S AND THE TRUSTEE’S RIGHT PRIOR TO ANY SUCH
TRANSFER, TO REQUIRE THE DELIVERY OF AN OPINION OF COUNSEL, CERTIFICATIONS AND/OR OTHER INFORMATION SATISFACTORY TO THE COMPANY AND THE TRUSTEE; AND 
 (3) AGREES THAT IT WILL DELIVER TO EACH PERSON TO WHOM THE SECURITY EVIDENCED HEREBY IS TRANSFERRED PURSUANT TO CLAUSE 2(B) OR CLAUSE 2(D) (EXCEPT A TRANSFER PURSUANT TO RULE 144 UNDER THE SECURITIES ACT
ABOVE) A NOTICE SUBSTANTIALLY TO THE EFFECT OF THIS LEGEND. 

  
 B-1

 DFC Global Corp. 
 3.25% Senior Convertible Notes Due 2017 
  

			
	CUSIP: [—]	  	
	ISSUE DATE: April [—], 2012	  	Principal Amount: $[—]

 No. 
 DFC Global Corp., a Delaware corporation, promises to pay to [—] or registered assigns, the principal amount of
[—] Dollars, on April 15, 2017. 
 Interest Rate: 3.25% per year. 

Interest Payment Dates: April 15 and October 15 of each year, commencing October 15, 2012. 

Interest Record Date: April 1 and October 1 of each year. 
 Reference is hereby made to the further provisions of this Security set forth on the reverse side of this Security, which further provisions shall for all purposes have the same effect as if set forth at
this place. 

  
 B-2

 IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed. 

 

							
	Dated:                     	 		 	DFC Global Corp.
				
		 		 	By:	 	  

				
		 		 	Title:	 	  

  
 B-3

			
	 TRUSTEE’S CERTIFICATE OF AUTHENTICATION
                                   
      ,
 U.S. Bank National Association as Trustee, certifies that this is one of the Securities referred to in the
within-mentioned Indenture.

		
	By	 	  

		 	Authorized Signatory

 Dated:
                     

  
 B-4

 [FORM OF REVERSE OF CERTIFICATED SECURITY IS IDENTICAL TO EXHIBIT A] 

  
 B-5

 EXHIBIT C 
 DFC Global Corp. 
 3.25% Senior Convertible Notes due 2017 

Transfer Certificate 
 In connection with any transfer of any of the Securities within the period prior to the expiration of the holding period applicable to the sales thereof under Rule 144(k) under the Securities
Act of 1933, as amended (the “Securities Act”) (or any successor provision), the undersigned registered owner of this Security hereby certifies with respect to $         principal amount of
the above-captioned Securities presented or surrendered on the date hereof (the “Surrendered Securities”) for registration of transfer, or for exchange or conversion where the securities issuable upon such exchange or conversion are
to be registered in a name other than that of the undersigned registered owner (each such transaction being a “transfer”), that such transfer complies with the restrictive legend set forth on the face of the Surrendered Securities
for the reason checked below: 
  

	 	[    ]	A transfer of the Surrendered Securities is made to the Company or any subsidiaries; or 

 

	 	[    ]	The transfer of the Surrendered Securities is pursuant to an effective registration statement under the Securities Act; or 

 

	 	[    ]	The transfer of the Surrendered Securities complies with Rule 144A under the Securities Act; or 

 

	 	[    ]	The transfer of the Surrendered Securities is pursuant to Rule 144 under the Securities Act and each of the conditions set forth in such rule have been met;

 and unless the box below is checked, the undersigned confirms that, to the undersigned’s knowledge, such Securities are
not being transferred to an “affiliate” of the Company as defined in Rule 144 under the Securities Act (an “Affiliate”). 
  

	 	[    ]	The transferee is an Affiliate of the Company. 

  

					
	DATE:	 		 	  

		 		 	Signature(s)

  
 C-1

 (If the registered owner is a corporation, partnership or fiduciary, the title of the person signing on
behalf of such registered owner must be stated.) 
  

			
	Signature Guaranteed
	
	  

	Participant in a Recognized Signature
		
	Name:	 	
		
	Address:	 	
		
	Tax I.D.:	 	

  
 C-2

 EXHIBIT D 
 DFC GLOBAL CORP. 
 NOTICE OF OCCURRENCE 

OF FUNDAMENTAL CHANGE 

[DATE] 
 To the Holders of the
3.25% Senior Convertible Notes Due 2017 
 (the “Securities”) issued by DFC Global Corp.: 

DFC Global Corp. (the “Company”) by this written notice hereby notifies you, pursuant to Section 3.02 of that certain Indenture
(the “Indenture”), dated as of April 16, 2012 between the Company and U.S. Bank National Association, that a Fundamental Change (as such term and other capitalized terms used herein and not otherwise defined herein is defined
in the Indenture) as described below has occurred. Included herewith is the form of Fundamental Change Repurchase Notice to be completed by you if you wish to have your Securities repurchased by the Company. 

1. Fundamental Change: [Insert brief description of the Fundamental Change and the date of the occurrence thereof.] 

2. Date by which Fundamental Change Repurchase Notice must be delivered by you to Paying Agent in order to have your Securities
repurchased: 
 3. Fundamental Change Repurchase Date: 
 4. Fundamental Change Repurchase Price: 
 5. Paying Agent and Conversion Agent:
[NAME] [ADDRESS] 
 6. Applicable Conversion Rate: To the extent described in Item 7 below, each $1,000 principal amount of
the Securities is convertible into [insert number of shares] shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), subject to adjustment. [Insert description of any applicable make-whole
pursuant to Section 10.01(c) of the Indenture.] 
 7. The Securities as to which you have delivered a Fundamental Change
Repurchase Notice to the Paying Agent may be converted if they are otherwise convertible pursuant to Article 10 of the Indenture and the terms of the Securities only if you withdraw such Fundamental Change Repurchase Notice pursuant to the
terms of the Indenture. Subject to Section 10.01 of the Indenture, you may be entitled to have your Securities converted into cash and shares of the Company’s common stock, if any: 

(i) prior to October 15, 2016, during any calendar quarter of the Company commencing after June 30, 2012 (and
only during such calendar quarter) if the Closing Sale Price (as defined in the Indenture) of the Company’s common stock for at least 20 Trading Days during the period of 30 consecutive Trading Days ending on the last Trading Day (as defined in
the Indenture) of the immediately preceding calendar quarter was more than 130% of the Applicable Conversion Price (as defined in the Indenture) on such last Trading Day; 

  
 D-1

 (ii) during the five business days immediately following any five
consecutive Trading Day period in which the Trading Price (as defined in the Indenture) per $1,000 original principal amount of the Securities for each day of that period was less than 98% of the product of the Closing Sale Price of the Common
Stock and the Applicable Conversion Rate (as defined in the Indenture) on each such day; 
 (iii) on or after
October 15, 2016; or 
 (iv) upon the occurrence of certain specified corporate transactions described in
the Indenture. 
 8. The Securities as to which you have delivered a Fundamental Change Repurchase Notice must be surrendered by
you (by effecting book entry transfer of the Securities or delivering Certificated Securities, together with necessary endorsements, as the case may be) to [Name of Paying Agent] at [insert address] in order for you to collect the Fundamental Change
Repurchase Price. 
 9. The Fundamental Change Repurchase Price for the Securities as to which you have delivered a Fundamental
Change Repurchase Notice and not withdrawn such Notice shall be paid, subject to receipt of funds and/or securities by the Paying Agent, promptly following the later of the Business Day immediately following such Fundamental Change Repurchase Date
and the date you deliver such Securities to [Name of Paying Agent]. 
 10. In order to have the Company repurchase your
Securities, you must deliver the Fundamental Change Repurchase Notice, duly completed by you with the information required by such Fundamental Change Repurchase Notice (as specified in Section 3.02 of the Indenture) and deliver such Fundamental
Change Repurchase Notice to the Paying Agent at any time until 5:00 p.m. (New York City Time) on the Business Day immediately preceding the Fundamental Change Repurchase Date. 
 11. In order to withdraw any Fundamental Change Repurchase Notice previously delivered by you to the Paying Agent, you must deliver to the Paying Agent, by 5:00 p.m. (New York City time) on the Business
Day immediately preceding the Fundamental Change Repurchase Date, a written notice of withdrawal specifying (i) the certificate number, if any, of the Securities in respect of which such notice of withdrawal is being submitted, (ii) the
principal amount of the Securities in respect of which such notice of withdrawal is being submitted and (iii) if you are not withdrawing your Fundamental Change Repurchase Notice for all of your Securities, the principal amount of the
Securities which still remain subject to the original Fundamental Change Repurchase Notice. 
 12. Unless the Company defaults
in making the payment of the Fundamental Change Repurchase Price owed to you, Interest and any Additional Amounts on your Securities as to which you have delivered a Fundamental Change Repurchase Notice shall cease to accrue on and after the
Fundamental Change Repurchase Date. 

  
 D-2

 13. CUSIP Number: [—] 

DFC Global Corp. 

  
 D-3

 SCHEDULE I 
 The following table sets forth the Stock Prices and the make whole premium per $1,000 principal amount of Securities. 
  

 

																																													
	 	 	Stock Price	 
												
	 Effective Date
	 	$	16.53	  	 	$	17.50	  	 	$	20.00	  	 	$	22.50	  	 	$	25.00	  	 	$	30.00	  	 	$	35.00	  	 	$	40.00	  	 	$	50.00	  	 	$	60.00	  	 	$	70.00	  
	 April 16, 2012
	 	 	13.5998	  	 	 	12.0406	  	 	 	9.0040	  	 	 	6.9300	  	 	 	5.4650	  	 	 	3.6027	  	 	 	2.5169	  	 	 	1.8293	  	 	 	1.0342	  	 	 	0.6044	  	 	 	0.3476	  
	 April 15, 2013
	 	 	13.5998	  	 	 	11.5669	  	 	 	8.4092	  	 	 	6.3032	  	 	 	4.8545	  	 	 	3.0828	  	 	 	2.1012	  	 	 	1.5047	  	 	 	0.8391	  	 	 	0.4867	  	 	 	0.2763	  
	 April 15, 2014
	 	 	13.5998	  	 	 	11.0099	  	 	 	7.6703	  	 	 	5.5140	  	 	 	4.0864	  	 	 	2.4413	  	 	 	1.6016	  	 	 	1.1248	  	 	 	0.6208	  	 	 	0.3594	  	 	 	0.2015	  
	 April 15, 2015
	 	 	13.5998	  	 	 	10.3776	  	 	 	6.7321	  	 	 	4.4869	  	 	 	3.0903	  	 	 	1.6400	  	 	 	1.0066	  	 	 	0.6902	  	 	 	0.3843	  	 	 	0.2257	  	 	 	0.1252	  
	 April 15, 2016
	 	 	13.5998	  	 	 	10.3122	  	 	 	5.4573	  	 	 	3.0163	  	 	 	1.6873	  	 	 	0.6203	  	 	 	0.3240	  	 	 	0.2225	  	 	 	0.1346	  	 	 	0.0826	  	 	 	0.0458	  
	 April 15, 2017
	 	 	13.5998	  	 	 	10.2466	  	 	 	3.1038	  	 	 	0.0000	  	 	 	0.0000	  	 	 	0.0000	  	 	 	0.0000	  	 	 	0.0000	  	 	 	0.0000	  	 	 	0.0000	  	 	 	0.0000

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00202-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00202-of-00352.parquet"}]]